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Abstract  
 
The aim of the project was to develop a novel method of protein labelling based 
upon split proteins. The proposed method would label a target protein via a small 
peptide sequence expressed at its N-terminus that is selectively targeted by its partner 
peptide carrying a tag. Split proteins were considered effective for a proximity-assisted 
labelling method because of the specificity of the peptide fragments for one another, 
and the extensive background literature available.  
 The project has studied bovine ribonuclease A (RNase A), chymotrypsin 
inhibitor 2 (CI2) and calbindin D9k, three well-documented split proteins. In each 
instance the sequence was divided into two peptides that were synthesized by Fmoc-
SPPS, with the exception of the S-protein of RNase A which was commercially 
available. Conformationally-assisted ligation with a peptide N-(Me)sulfonamide was 
initially explored using literature precedent, and the affinity of the interaction at this site 
was also measured by bio-layer interferometry (BLI) or UV/VIS spectroscopy. With 
limited success in attempts with both RNase A and CI2, calbindin D9k was chosen 
because of the high affinity reported in the literature between its peptides. Their 
interaction was assessed by BLI and their secondary structure in the presence of either 
calcium or a chelator was compared by circular dichroism. In this system 
conformationally-assisted ligation was observed along with proximity-assisted acyl 
transfer of a small peptide tag, with promising results. The peptides were also observed 
to enable click chemistry, when synthesized as a peptide with C-terminal azide and a 
peptide with N-terminal alkyne, with no requirement for a copper additive. 
 The results described are successful applications of conformationally-assisted 
chemical reactions, enabled by the specificity and high affinity imparted by the split 
protein peptides. The reactions are chemoselective and active at biologically relevant 
concentrations, and are encouraging for the future development of a novel protein 
labelling method. 
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1. Introduction 
1.1 Proximity-assisted protein labelling with split proteins 
1.1.1 Overview 
 The aim of the project was to develop a novel method of protein labelling using 
the peptides of a split protein and a proximity-assisted chemical reaction. These 
peptides would provide specificity, with one peptide selectively targeting the other 
expressed on the protein of interest. Ideally the smallest peptide possible would be 
covalently attached to the target protein in order to minimally impact upon the target 
protein’s activity. Split proteins were considered effective for a proximity-assisted 
labelling method because of the specificity of the peptide fragments for one another, 
their widespread use and the extensive background literature available. In addition to 
the flexibility in choice of small synthetic dyes or tags to that most suited for the 
technique used, such a labelling method would combine the selectivity of split proteins 
with the bioorthogonality of a chemical reaction. 
 
1.1.2 Background 
One of the most powerful and commonly-used methods of labelling involves 
expression of green fluorescent protein (GFP), a technique that has revolutionized the 
field of protein labelling (Tsien, 1998). However its size, 238 residues and ~ 27 kDa, 
has led to the search for alternative methods with smaller components to minimally 
interfere with the activity of the target protein (Thomas and Maule, 2000). There are 
many covalent tags that bind based on chemical reactions with residues within the target 
protein, Cys being particularly popular because of its high nucleophilicity. Cys residues 
occur rarely in nature, just 1.79 % in nuclear proteins (Fukuchi and Nishikawa, 2001), 
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and those present are typically buried or forming disulfide bonds rather than accessible 
at the surface. As such site-directed mutagenesis can be used to introduce a Cys to allow 
for site-specific labelling, though this Cys residue must be maintained in its reduced 
form and the effect of altering the sequence on the folding and activity of the protein 
verified. This method is better suited to in vitro labelling with purified proteins than to 
in vivo labelling due to a lack of specificity, though one method generates specificity by 
introducing a tetraCys motif into GFP for in vivo FLASH labelling (Tsien, 1998). The 
suggested split protein approach would overcome selectivity problems in a cellular 
environment by the affinity and specificity of the split protein peptide partners for one 
another. The proposed method would involve the expression of the acceptor peptide at 
the N-terminus of a protein. The termini of a protein are typically accessible, potentially 
due to their charged nature, their availability for post-translational modification, or due 
to thermodynamic and kinetic factors (Jacob and Unger, 2007). A number of labelling 
methods use the termini of the target protein, for example combining native chemical 
ligation at the N-terminus with oxime ligation at the C-terminus (Yi et al., 2011) and 
dual-labelling by expressed protein ligation (Cotton and Muir, 2000).  
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Labelling method Category Signature feature 
HaloTag (Los et al., 2008) 
Enzyme-based 
 
Chloroalkane linker with 
fluorescent tag 
Sortase (Tsukiji and 
Nagamune, 2009) 
Enzyme-based 
 
Recognises LPXTG motif 
FLAG-tag (Nonaka et al., 
2009) 
Affinity-based 
 
Recognised by Ni(II)-DpaTyr 
probe 
CA6D4  tag (Nonaka et 
al., 2010) 
Affinity-based 
 
α-Chloroacetyl functionality of 
probe 
Affibody (Holm et al., 
2009) 
Affinity-based 
 
Acrylamide modification binds 
nucleophilic side chains 
SpyTag-SpyCatcher 
(Zakeri et al., 2012) 
Affinity-based 
 
Spontaneous isopeptide bond 
formation 
Coiled-coils (Wang et al., 
2014) 
Affinity-based 
 
Thioether bond formation with 
α-chloroacetyl 
 
Table 1.1: Overview of selected proximity-assisted protein labelling methods 
 
Methods investigating proximity-assisted chemical reactions to avoid problems 
with selectivity were explored and are summarized in Table 1.1 and Figure 1.1. 
Enzymes proved to be popular, using labels such as in the HaloTag approach (Los et al., 
2008). The HaloTag is a modified haloalkane dehalogenase that covalently binds to 
ligands consisting of a chloroalkane linker and a fluorescent tag, compatible with in 
vivo imagine (Kosaka et al., 2009). Though this area of protein labelling has increased 
specificity the tags involved can still be quite large. A popular method is that of sortase 
labelling, based on its recognition of the short peptide sequence LPXTG (Tsukiji and 
Nagamune, 2009, Antos et al., 2009, Yamamura et al., 2011). Methods such as this 
involve more discrete components, but still require the addition of enzymes. 
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 In turn this work led to the development of affinity labelling techniques, 
spontaneous reactions that do not require the addition of enzymes. Proximity-directed 
acyl transfer for protein labelling explored the use of the FLAG-tag (DYKDDDDK) 
(Nonaka et al., 2009). Until then labelling a protein with the genetically-encoded 
FLAG-tag required the use of FLAG-tag antibodies, their cost and size often making 
their application problematic. This group pioneered the development of the Ni(II)-
DpaTyr probe selective for part of the FLAG-tag sequence, modified to contain a 
thioester (Figure 1.1a). When the probe and tag interact and form a binding complex the 
thioester is brought into close proximity with a Lys side chain of the FLAG-tag, 
inducing acyl transfer to form a covalent bond. This group later went on to label G-
protein coupled receptors (GPCR) containing the tag CAAAAAADDDD (CA6D4) with 
a Zn(II)-DpaTyr probe, the α-chloroacetyl modification of the probe reacting with the 
Cys of the tag (Nonaka et al., 2010). The FLAG-tag has previously been used to label 
GFP by way of protein trans-splicing with split inteins (Giriat and Muir, 2003). In an 
effort to overcome the limitation in some cases of antibody affinity an affibody, a non-
immunoglobulin scaffold, was used to induce proximity-assisted covalent bond 
formation for cell surface labelling of the Z domain of Staphylococcous aureus Protein 
A (ZSPA) (Holm et al., 2009). Using a modified affibody with a weak electrophile, 
acrylamide, near the binding site allows for covalent bond formation with nucleophilic 
side chains in the target protein, only doing so upon interaction with the target protein 
(Figure 1.1b). An impressive example of affinity labelling is the SpyTag-SpyCatcher 
method where the split protein fibronectin-binding protein FbaB of Streptococcus 
pyogenes generates two components that rapidly form an amide bond (Zakeri et al., 
2012). The second immunoglobulin-like collagen adhesion domain (CnaB2) of this 
protein is split at the CnaB2 triad (Lys31, Asp117 and Glu77) to produce a 13-mer 
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peptide termed SpyTag and its 113-mer protein partner SpyCatcher. These split protein 
fragments undergo rapid covalent bond formation, with a spontaneous isopeptide bond 
forming between Lys31 and Asp117 (Figure 1.1c). Coiled-coils have been shown to 
combine the stability of proteins with the cost-effective nature of peptide synthesis 
(Chao et al., 1998, Thomas et al., 2013, Sanchez-Ruiz et al., 2013, Ryadnov and 
Woolfson, 2007). In a recent example protein labelling is brought about by a proximity-
assisted reaction between coiled-coil peptides, one with a Cys and the other with an α-
chloroacetyl modification (Wang et al., 2014). The peptides were 21 residues in length, 
and the covalent bond formation upon assembly of coiled-coil pairs demonstrated in 
vitro labelling in addition to labelling of proteins at the cell surface. However one 
concern with the use of coiled-coils in a labelling approach is the potential for 
oligomerisation of the peptides.  
 A detailed review on the use of chemical tags in fluorescence imaging can be 
found by Wombacher and Cornish (Wombacher and Cornish, 2011). 
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Figure 1.1: Overview of selected proximity-assisted protein labelling methods 
a. FLAG-tag approach, with Ni(II)-DpaTyr probe. Adapted from Nonaka et al, 2009. 
b. Affibody approach, with nucleophilic side chain recognised by acrylamide. Adapted from 
Holm et al, 2009. 
c. Isopeptide bond formation in the SpyTag-SpyCatcher approach. Adapted from Zakeri et al, 
2012. 
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1.2 Split proteins 
1.2.1 Introduction to split proteins 
Split proteins are those that are separable into peptides that can reconstitute via a 
non-covalent interaction with a high and specific affinity, reconstitution being well-
studied in a number of systems as reviewed by Linse and colleagues (Carey et al., 
2007). Split proteins are commonly used in the fields of cell and chemical biology, 
particularly the use of split inteins (Mootz, 2009, Shah and Muir, 2014). Split inteins 
have found uses in techniques for peptide cyclization (Scott et al., 1999), along with the 
preparation of semisynthetic proteins by protein trans-splicing (Muralidharan and Muir, 
2006, Paulus, 2000, Giriat and Muir, 2003) and expressed protein ligation (Muir et al., 
1998, Severinov and Muir, 1998, Muir, 2003) (Scheme 1.2). As with the proposed split 
protein approach, the affinity of the split intein fragments for one another allows for a 
specific and localised reaction (Shi and Muir, 2005). Inteins are internal protein 
domains that are able to excise themselves out of a precursor protein. This autocatalytic 
reaction was first identified from discrepancies between the size of mature yeast 
vacuolar ATPase and that predicted from its gene sequence (Hirata et al., 1990). In the 
development of split intein-based approaches, the mechanism by which naturally-split 
inteins associate has recently been elucidated (Shah and Muir, 2014). Muir and 
colleagues found that just the N-intein fragment is partially folded while the C-intein 
fragment is disordered, and that the disordered section is key to their interaction via a 
capture step that forms an intermediate. This subsequently collapses into the functional 
conformation, the native structure with the unique intein fold. 
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Scheme 1.2: Preparation of semisynthetic proteins by expressed protein ligation and protein trans-
splicing 
a. Expressed protein ligation involves a recombinant protein expressed N-terminal to an intein, complete 
with chitin binding domain (CBD) for purification, that is cleaved upon treatment with thiols. The 
recombinant protein thioester is then free to undergo native chemical ligation with a synthetic peptide 
containing an N-terminal Cys. 
b. Protein trans-splicing uses a split-intein separated into N- and C-pieces that associate non-covalently 
to effect protein splicing, only doing so upon association with one another. 
Adapted from Muir, 2003. 
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Split proteins play an important role in protein-fragment complementation assay, 
with the yeast two-hybrid system being a classic example. Yeast Gal4 is split into two 
domain proteins, both of which are essential for LacZ transcription. LacZ acts as a 
reporter gene, and the assayed proteins are fused to each of the Gal4 domains. If these 
proteins interact, Gal4 is reconstituted and thus LacZ is transcribed (Fields and Song, 
1989). The split-ubiquitin two-hybrid system overcomes the solubility issues associated 
with the yeast two-hybrid system, and allows for the assay of interactions between 
insoluble membrane proteins (Stagljar et al., 1998). This is based on the development of 
split-ubiquitin for assaying in vivo protein interactions, where a reporter protein fused to 
the C-terminal ubiquitin fragment is cleaved upon reconstitution if the N-terminal 
ubiquitin fragment is present (Johnsson and Varshavsky, 1994). Additionally split-
tobacco etch virus (TEV) monitors the return of proteolytic activity upon interaction of 
fused proteins (Wehr et al., 2006). Reassembly of split-GFP was first reported with GFP 
fragments non-covalently associated with leucine zippers (Ghosh et al., 2000), paving 
the way for the use of GFP reconstitution in protein-fragment complementation assay. 
Variants of split-GFP used, in a form of protein-fragment complementation assay 
known as bimolecular fluorescence complementation, include self-complementing split-
GFP (Cabantous et al., 2005), split-superpositive GFP (Blakeley et al., 2012) and a 
tripartite split-GFP (Cabantous et al., 2013). It is important to note that the split proteins 
used in PCA do not reconstitute by way of their affinity for one another or their 
conformation, but solely upon interaction of their fused moieties. The study of split 
proteins as part of this project concentrates on the influence of their conformation on 
ligation.  
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As discussed earlier the balance between the size of the labelling components 
and their selectivity must be carefully considered. Split proteins would provide the 
specificity required, and would provide a regioselective template for a proximity-
assisted chemical reaction to join the peptides and label the protein. Many of the split 
proteins detailed in Table 1.2 have small acceptor fragments that are potentially ideal 
for covalent attachment to the target protein, those investigated as part of this project are 
highlighted. 
 
Table 1.2: A comparison of split protein peptide affinities and lengths 
Adapted from Carey et al, 2007. 	  
Protein 
Kd 
(nM) 
N-terminal 
peptide length 
(residues) 
C-terminal 
peptide length 
(residues) 
RNase A (Dwyer et al., 2001) 599 20 103 
Cytochrome C (Hantgan and Taniuchi, 1977) 300 53 51 
Thioredoxin (Holmgren, 1972) 6000 37 71 
Chymotrypsin inhibitor 2 (de Prat Gay et al., 
1994) 
40 39 25 
Monellin (Xue et al., 2004) 40 45 50 
Protein G B1 (Kobayashi et al., 1995) 9000 41 15 
Split ubiquitin (Müller and Johnsson, 2008) 7000 34 41 
Dihydrofolate reductase (Smith and 
Matthews, 2001) 
40 86 73 
Synechocytis sp. (Ssp) DnaE (Shi and Muir, 
2005, Wu et al., 1998) 
36 ± 12 123 36 
Calbindin D9k (Berggård et al., 2001) 0.003 43 32 
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1.2.2 Choice of split proteins 
The work detailed in the main results chapters is based on experiments involving 
bovine ribonuclease A (RNase A), chymotrypsin inhibitor 2 (CI2) and a calbindin D9k 
variant. Each of these split proteins and the reason for their choice is detailed in the 
remainder of this chapter and in the introduction for their individual results chapters. 
Briefly, RNase A was the first demonstration of protein reconstitution (Richards, 1958, 
Richards and Vithayathil, 1959) and has been extensively studied, providing a thorough 
profiling in the literature for us to draw upon. Like RNase A, CI2 is a classic protein for 
folding and structural studies and its sequence too has been optimised (de Prat Gay and 
Fersht, 1994). In addition to the large amounts of previously published work, both of 
these protein systems were demonstrated to perform conformationally-assisted ligation 
(Beligere and Dawson, 1999). After investigating both of these systems, we also turned 
to a calbindin D9k variant known in the literature for a strong affinity between its 
peptide fragments (Berggård et al., 2001) to attempt several conformationally-assisted 
chemical reactions. 
 
1.2.2.1  RNase A 
 The first split protein system under investigation in this project was RNase A. In 
1958 Frederic Richards demonstrated that subtilisin digestion of the 124 mer protein 
specifically produced two fragments of 20 and 104 residues termed the S-peptide and S-
protein, ‘S’ denoting subtilisin digestion, respectively (Figure 1.1). This was the first 
demonstrated example in the literature of reconstitution, showing that the S-peptide and 
S-protein interact non-covalently to form the complex RNase S to regenerate 
ribonuclease activity (Richards, 1958, Richards and Vithayathil, 1959). Subsequent 
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work involved identifying those residues necessary for reconstitution, identifying the 
fewest residues required and those with better binding affinity (Potts et al., 1962, Dwyer 
et al., 2001, Shoemaker et al., 1987). It was found that just the first fifteen residues of 
the S-peptide were required for successful interaction with the S-protein, notably of the 
importance of the Asp-Ser dipeptide at positions 14 and 15 respectively (Potts et al., 
1963). This was supported by the use of this 15-mer in the S-tag protein purification 
system as a carrier in fusion proteins with 20 fmol sensitivity of detection (Raines et al., 
2000). The subtilisin digestion-liberated fragments were also shown to ligate with 
conformational assistance, using the structure of the two components under folding 
conditions to form a native amide bond at the native Ala-Ser site (Beligere and Dawson, 
1999). 
RNase A is investigated as the proof of principle system for this work, making 
use of the extensive background literature and optimisation. Although the tag acceptor 
peptide, the S-protein, is potentially too large to feasibly be used in the final labelling 
approach, it is commercially available and the S-peptide fragment can be prepared 
synthetically. Once suitable conditions have been established in this system we can then 
turn our attention to other split protein candidates. 
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Figure 1.2: Structure of RNase A 
3D structure of bovine RNase A (PDB 2AAS) as determined by NMR spectroscopy (Santoro et al., 
1993). The S-peptide is coloured red and the S-protein coloured blue. 
 
	  
	  
Figure 1.3: Structure of CI2 
3D structure of barley CI2 (PDB 3CI2) as determined by NMR spectroscopy (Ludvigsen et al., 1991). 
CI2(20-59) is coloured red and CI2(60-83) is coloured blue. 
  
31	  
	  
1.2.2.2  CI2 
CI2 was also chosen as a model split protein to study. As detailed in Table 1.2 
its acceptor peptide is just 25 residues, preferable to the 104 residues in RNase A for 
potential use in the proposed method, and contains no Cys residues. It is a serine 
proteinase inhibitor consisting of 83 amino acid residues (Svendsen et al., 1980). The 
truncated protein was used in classic folding studies by the Fersht group (de Prat Gay et 
al., 1994, de Prat Gay and Fersht, 1994). This truncated form consists of 64 residues and 
was cleaved using cyanogen bromide (CNBr), selectively cleaving the peptide bond 
adjacent to the Met residue (Gross and Witkop, 1962), to generate CI2(1-39) and 
CI2(40-64) (Figure 1.2). The residue at position 40 is methionine, the only one in the 
sequence. The non-covalent re-association of CI2(1-39) and CI2(40-64) was 
demonstrated using circular dichroism (CD), fluorescence experiments and the 
inhibition of chymotrypsin (de Prat Gay and Fersht, 1994).  
CI2 has been the subject of a number of folding studies with the component 
peptides generated by CNBr cleavage. The first four residues of the α–helix in CI2(20-
59) play an important role in its stabilization (Elmasry and Fersht, 1994, de Prat Gay 
and Fersht, 1994) with the secondary and tertiary structure forming together during their 
association (de Prat Gay and Fersht, 1994). Conformationally-assisted ligation with 
these peptides was demonstrated, using the structure of the peptides under folding 
conditions to assist ligation (Beligere and Dawson, 1999). Remarkably, ligation was 
observed to take place not just with a Cys at the N-terminus of CI2(40-64) but with the 
native Met too (see Chapter 5). 
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1.2.2.3  Calbindin D9k 
The calbindin D9k split protein was also chosen (Figure 1.3). It is a member of 
the calmodulin superfamily of proteins, calcium-binding proteins that share a common 
EF-hand motif. An EF-hand is a helix-loop-helix calcium binding subdomain, and is 
named after the E and F helices from the C-terminal subdomain of parvalbumin 
(Kretsinger and Nockolds, 1973). Calmodulin (Chattopadhyaya et al., 1992) is probably 
the best known member of this family but other members include the aforementioned 
parvalbumin, calbindin D28k (Kojetin et al., 2006) and calbindin D9k (Svensson et al., 
1992). The 9k and 28k descriptions refer to the molecular weight, around 9 kDa and 28 
kDa respectively. Calbindin D9k is one of the smallest members of this family, is mainly 
expressed in mammalian enterocytes (Wasserman et al., 1992), and has two EF-hand 
subdomains that associate to form a 4-helix bundle. The first study of the individual EF-
hands of calbindin D9k used CNBr to cleave at a Met introduced in place of Pro43 in the 
connecting loop region (Finn et al., 1992). It is during this work that the Ser adjacent to 
the mutated Met43 residue and the associated problems are addressed. Cleavage with 
CNBr can generate a homoserine lactone from the iminolactone. A side reaction can 
take place if a Ser residue is adjacent, where the side chain of the Ser residue can attack 
the iminolactone to form a homoserine and an amide bond (Schroeder et al., 1969, 
Kaiser and Metzka, 1999, Corradin and Harbury, 1974, Proudfoot et al., 1989). This 
particular paper discusses methods to bypass this side reaction, and to reduce 
incomplete cleavage. The EF-hand peptides maintained structure after treatment with 
CNBr, demonstrating that the main contributor to their structure is the non-covalent 
forces between the peptides rather than the covalent bond between them. Stabilization 
of the peptides by calcium binding indicated that calcium coordination induces the 
preferred conformation for dimerization (Finn et al., 1992). Each EF-hand binds one 
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calcium ion, electrostatic interactions playing a key role in calcium coordination. In 
particular studies have shown that negatively charged residues at the binding site help 
(Linse et al., 1988), and mutants where surface carboxylates are replaced with amides 
demonstrated the role of protein surface charges (Linse et al., 1991). Fragment 
complementation studies involving the cleavage of calbindin D9k between its two EF-
hand subdomains, EF1 and EF2, established a Kd of 3 pM (Berggård et al., 2001). As 
such we were keen to investigate the potential of this protein for the proposed 
experiments (see Chapter 6).  
 
	  
Figure 1.4: Structure of calbindin D9k 
Structure of calbindin D9k as determined by X-ray crystallography (Svensson et al., 1992). EF1 is 
coloured red and EF2 is coloured blue, and the two coordinated calcium ions are shown in green. 
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1.3 The development of conformationally-assisted chemical 
reactions 
 Several of the labelling methods discussed earlier in this chapter are based upon 
proximity-induced chemical reactions. In the proposed method the split protein would 
provide the proximity, so to establish the suitability of the reaction site in each of the 
chosen split protein systems the first experiments involved ligating the peptide at this 
site. Though these were conformationally-assisted ligations we must begin by first 
introducing the technique from which this form of ligation stemmed, and that is native 
chemical ligation. 
 
1.3.1 Native chemical ligation 
 Native chemical ligation (NCL) involves the chemoselective coupling of two 
unprotected peptides, one with an N-terminal cysteine and the other with a C-terminal 
thioester, to form a native amide bond (Dawson et al., 1994) (Scheme 1.3). It has 
proven to be a very powerful technique providing synthetic access to proteins too large 
for solid phase peptide synthesis (SPPS) (Kent, 2009). Thioester peptide ligation to N-
terminal cysteine peptides has been successfully demonstrated with most residues at the 
C-terminus, with only β–branched (Ile, Thr and Val) and Pro ligating slowly (Hackeng 
et al., 1999). The ability of split proteins that perform NCL to also undergo 
conformationally-assisted ligation was investigated during later stages of the project. 
Part of the generality of NCL is the use of denaturing conditions to overcome the poor 
solubility and aggregation properties of many peptides that can form structure in 
aqueous solutions, whereas conformationally-assisted ligation exploits peptide structure 
under folding conditions. It is a form of ligation that uses the structure and conformation 
35	  
	  
possessed by peptides to encourage ligation to occur, meaning that under folding 
conditions the C-terminus of one peptide will be in close proximity to the N-terminus of 
the other.  
 
 
 
 
 
Scheme 1.3: Proposed mechanism for native chemical ligation 
Two unprotected peptides, one with a C-terminal thioester and the other with an N-terminal Cys, couple 
chemoselectively and form a native amide bond at neutral pH. The first step involves the nucleophilic 
attack of the α–carboxyl group of peptide 1 by the Cys side chain of peptide 2, forming a thioester-linked 
intermediate. This intermediate then rearranges and through an SàN acyl shift the peptides are linked by a 
native amide bond. 
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1.3.2 Conformationally-assisted ligation 
 Conformationally-directed chemical reactions have long been a subject of 
interest. They differ from NCL in that they do not necessarily require a Cys at the 
reaction site, but rely on the conformation of the components to bring the reacting site 
termini into close proximity. This proximity raises the effective concentration of the 
reactive components (Way, 2000), and induces ligation.  
 Early work with cytochrome c showed that component fragments are able to 
form complexes echoing the conformation and, to an extent, the activity of the native 
protein, particularly if the fragments are sequential (Wallace and Proudfoot, 1987, 
Proudfoot et al., 1989, Wallace et al., 1986). The reaction is catalysed by the proximity 
of the peptides that increases the effective concentration of the components at the 
reactive site (Wallace et al., 1986), a mechanism upon which most semisyntheses of 
cytochrome c depended. The majority of syntheses of cytochrome c rely on CNBr 
cleavage, an important step due to the generation of few fragments by the low frequency 
of Met residues in proteins. Early work exploring this developed conditions for cleavage 
at the accessible Met65 rather than the heme-coordinating Met80 (Corradin and 
Harbury, 1970), and showed that a mixture of the fragments generated formed a 
reconstituted 1:1 complex in aqueous solution (Corradin and Harbury, 1971). Of 
particular interest was the homoserine lactone coupling method, whereby the 
homoserine lactone formed from CNBr treatment can spontaneously re-form the peptide 
bond. More recent work has exploited the use of CNBr cleavage to generate the N-
terminal homoserine lactone peptide for the semisynthesis of cytochrome c to 
incorporate carbon-deuterium bonds for time-resolved studies on labelling and folding 
measurements (Sagle et al., 2004, Sagle et al., 2006). 
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 Templated synthesis combines chemical ligation with self-assembling peptides, 
early work in this area using coiled-coils to template a ligation between a C-terminal 
thioester peptide and an N-terminal Cys peptide (Severin et al., 1997, Yao et al., 1997). 
Ligation at a Cys-free site has been effected using leucine-zipper sequences in a self-
assembling fiber system containing peptides (Ryadnov and Woolfson, 2007). Rational 
design of coiled-coils has established systems with dissociation constants in the 
subnanomolar range that are being used for exploration of protein-protein interactions 
(Thomas et al., 2013).  
 Coiled-coils consist of heptad repeats of hydrophobic and polar residues, and 
when folded into an α-helix create a hydrophobic interface through which they interact 
and assemble (Crick, 1953, Pauling and Corey, 1953, Lupas, 1996). We chose not to 
use coiled-coils in the labelling method to avoid the potential risks associated with 
oligomerization, but additionally we wanted a specific ligation at the N-terminus of the 
expressed peptide and not in the middle of the sequence as with coiled-coils. As a result 
we focused more on the conformationally-assisted ligation of peptides at a Cys-free site 
under folding conditions, as with the conformationally-assisted ligation of RNase A and 
CI2 (Beligere and Dawson, 1999) discussed earlier in this chapter and later in Chapters 
4 and 5. 
 
1.3.3 Click chemistry 
 When conformationally-assisted ligation was observed between split protein 
peptide fragments it was thought that perhaps a similar approach could be applied to the 
development of a reaction usually requiring a catalyst to proceed. One branch of click 
chemistry in particular, Huisgen 1,3-dipolar cycloaddition, has been the subject of a 
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number of studies looking to obviate the need for a copper (Cu) I catalyst (Jewett and 
Bertozzi, 2010), and so we wondered if the calbindin D9k peptides could ligate in this 
manner.  
 The term “click chemistry” was first applied by Sharpless and colleagues, and 
covers a range of reactions that aim to join together small units via heteroatom links 
(Kolb et al., 2001). For a reaction to be classed as following click chemistry it must 
adhere to a number of criteria including simple reaction conditions, high yields, wide 
scope, benign/no solvent, readily available starting materials and stability under 
physiological conditions. They are described as “spring-loaded” reactions due to their 
selectivity for and rapid reaction toward a specific product. One area of click chemistry 
covers cycloaddition reactions, probably the most popular of which is Huisgen dipolar 
cycloaddition (Huisgen, 1963). Original Huisgen cycloaddition between an azide and a 
terminal alkyne to form a triazole required elevated temperatures in order to proceed, 
until two separate groups performed ligation at room temperature using a Cu(I) catalyst 
(Rostovtsev et al., 2002, Tornoe et al., 2002). Such a reaction, referred to as Cu(I)-
catalysed azide-alkyne cycloaddition (CuAAC), solely generates 1,4-distributed 1,2,3-
triazoles (Scheme 1.4), though such a metal catalyst is toxic to the cell (Baskin et al., 
2007).  
 Efforts to achieve click chemistry in the absence of copper include the use of 
ring strain with strained alkynes (Agard et al., 2004, Li et al., 2004). However prior to 
the inclusion of copper catalysts, work had been conducted whereby cycloaddition 
could be accelerated by the templating of the reactants. The formation of a triazole is 
accelerated by the addition of cucurbituril, a nonadecacyclic caged compound (Freeman 
et al., 1981), that binds the peptide azide and alkyne to orientate them favourably (Mock 
et al., 1983, Mock et al., 1989). This rate improvement relies upon the formation of this 
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transient complex, and follows the Pauling principle of catalysis: the binding capacity of 
cucurbituril favours the reaction transition state rather than the substrates, with the 
complementarity of cucurbituril greater for this intermediate.  
 A proximity-induced thermal 1,3-dipolar cycloaddition forming a 1,2,3-triazole 
product has also been used to identify acetylcholinesterase (AChE) inhibitors (Lewis et 
al., 2002), a form of target-guided click chemistry where recognition results from the 
spatial orientation of the peptide reactive components. The binding pocket of AChE is a 
narrow cleft into which ligands containing an azide or alkyne were introduced, the 
confines of the cleft encouraging the reaction to take place by initiating favourable 
orientation of the azide and alkyne. This method is known as small molecule in situ 
click chemistry (SISC) and has also been used to identify inhibitors in a number of other 
systems (Mamidyala and Finn, 2010, Millward et al., 2013). A recent report on the 
search for histone deacetylase (HDAC) inhibitors found that the presence of trace 
amounts of Cu associate with the enzyme in its active site increased the rate of triazole 
formation, combining proximity-assisted and Cu-catalyzed AAC (Suzuki et al., 2010). 
Studies such as these confirm that these components are able to function with stability 
in water, are easy to incorporate into the system of choice, and compatible with 
physiological conditions (Saxon, 2000, Kiick et al., 2001, Baskin et al., 2007).  
 A similar form of proximity-assisted click chemistry is iterative peptide in situ 
click chemistry (IPISC), focusing on the identification of ligands that bind target 
proteins with antibody-like affinity. The aim is to combine the affinity and specificity 
seen in monoclonal antibodies with the synthetic accessibility of peptides. The binding 
of a primary ligand to the target protein identifies a secondary ligand, and the peptides 
bind to form a triazole-linked biligand. The biligand can then be used to identify a 
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tertiary ligand, and so on. This method was first used to generate a triligand for carbonic 
anhydrase II (Agnew et al., 2009). 
 In situ click chemistry, with examples such as the AChE work discussed earlier, 
preceded CuAAC and has been used in the design of synthetic receptors that can 
regulate specific protein-protein interactions, such as the Grb2-SH2 domain mimic that 
was shown to induce cytotoxicity and inhibition of tumour growth in cancer cells 
(Tanaka et al., 2012). The use of low concentrations of Cu(I) provide slow 1,3-dipolar 
cycloaddition to reduce background reactions. In this instance the anchor is resin-bound 
bis-Lys that binds to phosphate, modified to contain two azides, and the target is a 
phosphorylated cyclic peptide selective for the Grb2-SH2 domain. The azides form 
triazole linkages with members of an alkyne-containing tetrapeptide library, and 
specifically binds to Grb2-SH2 interacting proteins both in vitro and in vivo. 
 
 
	  
Scheme 1.4: Huisgen 1,3-dipolar cycloaddition products 
A peptide azide and a peptide alkyne can ligate to form the 1,2,3-triazole product. This product can take 
the form of either the 1,4- or the 1,5-regioisomer, but solely the 1,4-regioisomer if a Cu(I) catalyst is used 
(Tornoe et al., 2002, Rostovtsev et al., 2002). 
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2. Materials and methods 
2.1 Reagents and chemicals 
 All chemicals and reagents purchased from Sigma Aldrich with the exception of 
the following. 
All L-amino acids and Fmoc-Asp(OtBu)-Ser(ψMe,Mepro)-OH were purchased 
from Novabiochem, in addition to Fmoc-Gly-4-sulfamylbutyryl rink amide AM, Fmoc-
Ala-sulfamylbutyryl sieber amide, Fmoc-PEG biotin NovaTag and azido NovaTag 
resins. PL rink and Fmoc-Gly-Wang resins were purchased from Agilent Technologies. 
Tris(2-carboxyethyl)phosphine hydrochloride (TCEP-HCl) and guanidine hydrochloride 
(Gdn.HCl) were purchased from Thermo Scientific. 1-hydroxybenzotriazole (HOBT) 
was purchased from CS Bio. Trifluoroacetic acid (TFA), piperidine and acetonitrile 
(AcN) were purchased from Romil. N,N-Dimethylformamide (DMF) in bottles was 
purchased from Severn Biotech Ltd., and in 25 L drums from AGTC Bioproducts Ltd. 
Diethyl ether, dichloromethane (DCM) and ethylenediaminetetraacetic acid (EDTA) 
were purchased from Fisher Scientific. Calcium chloride was purchased from VWR 
International. Nα,Nɛ-bis-Boc-L-Lys-OH was purchased from Santa Cruz 
Biotechnology. 
The LAPAG-MPAL thioester peptide of section 6.4 was synthesized and 
generously donated by Richard Raz. 
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2.2 Buffers and cocktails 
 All buffers are specified in figure legends. Buffers and cocktails in the main text 
adhere to the following recipes, changes or additive specified where included. 
• HPLC buffer A: TFA (0.1 %) in H2O. 
• HPLC buffer B: TFA (0.1 %), AcN (90 %) in H2O. 
• LCMS buffer A: formic acid (0.1 %) in H2O. 
• LCMS buffer B: AcN. 
• Denaturing buffer: Gdn.HCl (6 M), sodium phosphate (200 mM), EDTA (2 
mM), pH 7.5. 
• Non-denaturing buffer: sodium phosphate (100 mM), EDTA (2 mM), pH 7.5. 
• Calcium non-denaturing buffer: sodium phosphate (100 mM), calcium chloride 
(2 mM), pH 7.5. 
• BLI/CD calcium buffer: HEPES (10 mM), Tween (0.005 %), calcium chloride 
(2 mM), pH 7.0. 
• CD EDTA buffer: HEPES (10 mM), Tween (0.005 %), EDTA (2 mM), pH 7.0. 
• General cleavage cocktail: TFA (5 ml), H2O (250 µl) and triethylsilane (TES, 
250 µl). 1,2-ethanedithiol (EDT, 100 µl) included for Met/Cys-containing 
peptides. 
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2.3 Preparation of peptides 
2.3.1 9-Fluorenylmethoxycarbonyl solid phase peptide synthesis 
 In 9-Fluorenylmethoxycarbonyl solid phase peptide synthesis (Fmoc-SPPS) the 
α–amino of each residue is protected by the base-labile Fmoc protecting group, unlike 
the acid-labile t-butoxycarbonyl (Boc) group of Boc-SPPS. The side chain protecting 
groups and resin linker are acid labile, and thus can be cleaved simultaneously. The use 
of milder conditions during these steps makes the Fmoc method more readily accessible 
than the Boc method: the HF required in Boc-SPPS is highly dangerous and handling 
requires specialist equipment.  
 The peptide chain is built off the solid support via a linker that provides a 
cleavage site and determines the functionality of the C-terminus. Each amino acid has 
side chain protection to prevent unwanted side reactions between potentially reactive 
groups, and each amino acid is introduced with an Nα-protecting group to ensure 
coupling of one residue at a time. Depending on the synthesizer used, the amino acid 
and coupling reagents are either pre-mixed or are mixed in the reaction vessel itself. 
Simply, a single cycle in Fmoc-SPPS will begin with deprotection of the Nα-protecting 
group, the Fmoc group. With the N-terminus of the amino acid now free the next amino 
acid building block, activated by the coupling reagents, is added. With sufficient wash 
steps between each process the cycle is ready to begin again, until the synthesis is 
complete and the peptide is cleaved (Scheme 2.1). Microwave-assisted Fmoc-SPPS uses 
microwave radiation and elevated temperatures during the coupling and deprotection 
steps to reduce reaction times (Bacsa et al., 2006). 
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Scheme 2.1: Overview of Fmoc-SPPS 
The first step is to couple the C-terminal amino acid to a resin bead with linker. Following deprotection of 
the Fmoc group of this amino acid, the next amino acid is coupled. This cycle of Fmoc deprotection and 
subsequent amino acid coupling is repeated for the rest of the sequence. Final deprotection of the Fmoc 
group is followed by simultaneous cleavage of the peptide from the resin and cleavage of the side chain 
protecting groups, yielding the unprotected peptide target. R and R’ = amino acid side chains. 
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Two common methods for testing successful deprotection or coupling are the 
Kaiser test (Kaiser et al., 1970) and the 2,4,6-trinitrobenzene-sulphonic acid (TNBS) 
test (Hancock and Battersby, 1976). The first is a reaction of ninhydrin with amines, and 
is most sensitive to primary amines. The second test involves adding mixtures of N,N-
diisopropylethylamine (DIEA) and TNBS to resin beads washed with dichloromethane 
(DCM). The dibenzofulvene released during Fmoc cleavage is a strong chromophore 
and provides an additional avenue for monitoring deprotection by UV spectroscopy. 
 Upon completion of the synthesis the cleavage of both the peptide from the resin 
and the side chain-protecting groups occurs simultaneously when treated with 
trifluoroacetic acid (TFA). Scavengers are also required to prevent the side chain 
deprotection from reversing. Common scavengers include water, triethylsilane (TES) to 
quench carbocations and 1,2-ethanedithiol (EDT) for peptides containing Met or Cys 
whose deprotected side chains are acid-sensitive. 
 Fmoc-SPPS is not without its side reactions, which must be managed in order to 
achieve efficient peptide synthesis. One such problem encountered in this project is 
reduced solubility, resulting in aggregation that can affect the efficiency of both amino 
acid coupling and deprotection. This is the self-association of the peptide on-resin that 
often leaves the reaction site obstructed. One aid in minimizing aggregation is the 
introduction of pseudoprolines into a sequence. A pseudoproline is an oxazolidine 
derivative of either a Ser or Thr residue, being the C-terminal residue of a dipeptide 
(Wohr and Mutter, 1995). These building blocks introduce a ‘kink’ into the peptide 
backbone by inducing a cis amide bond, acting like Pro to disrupt regular structure and 
hydrogen-bonding. The TFA treatment at the end of the synthesis to simultaneously 
cleave the side chain-protecting groups and the peptide from the resin leads to ring 
opening and the leaving of a regular Ser or Thr at the site (Haack and Mutter, 1992). 
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Another solution is to add N-(2-hydroxy-4-methoxybenzyl) (Hmb)-protected amino 
acids into the synthesis, ideally every six or so residues (Johnson et al., 1993, Hyde et 
al., 1994, Simmonds, 1996), preceding the problematic area to disrupt the problematic 
hydrogen-bonding. Like pseudoprolines, these are easily cleaved at the end of the 
synthesis during the TFA treatment. Hmb protection is also particularly useful in the 
prevention of aspartimide formation, where the side chain of Asp or Asn can attack the 
amino group of the preceding amino acid following proton abstraction from the nitrogen 
under basic conditions. The main factors that can encourage aspartimide formation are 
the base used and the C-terminal amino acid, particularly when preceded by Gly, Ser or 
Thr (Bodanszky and Kwei, 1978, Nicolas et al., 1989). The use of the Hmb protecting 
group has proven very powerful in the prevention of aspartimide formation by 
providing backbone protection (Quibell et al., 1994, Offer et al., 1996). 
 
For this work peptides were synthesized by Fmoc-SPPS using automated solid 
phase synthesis, either with (CEM Liberty 1) or without (CS Bio) microwave-assisted 
coupling and deprotection. For microwave-assisted syntheses deprotection of the Fmoc 
group was achieved using piperidine (20 %) in DMF (Scheme 2.2a), and subsequent 
amino acid activation/coupling using N,N’-diisopropylcarbodiimide (DIC, 0.8 M) in 
dimethyl sulfoxide (DMSO) and HOBT (0.5 M) in DMF (Scheme 2.2b). Amino acids 
(0.2 M) in DMF were coupled with a 10 min, 75 °C, 25 W microwave-assisted 
coupling. β–branched amino acids and their N-terminal residue were double coupled, to 
combat potential reduced coupling efficiency due to steric hindrance. An initial 
deprotection of 30 s at 75 °C and 25 W was followed by a 3 min, 75 °C, 25 W 
microwave-assisted deprotection.  
Any alteration to these standard conditions is detailed in the appropriate section. 
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Scheme 2.2: Fmoc deprotection and coupling mechanisms 
a. Fmoc deprotection. The acidic proton eliminates a dibenzofulvene during base treatment via 
an E1cB elimination, the two phenyl groups helping to stabilize the anion. Loss of CO2 
generates an amine, allowing for the coupling of the next amino acid building block.	  
b. DIC/HOBT coupling. The carboxyl group of the Nα-protected amino acids must be activated 
in order to couple to the resin-bound deprotected peptide. DIC activates the amino acid by 
providing a better leaving group, and couples to form a transient O-acylurea. To minimise 
racemization HOBT is introduced and reacts to form a less reactive activated ester. This then 
couples to the preceding deprotected amino acid in the sequence, forming an amide bond.	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2.3.2 Cleavage from resin and purification 
Resin subjected to a DCM wash (5 x 10 ml) and dried under vacuum (ILMVAC 
GmbH) for weighing, and divided into two portions prior to cleavage. To each either the 
general or EDT-containing cleavage cocktail was added, depending on the presence of 
cysteine or methionine residues. Following a 1.5 h cleavage time the resin was filtered, 
the TFA sparged (N2), and the peptide precipitated in Na-dried ether (40 ml). After 
cooling on dry ice for a minimum of 10 min the precipitated peptide was pelleted by 
centrifuging (4000 rpm for 10 min at 4 °C, eppendorf 5810 R centrifuge), and the ether 
decanted. Peptides were resuspended in either HPLC buffer A with minimal buffer B or, 
if solubility was more problematic, the denaturing buffer.  
Samples were filtered prior to purification using a Whatman 13 mm disposable 
PVDF filter with 0.2 µm pore size. Buffer A was filtered (Nalgene 0.2 µm) and both 
buffers degassed (ILMVAC GmbH) for preparative high-performance liquid 
chromatography. Purification by preparative-HPLC (Waters 600E) with an appropriate 
linear gradient, monitoring at 214 nm using either a Grace Vydac RP-C18 (218TP1022 
22 x 250 mm) with a flow rate of 15 ml min-1, or an RP-C18 (218TP1010) with a flow 
rate of 5 ml min-1. Sample-containing fractions were pooled according to purity and 
freeze-dried. 
 
2.3.3 Peptide characterization 
2.3.3.1  Matrix assisted laser desorption/ionization time-of-flight mass  
  spectrometry 
 Matrix assisted laser desorption/ionization time-of-flight mass spectrometry 
(MALDI-TOF MS) was developed by Tanaka (Tanaka et al., 1988), Hillenkamp and 
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Karas (Karas et al., 1985), and involves ionization of the sample by a laser before 
collecting the resulting ionized molecules. Firstly the sample is mixed with a matrix that 
transfers the ionization energy from the laser to the sample, with around 1 µl added to 
the target plate and allowed to co-crystallize. There are a variety of matrix substances 
depending on the type of sample in question, due to differences in the energy needed for 
ionization along with sample stability. The sample/matrix mix is then shot with a laser 
to generate ions, where desorption by the laser beam results in ablation of the top layer 
of the matrix/sample mix and subsequent ionization of the sample. Ionization of neutral 
molecules [M] typically generates [M+H]+ with a proton added, [M-H]- with a proton 
removed, [M+nH]n+ with multiply charged ions, [M+Na]+ with a sodium ion added and 
[M+K}+ with a potassium ion added. These ions must then be detected and analysed 
(Scheme 2.4). 
 A TOF mass spectrometer separates these charged ions according to their flight 
times. The linear mode of analysis gives limited mass resolution and so the 
homogeneity of the sample/matrix mix is crucial for optimising the balance between 
resolution and spatial spread, whereas reflectron mode improves resolution by efficient 
ion focusing. The reflectron has an ‘ion mirror’ that reflects ions using an electric field, 
doubling the flight path of the ionized molecules and thus improving mass accuracy. It 
diminishes the spread of the flight times of ionized molecules with the same mass-to-
charge ratio (m/z). 
 Prior to analysing a sample an external calibrant is typically used to remove any 
error generated from moving the stage in and out when loading the target plate. The 
calibrant is a known mixture of proteins or peptides corresponding to a list in the 
analysis software, allowing for peaks to be assigned to the correct mass if necessary. 
This calibration can then be applied to sample spectra. 
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MALDI-TOF MS (Bruker microflex) used α-cyano-4-hydroxycinnamic acid 
(CHCA) matrix (10 mg ml-1 in H2O:AcN:TFA 50:50:0.1), generally with ion positive 
reflector mode for peptides with m/z < 4000 and ion positive linear mode for > 4000.  
 
 
 
	  
	   	  
 
Scheme 2.3: Outline of MALDI-TOF MS 
The sample is mixed with the appropriate matrix and dotted onto the target plate. A laser ionizes the 
sample molecules which are separated by their flights times in the TOF MS, with smaller molecules 
(green) flying faster than larger molecules (purple), before arriving at the detector. 
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2.3.3.2  Liquid chromatography-mass spectrometry 
 Liquid chromatography-mass spectrometry (LCMS) combines the sample 
separation of HPLC with the mass analysis of MS, most often using electrospray 
ionisation (ESI) to link the two processes. One advantage that this method holds over 
MALDI is that it can produce multiply charged ions, therefore extending the mass range 
of the analyser. 
 The sample is introduced to the mobile phase and pressurized for column 
separation, with pumps controlling the composition and flow rate. Desolvation during 
ESI gives a fine aerosol that is dispersed by electrospray, and non-volatile molecules 
with multiple charges are now in the gas phase. For the specific equipment used this 
method can detect peptides and proteins up to 100 kDa, and from as low as 150 Da. The 
detector in this model is a single quadrupole mass analyser, and can detect both positive 
and negative ions. This mass analyser sorts ions based on their m/z, their separation 
based upon the stability of their trajectories along the length of the four rods. A radio 
frequency voltage is applied between the pairs of rods, and a direct current voltage is 
superimposed. Only ions with a certain m/z will travel the length and reach the detector 
under a specific ratio of these applied voltages, and others will have unstable trajectories 
and hit the rods. This allows for selection of a specific m/z but also for monitoring a 
range by varying the voltages. 
 
LCMS (Shimadzu LCMS-2010 EV) used a Shim-pack XR-ODS II 2.0 mmi.d x 
75 mm column with a linear gradient of 0 – 95 % B in 10 min and a flow rate of 0.5 
ml min-1, monitoring at 214 nm. LCMS was used for peptide characterization during 
peptide preparation. 
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2.3.3.3  High performance liquid chromatography 
 High performance liquid chromatography (HPLC) is a technique for separating 
and identifying components of a mixture. It can also be used to purify a sample, for 
example following SPPS, by separating the components and delivering them to a 
fraction collector. 
 A pressurized system controls solvent flow and is used to move the sample 
through a column to separate, separation depending on the type of column used and the 
interaction of the molecules with the column material. The sampler delivers the sample 
from the injection loop into the ‘mobile phase’, a mixture of solvents, the flow rate and 
composition of which is controlled by the pump. Once the sample has passed through 
the column the detector relays the information gathered into a signal corresponding to 
the separation of the sample molecules. 
 Reverse phase-HPLC (RP-HPLC) separates molecules based on their 
hydrophobicity, using a non-polar stationary phase and a polar mobile phase. The most 
common stationary phase is probably silica modified such that the surface of the 
particles is coated with hydrophobic alkyl chains of varying lengths, such as the C18 
and C4 columns used during this project. The mobile phase can be of constant (isocratic 
flow) or varied (gradient flow) composition. In gradient flow ‘solvent A’ refers to the 
aqueous component and ‘solvent B’ refers to the organic solvent, typically water and 
acetonitrile respectively. Less polar molecules will have longer retention times, and 
retention times can be controlled by the composition of the mobile phase. Detectors 
typically monitor at 214 nm to detect the absorbance of the peptide backbone, unless 
using a diode array detector (DAD) that monitors a range of wavelengths. 
 
53	  
	  
During this project analytical-HPLC (Agilent 1200 series, and VWR Hitachi 
ELITE LaChrom) generally used linear gradients with a variety of columns, monitoring 
at 214 nm for determination of peptide purity and retention time. Columns specified in 
appropriate sections, and all figure legends. 
For the duration of this work, and specified in figure legends, the following 
columns were used: 
• Grace Vydac RP-C18 (218TP 5µ 150 mm x 4.6 mm) 
• Phenomenex RP-C18 (Gemini 3µ 150 mm x 4.6 mm) 
• Grace Vydac RP-C4 (214TP 5µ 150 mm x 4.6 mm) 
• Chromolith RP-8 column (Merck RP-8e 4.6 mm x 100 mm) 
 
2.3.3.4  Yield calculation 
 Peptide yields were calculated from the weight of final dried peptide, its mass 
including that of the CF3COO- counter ion, in relation to either the scale of the synthesis 
based upon the loading of the resin or the amount of starting materials used. 
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2.4 Biophysical characterization 
2.4.1 Ultraviolet/visible spectroscopy 
 Ultraviolet/visible (UV/VIS) spectroscopy is a form of absorbance spectroscopy, 
measuring transitions from the ground state to the excited state in molecules containing 
π electrons that can absorb light in this spectrum. Using a UV/VIS spectrophotometer 
light passes from the radiation source through the monochromator or prism to separate 
the wavelengths, and any light that passes through is measured by the detector. The 
intensity of light transmitted through the sample-containing cuvette (I) is compared to 
the intensity before it passes through (I0). This ratio gives the absorbance (A) by the 
equation: 
A = log10(I0/I) 
One use of this technique is the determination of a sample’s concentration in 
solution. A number of biophysical techniques used in this project require accurate 
concentrations, notably circular dichroism and bio-layer interferometry. Molecules with 
chromophores have specific absorbance maxima at a set wavelength. These maxima 
(λmax) can be plotted as an absorbance spectrum and used to identify concentration. A 
compound-specific extinction coefficient (Ɛ) for a set wavelength can be used for 
calculation using the Beer-Lambert law: 
A = Ɛ  x c x l 
where A is the absorbance at 280 nm (A280), Ɛ is the extinction coefficient                       
(5560 M-1 cm-1 for each Trp, 1200 M-1cm-1 for each Tyr), c is the concentration and l is 
the path length. This states that the absorbance of chromophores such as Trp and Tyr is 
directly proportional to their concentration and the path length.  
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Another form of UV/VIS spectroscopy uses a NanoDrop instrument. This 
technique is particularly useful when dealing with small volumes, such as the ligations 
discussed in later chapters, as no cuvette is used and so there is no need for a minimum 
volume. µl amounts are pipetted directly onto the instrument’s pedestal, and when the 
arm is lowered to make contact with the droplet a sample column forms. The pedestal 
then moves to adjust to the ideal path length, and the measurement is conducted in 
much the same way as described above. Advantages include easy sample preparation, 
quick measurements and requiring just µl volumes of sample. 
 
UV/VIS spectroscopy (Jasco V-550 spectrophotometer) was employed to 
determine peptide concentration. The model used has a double beam optical system 
with a single monochromator, with deuterium and halogen lamps and a photomultiplier 
R928 detector. Absorbance at 280 nm (A280) was measured using a cuvette with 10 mm 
light path (Hellma Suprasil quartz 105B-QS). Concentration was calculated using the 
Beer-Lambert law once a value for absorbance has been established. 
NanoDrop2000 (Thermo Scientific) was used to determine ligation component 
concentrations, monitoring absorbance at 280 nm. 
 
2.4.2 Fluorescence spectroscopy 
Fluorescence spectroscopy is a form of electromagnetic spectroscopy that 
analyses the fluorescence of a sample, where excitation of the electrons of aromatic 
amino acids by UV light results in light emission. UV light passes through a filter or a 
monochromator to select the wavelength before hitting the sample in solution in a 
cuvette with a determined path length. Fluorescence light is emitted by specific residues 
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and is passed through a second filter or monochromator prior to reaching a 
photomultiplier detector, usually at 90 ° to prevent the reflection of the incident light 
from reaching the detector. Most fluorescence emitted comes from Trp but there can 
also be emission due to Tyr and Phe residues. Fluorescence spectroscopy can be used to 
study protein folding, whereby the fluorescence emitted by these residues will decrease 
as the protein folds and they become buried.  
 
 Fluorescence data were collected (Varian Cary Eclipse fluorescence 
spectrophotometer) by monitoring absorbance at 345 nm and using a cuvette with 3 mm 
light path (Hellma Suprasil quartz 105.251-QS). The model used has a Xe lamp, 
monochromators with filters, Schwarzchild collection optics and photomultiplier tube 
detectors. 
 
2.4.3 Bio-layer interferometry 
Bio-layer interferometry (BLI) is an optical technique based upon the analysis of 
a white light interference pattern, and is a label-free method for monitoring 
biomolecular interactions. White light is reflected from two places, one being the 
interface between solvent and protein bound at the tip of the sensor and the other an 
internal reference point. As the partner peptide interacts with the bound peptide this 
layer of protein becomes thicker, causing a shift in the interference pattern that is 
monitored in real time (Scheme 2.5). Only peptides that are bound at the sensor tip 
contribute, therefore unbound molecules have no effect. It could thus be said that BLI 
essentially measures a change in mass. 
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BLI measures the equilibrium dissociation constant (Kd) from a ratio of kinetic 
constants. For a 1:1 reaction the time dependence of the response from the sensor (R) 
during the association phase, when the when the partner protein binds that at the tip, is 
described by the equation: 
R = Req(1 – e-kobst) 
where kobs is a pseudo first-order rate constant (= kon[C] + koff, where kon is the 
association rate constant, koff is the dissociation rate constant and [C] is the 
concentration of the interacting protein) and Req is the equilibrium response. The 
dependence of kobs on the concentration of the interacting protein for its bound partner 
allows for the determination of kon from the slope of kobs plotted against [C]. When the 
intercept is too close to zero the koff value cannot be accurately determined. In such 
instances koff can be calculated from the dissociation phase, where the time dependence 
of R is then described by the equation: 
R = R0e-kofft 
where R0 is the biosensor response before the start of dissociation. 
 
 BLI was carried out using the Octet Red system (FortéBio). Streptavidin sensors 
(FortéBio SA Dip and Read biosensors for kinetics) were allowed to soak in the BLI 
calcium buffer of HEPES (10 mM), Tween (0.005 %) and calcium chloride (2 mM), pH 
7.0 for ≥ 20 min prior to experimentation. 96 well plates included a row of buffer for 
washing, a row of the biotinylated peptide (including buffer blank wells as control) and 
rows of corresponding partner peptide at varying concentrations. 
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Scheme 2.4: Outline of an Octet experiment with a biotinylated peptide and streptavidin-coated 
sensors 
a. Steps involved in typical Octet BLI experiment. Following equilibration of streptavidin-coated 
sensor in buffer, the biotinylated peptide is loaded onto it. When this is added to the interacting 
peptide the peptides associate, before their dissociation is then measured.  
b. Example of an Octet experimental trace. 1: A streptavidin-coated sensor is allowed to equilibrate 
in buffer. 2: The sensor is then moved to the wells containing biotinylated peptide, for loading. 
3: The loaded sensor is then replaced in the buffer, to wash away any unbound biotinylated 
peptide. 4: The loaded sensor is moved to the wells containing the interacting peptide, to monitor 
their association. 5: The loaded sensor with bound interacting peptide is then replaced into the 
buffer wells to wash away the interacting peptide, to monitor their dissociation. 
	  
 
59	  
	  
2.4.4 Circular dichroism spectroscopy 
 Circular dichroism (CD) is the differential absorption of left- or right-handed 
circularly polarized light by optically active proteins, and is an effective method for 
monitoring conformational changes of a sample. Light can be polarized using filters or 
prisms to cause the electric field I to oscillate in a sinusoidal manner in one plane, either 
rotating clockwise or anticlockwise when viewed front-on. During a CD experiment 
using far-UV light to investigate protein secondary structure a sample is subjected to 
equal amounts of both left- and right-circularly polarized light alternately. One will be 
better absorbed than the other and this difference is measured. Data in millidegrees are 
converted to ΔA (= Aleft – Aright) and then to mean residue ellipticity (MRE,  
deg cm2 dmol-1 res−1), normalized for the concentration of peptide bonds and path 
length.  
CD can be used to determine the secondary structure of a protein, as different 
structural compositions display characteristic spectra: α-helices give spectra with 
minima at 222 nm and 208 nm, and a maximum at 193 nm (Holzwarth and Doty, 1965); 
β-sheets give spectra with a minimum at 218 nm and a maximum at 195 nm (Greenfield 
and Fasman, 1969); disordered proteins, the content that is not α–helix or β–sheet/turn 
but can be just as rigid, give spectra with a minimum at around 195 nm and display low 
ellipticity above 210 nm (Venyaminov et al., 1993). Though unable to give structural 
detail on a residue by residue basis, unlike nuclear magnetic resonance (NMR) 
spectroscopy or X-ray crystallography for example, it does have the benefits of 
requiring little amounts of material and generally taking less time. Other requirements 
include the use of high-transparency quartz cuvettes, buffers should not contain 
anything optically active, and sample concentrations must be determined prior to 
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experimentation. Further information on CD protocols can be found in the Greenfield 
Nature Protocols review (Greenfield, 2006). 
 CD (Jasco J-815 spectrometer) data were collected by mixing the peptides in a 
1:1 ratio in either the CD calcium buffer of HEPES (10 mM), Tween (0.005 %) and 
calcium chloride (2 mM), pH 7.0 or the CD EDTA buffer of HEPES (10 mM), Tween 
(0.005 %) and EDTA (2 mM), pH 7.0. First the peptides were investigated individually 
to determine the level of ordered structure, before mixing the peptides to observe any 
structural changes.  
 
2.4.5 Ligation and thioester exchange 
 All ligation buffers thoroughly degassed whilst stirred (Buchi V-700 vacuum 
pump) and kept under argon, unless otherwise specified. For 1 ml of buffer a 5 ml round 
bottom flask was used. Any additives were introduced prior to setting the pH with 4 M 
NaOH or 12 M HCl as required. The final volume of ligation buffer was added first to 
the N-terminal peptide and then transferred to the C-terminal peptide. The reaction 
mixture was diluted in HPLC buffer A prior to injection onto analytical-HPLC, the 
specific dilutions detailed in individual sections. 
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3. Native chemical ligation with peptide                        
N-(Me)sulfonamides 
3.1 Introduction 
NCL is a very powerful technique for protein semisynthesis. Though peptide 
thioesters were traditionally synthesized by Boc-SPPS there has been extensive progress 
toward peptide thioester synthesis by the more prevalent Fmoc-SPPS (Mende and Seitz, 
2011, Kang and Macmillan, 2010) for a number of reasons. The anhydrous hydrogen 
fluoride (HF) required for final deprotection and cleavage from the resin in Boc-SPPS is 
highly toxic, complex in handling and increasingly difficult to obtain. One problem in 
optimising an Fmoc-based method for synthesizing peptide thioesters is that the 
thioester linkage to the resin is sensitive to strong nucleophiles such as the piperidine 
used repeatedly throughout this method of synthesis. A number of approaches have 
been successfully developed, the most popular of which is probably the use of an 
acylsulfonamide safety-catch (acid and base stable) linker. Acylsulfonamides are 
resistant to alkaline hydrolysis because the base ionises the NH group which is acidic 
(Rudinger, 1963). Upon completion of peptide synthesis alkylation of a sulfonamide 
linker labilises it to nucleophilic cleavage, generating the fully-protected N-alkyl 
acylsulfonamide peptide (Kenner et al., 1971). The first application of this method for 
synthesizing peptide thioesters was developed by Pessi, where the thioester peptide was 
produced following activation and subsequent thiol displacement of the linker (Ingenito 
et al., 1999).  
 Published findings from our lab have shown the use of the sulfamylbutyryl 
linker to synthesise peptides for direct use in chemical ligation, the peptide N-
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(Me)sulfonamide undergoing chemical ligation in the presence of excess thiols (Burlina 
et al., 2012). By using a double linker strategy of the sulfamylbutyryl linker in 
conjunction with a Sieber amide resin, a mildly activated group is achieved by 
methylation and cleavage without the need for the thioester conversion steps previously 
seen with this linker (Scheme 3.1). Trimethylsilyl-diazomethane (TMS-diazomethane) 
(Murphy et al., 2009) 2.0 M in hexanes was chosen for activation from previous work 
(Ingenito et al., 1999, Mezzato et al., 2005). This methylation reaction results in a 
mildly reactive peptide sulfonamide, reducing the risk of unwanted side reactions. 
During ligation reactions an intermediate thioester exchange step occurs between the 
peptide N-(Me)sulfonamide and 4-mercaptophenylacetic acid (MPAA) which is 
instantly captured by the N-terminal cysteine (Scheme 3.1).   
 
Scheme 3.1: Preparation of a peptide N-(Me)sulfonamide for NCL 
a. Double linker strategy for the preparation of a peptide N-(Me)sulfonamide. Following Fmoc 
SPPS treatment with TMS-diazomethane and TFA generates the activated, unprotected peptide 
N-(Me)sulfonamide. 
b. In the presence of excess thiols the peptide N-(Me)sulfonamide undergoes thioester exchange 
before ligating to a peptide with an N-terminal Cys. 
Adapted from Burlina et al, 2012. 
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Though not discussed in depth in this body of work our lab has used alkyl 
substitution of Cys to develop an additional method for the synthesis of thioester 
precursor peptides, synthesizing peptides with C-terminal α–methylcysteine (Burlina et 
al., 2014). Model ligations with LAPAGα-MeC and LAPAAα-MeC included a version 
with a LAPAGC control, before demonstrating ligation with BPTI, murine KC and a 
fragment of ColE1-Rop at Gly-Cys, His-Cys and Leu-Cys sites respectively. 
 
3.2 Ligation with model peptides 
This technique was first demonstrated using small model peptides in the form of 
AYRAA-N(Me)sufonamide and CFALRGWR-NH2. Model peptides allow for 
replication of standard NCL conditions with their low molecular weight, use of 
denaturing buffer and high concentrations. 
 
3.2.1 Preparation of peptides 
AYRAA N-(Me)sulfonamide was synthesized on pre-loaded Fmoc-Ala-
sulfamylbutyryl sieber amide resin (0.32 mmol g-1 loading, 0.1 mmol). Upon 
completion of the synthesis the resin was methylated by overnight treatment with TMS-
diazomethane in hexanes (2.0 M). Cleaved from the resin and purified by preparative-
HPLC: RP-C18 column with a gradient of 0 – 30 % B in 30 min and a flow rate of 15 
ml min-1. Purified peptide freeze-dried (26.8 mg, 32.4 % yield). 
CFALRGWR was synthesized on PL-AMS resin with a rink amide linker (0.39 
mmol g-1 loading, 0.1 mmol). Cleaved from the resin and purified by preparative-
HPLC: RP-C18 column with a gradient of 10 – 70 % B in 30 min and a flow rate of 15 
ml min-1. Purified peptide freeze-dried. 
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3.2.2 Ligation of AYRAA N-(Me)sulfonamide and CFALRGWR 
AYRAA N-(Me)sulfonamide (0.65 mM, 0.36 mg) was added to CFALRGWR 
(1 mM, 0.42 mg) in degassed denaturing buffer with TCEP-HCl (50 mM) and MPAA 
(60 mM), pH 7.5. The reaction was performed at 40 °C and monitored over time by 
analytical-HPLC: Chromolith RP-8 column with a gradient of 0 – 30 % B in 10 min and 
a flow rate of 3 ml min-1. Ligation was complete in 2 h and the product 
AYRAACFALRGWR-NH2 collected for MALDI-TOF analysis: observed mass = 
1539.7 Da in positive reflector mode, calculated mass = 1539.8 Da. 
 
 
 
Figure 3.1: Ligation of AYRAA N-(Me)sulfonamide and CFALRGWR (Burlina, Morris et al, 2012)  
Ligation conditions: peptides (10 mM), sodium phosphate (200 mM), GdnHCl (1 M), EDTA (2 mM), 
TCEP-HCl (50 mM), MPAA (60 mM), pH 7.5. HPLC conditions: Chromolith RP-8 column, 0 – 30 % B 
(TFA (0.1 %), AcN (90 %)) in 10 min, 3 ml min-1. A = AYRAA N-(Me)sulfonamide, B = CFALRGWR, 
C = ligation product, * = MPAA. 
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3.3 Ligation with bovine pancreatic trypsin inhibitor 
Having first demonstrated this form of ligation using model peptides, the 
technique was then demonstrated on a larger scale with peptides of higher molecular 
weight and with all side chain functionalities, in addition to lowered concentrations. 
Bovine pancreatic trypsin inhibitor (BPTI) is a well-studied protein that has 
previously been totally chemically synthesized (Lu et al., 1998), where BPTI(1-
37)αCOSR and BPTI(38-58) successfully ligated in 24 h. Here we have synthesized it 
as two fragments, BPTI(1-37) N-(Me)sulfonamide and BPTI(38-58). Using these 
peptides it should be possible to demonstrate the technique on a larger scale with 
peptides of higher molecular weight and with all side chain functionalities, in addition 
to lowered concentrations. 
 
3.3.1 Preparation of peptides 
BPTI(1-37) N-(Me)sulfonamide was synthesized on pre-loaded Fmoc-Gly-4-
sulfamylbutyryl rink amide AM resin (0.26 mmol g-1 loading). Upon completion of the 
synthesis the resin was methylated by solvation in DCM and overnight treatment with 
TMS-diazomethane in hexanes (2.0 M). Cleaved from the resin and purified by 
preparative-HPLC: RP-C18 column with a gradient of 15 – 35 % B in 5 min, 35 – 50 % 
B in 30 min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (9 % yield). 
BPTI(38-58) was synthesized on pre-loaded Fmoc-Ala-Wang resin (0.42   
mmol g-1 loading). Cleavage from the resin and purified by preparative-HPLC: RP-C18 
column with a gradient of 10 – 50 % B in 30 min and a flow rate of 15 ml min-1. 
Purified peptide freeze-dried (14 % yield). 
 
 
66	  
	  
3.3.2 Ligation of BPTI(1-37) N-(Me)sulfonamide and BPTI(38-58)  
BPTI(1-37) N-(Me)sulfonamide (0.65 mM, 0.36 mg) was added to BPTI(38-58) 
(1 mM, 0.42 mg) in degassed denaturing buffer with TCEP-HCl (50 mM) and MPAA 
(60 mM), pH 6.3. The reaction was performed at 40 °C and monitored over time by 
analytical-HPLC: Phenomenex RP-C18 column with a gradient of 0-70 % B in 25 min 
and a flow rate of 1 ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for 
injection (Figure 3.2). Over time observe the formation of the ligation product BPTI, 
collected for characterization by MALDI-TOF: observed mass = 6519.4 Da in positive 
linear mode, calculated mass = 6517.6 Da. 
This ligation was repeated on a larger scale and the product purified by 
preparative-HPLC. BPTI(1-37) N-(Me)sulfonamide (10 mg) was added to BPTI(38-58) 
(5.8 mg) in degassed denaturing buffer with TCEP-HCl (50 mM) and MPAA (60 mM) 
additives, pH 6.3. The reaction was performed at 40 °C and after 10 h the product 
purified by preparative-HPLC: RP-C18 column with a gradient of 0 – 20 % B in 5 min, 
20 – 65 % B in 30 min and a flow rate  of 15 ml min-1 (2.4 mg, 15.2 % yield).   
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Figure 3.2: Ligation of BPTI(1-37) N-(Me)sulfonamide with BPTI(38-58) 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 6519.4 Da, calculated product 
mass = 6517.6 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), GdnHCl (6 M), 
sodium phosphate (200 mM), TCEP-HCl (50 mM) and MPAA (60 mM), pH 6.3, 40 °C. HPLC 
conditions: RP-C18 column, 0 – 70 % B (TFA (0.1 %), AcN (90 %)) in 25 min, 1 ml min-1. A = 
BPTI(38-58), B = BPTI(1-37) N-(Me)sulfonamide, B’ = BPTI(1-37), C = ligation product, * = 
MPAA (peak truncated). 
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3.4 Peptide N-(Me)sulfonamides ligate to N-terminal Cys peptides in 
the presence of excess thiols 
This chapter overviews the work establishing a new and viable method for 
synthesizing peptide thioesters by Fmoc-SPPS. Peptide N-(Me)sulfonamides were 
synthesized using a double linker strategy to generate a mildly activated group 
following methylation and cleavage, without the requirement of a thioester conversion 
step previously undertaken with this linker. The double linker strategy allows for test 
cleavages during the synthesis of the peptide to monitor progress, including the final 
activation (Mezzato et al., 2005). Methylation resulted in a mildly reactive peptide 
sulfonamide, reducing the risk of unwanted side reactions. During ligation an 
intermediate thioester exchange step takes place between the peptide N-
(Me)sulfonamide and the excess thiols present, before this thioester peptide then ligates 
to an N-terminal Cys peptide. This was initially carried out with model peptides, 
AYRAA N-(Me)sulfonamide with CFALRGWR (Figure 3.1), before BPTI was chosen 
as the target for a more thorough investigation. BPTI(1-37) N-(Me)sulfonamide ligated 
with clean analytical-HPLC traces to BPTI(38-58) at a Gly-Cys ligation site with 
MPAA as the thiol additive (Figure 3.2), these peptides based on the published total 
chemical synthesis. The BPTI(1-37) MPAA thioester is not observed during this 
ligation as it immediately undergoes transthioesterification with BPTI(38-58) to form 
the ligation product. The majority of the product had formed by 8 h, which makes the 
ligation with BPTI(1-37) N-(Me)sulfonamide described here comparable to the 
published total chemical synthesis. 
The success of these peptide N-(Me)sulfonamides in ligation will now be 
applied to the split proteins discussed in later chapters, to establish their ability for use 
in the proposed labelling method.  
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3.5 Summary 
 A double linker strategy using the popular sulfamylbutyryl linker has afforded 
peptide N-(Me)sulfonamides that are able to directly undergo ligation. In the presence 
of excess thiols the peptide N-(Me)sulfonamide undergoes a thioester exchange step 
before ligating to N-terminal Cys-containing peptides, bypassing the previously separate 
thioester conversion step and allowing for monitoring throughout the synthesis. Ligation 
with model peptides paved the way for ligation with BPTI peptides, with results 
comparable to that of published NCL.  
  
70	  
	  
4. Conformationally-assisted ligation with 
RNase A 
4.1 Introduction 
 Bovine RNase A was chosen as it was the classical system in which the first 
demonstrated example of reconstitution (Richards, 1958) and later conformationally-
assisted ligation (Beligere and Dawson, 1999) were demonstrated. Additionally the S-
peptide can be accessed by Fmoc-SPPS, and the larger S-protein is commercially 
available. Furthermore the activity of the authentic ligation product could be assayed 
using fluorescently labelled nucleotides, such as the RNaseAlert assay (Ambion). 
RNase A, isolated from crystalline ribonuclease, was treated with subtilisin, 
cleaving the Ala-Ser bond 20 amino acids from the N-terminus of the protein (Richards, 
1958). This liberated the 20 reside ‘S-peptide’ and the 104 residue ‘S-protein’, 
confirmed by amino acid analysis and Edman degradation (Richards and Vithayathil, 
1959, Hirs et al., 1960), with 80-90 % conversion success. This complex, termed RNase 
S, was dissolved in trichloroacetic acid for separation of the components following 
centrifugation, the precipitant containing the S-protein and the supernatant the S-
peptide. Activity was measured using either the acid-soluble method (Anfinsen et al., 
1954) or the Kunitz spectrophotometric method (Kunitz, 1946). When the two 
components were mixed stoichiometrically 100 % of the original activity was observed. 
The reconstitution had no lag, and was immediate even for peptide concentrations under 
1 µM. Later work established that the five C-terminal residues of S-peptide were not 
necessary for effective reconstitution, as stoichiometric amounts of this truncated S-
peptide resulted in a return to full activity when mixed with S-protein as did the full-
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length peptide (Potts et al., 1963). Work such as this on the optimisation of the system 
contributed to the decision of using RNase A in initial experiments. 
Further key work that convinced us to use RNase A as a model system was the 
report of a conformationally-assisted ligation between an S-peptide thioester and the S-
protein (Beligere and Dawson, 1999). Synthetic S-peptide thioester successfully ligated 
and formed an amide bond at the non-Cys N-terminus of S-protein under folding 
conditions with both peptides at 1 mM concentration, with the native Ser at the N-
terminus of the S-protein. This report was novel as it demonstrated that N-terminal Cys 
wasn’t necessary at the ligation site where the two fragments were held in close 
proximity. Ligation was complete in 10 h and the product possessed comparable activity 
to RNase A. Activity was assayed by cleavage of a fluorescent substrate (Kelemen et 
al., 1999, Song and Ismagilov, 2003). 
 
4.2 Conformationally-assisted N-(Me)sulfonamide ligation and 
 thioester exchange 
We wanted to establish if we could use an S-peptide N-(Me)sulfonamide in 
place of a peptide thioester to ligate to S-protein with conformationally-assisted 
ligation. Because of the number of variants of S-peptide known and their different 
affinity to the S-protein we reasoned that this system would give us an idea of what 
affinity would be optimum for rapid ligation and eventually rapid labelling. We first 
wanted to repeat the work of Beligere and Dawson (Beligere and Dawson, 1999) and 
use conformational-assistance to ligate our synthetic S-peptide with the commercially 
available S-protein. Continuing from the previous chapter we decided to use peptide N-
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(Me)sulfonamides instead of peptide thioesters for conformationally-assisted ligation 
with the split protein candidates. 
 
4.2.1 Preparation of peptides 
S-peptide N-(Me)sulfonamide 
S-peptide N-(Me)sulfonamide was synthesized on pre-loaded Fmoc-Ala-
sulfamylbutyryl sieber amide resin (0.32 mmol g-1 loading, 0.05 mmol) using 
microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine deprotection. 
Upon completion of synthesis the resin was methylated by solvation in DCM and 
overnight treatment with TMS-diazomethane in hexanes (2.0 M).  
Integration of the methylated and unmethylated peaks by analytical-HPLC 
revealed 40 % conversion to methylated product (Figure 4.1 a.). Methylation of S-
peptide showed no improvement after repeated treatments with methylation agent. One 
attempt to improve this was to include a Boc-protected amino acid at the N-terminus 
directly rather than independently coupling a Boc group on after the Fmoc-protected 
amino acid at this position was deprotected. If the Boc protection were incomplete then 
potentially the TMS-diazomethane would methylate at the N-terminus. Additionally we 
were concerned that some of the reagent used to introduce Boc may cleave the 
sulfonamide from the resin (Mezzato et al., 2005). Initially 5 eq Boc carbamate in 
minimal DMF was added to deprotected peptide at the end of the synthesis and left for 
30 min with shaking, however this was later changed to Nα,Nɛ-bis-Boc-L-Lys-OH for 
coupling at the N-terminus. Another modification that was introduced at the same time 
was the inclusion of a pseudoproline into the sequence. In addition to the possibility of 
multiple methylation sites, we reasoned that the solubility of the peptide and therefore 
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its accessibility to the methylating reagent could be a problem. Consequently peptide 
chain aggregation hinders the accessibility of the methylation agent to the peptide 
leading to a reduction in methylation efficiency. Introducing the pseudoproline Fmoc-
Asp(OtBu)-Ser(ψMe,Mepro)-OH along with Nα,Nɛ-bis-Boc-L-Lys-OH into the 
sequence increased methylation to approximately 70 % (Figure 4.1 b.). Though the 
amount of methylated product improves with repeated overnight treatments, the 
question is whether this outweighs increased handling of the toxic methylation agent. 
An alternative methylation method in the form of methyl iodide and caesium carbonate 
was investigated, leaving the peptide overnight with 1 eq caesium carbonate and 2 eq 
methyl iodide in DMF (Hossan et al., 2012), but with poor results (data not shown). In 
an attempt to further improve the amount of methylated S-peptide using TMS-
diazomethane the temperature of the methylation step was increased, first to 30 °C and 
then to 50 °C. These changes resulted in approximately 65 % and 66 % methylated 
product respectively (Figure 4.1 c.), which is no improvement. An overview of the 
effect of these modifications is given in Table 4.1 
Following a synthesis modified in the above ways, the peptide was cleaved from 
the resin and purified by preparative-HPLC: RP-C18 with a gradient of 10 – 50 % B in 
30 min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (14 mg, 9.7 % 
yield). 
 
Methylation attempt Unmethylated (approximate %) Methylated (approximate %) 
Standard synthesis 60 40 
Bis-boc-Lys/Pseudoproline 33 67 
30 °C 35 65 
50 °C 34 66 
 
Table 4.1: Comparison of S-peptide sulfonamide methylation conditions 
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Figure 4.1: Preparation of S-peptide N-(Me)sulfonamide 
a. Overnight treatment with TMS-diazomethane (2.0 M in hexanes) resulted in 40 % methylation, 
and this was not improved by subsequent overnight treatment. HPLC conditions: RP-C18 
column, 10 – 50 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = S-peptide 
sulfonamide, A’ = impurity, B = S-peptide N-(Me)sulfonamide. 
b. Overnight treatment with TMS-diazomethane (2.0 M in hexanes) following the inclusion of 
Nα,Nɛ-bis-boc-L-Lys and Fmoc-Asp(OtBu)-Ser(ψMe,Mepro)-OH. Two subsequent overnight 
treatments improved the amount of methylated material. HPLC conditions: RP-C18 column, 0 – 
60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = S-peptide sulfonamide, B = S-
peptide N-(Me)sulfonamide.  
c. Overnight treatment with TMS-diazomethane (2.0 M in hexanes) at increased temperatures, at 
30 °C and 50 °C. There appears to be no difference in the amount of product at elevated 
temperatures. HPLC conditions: RP-C18 column, 10 – 50 % B (TFA (0.1 %), AcN (90 %)) in 30 
min, 1 ml min-1. A = S-peptide sulfonamide, A’ = impurity, B = S-peptide N-(Me)sulfonamide. 
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4.2.2 Ligation with thiophenol 
The first attempt to repeat conformationally-assisted ligation used the non-
denaturing buffer, in contrast to classical NCL which is performed in denaturing buffer 
containing GdnHCl, to exploit the secondary structure inherent to both components of 
RNase A, following the conditions reported by Beligere and Dawson (Beligere and 
Dawson, 1999). 
S-peptide N-(Me)sulfonamide (10 mM, 0.4 mg) was added to S-protein (5 mM, 
1 mg) in degassed non-denaturing buffer with thiophenol (2 % v/v), pH 7.5. The 
reaction was performed at RT and monitored by analytical-HPLC: RP-C18 column with 
a isocratic flow of 29 % B in 30 min and a flow rate of 1 ml min-1.  
Despite the successful identification of isocratic HPLC conditions to distinguish 
between S-protein and RNase A (Figure 4.2), ligation was not observed under these 
conditions (data not shown). 
 
4.2.3 Ligation with 180 mM MPAA 
MPAA was verified as a compatible thiol additive to the peptide N-
(Me)sulfonamide approach in Chapter 3 and so the next attempt used this thiol additive 
in place of thiophenol as higher concentrations could be obtained to assist the ligation.  
S-peptide N-(Me)sulfonamide (1 mM, 0.14 mg) was added to S-protein (1 mM, 
0.68 mg) in degassed non-denaturing buffer with MPAA (180 mM), pH 7.5. A new 
gradient was developed for HPLC analysis, using the Chromolith RP8 column to 
establish a gradient over a quicker time frame and at a higher flow rate: Chromolith RP-
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8 column with a linear gradient of 0 – 30 % B in 10 min and a flow rate of 3 ml min-1 
(Figure 4.3).  
There is hydrolysis of the S-peptide from the start of the reaction, though it does 
not appear to worsen with time. The product of the intermediate step, S-peptide MPAA 
thioester, is visible from as early as 30 min. The reconstituted ligation product, RNase 
A, is observed under these conditions and was collected and characterized by MALDI-
TOF confirmation: observed mass = 13688.2 Da in positive linear mode, calculated 
mass = 13682.65 Da. 
The experiment was repeated at higher MPAA concentration and lower pH, with 
no improvement of the ligation. 
 
 
 
 
Figure 4.2: Development of an isocratic flow to distinguish between the S-protein and RNase A 
An isocratic flow of 29 % B (TFA (0.1 %), AcN (90 %)) in 30 min with a flow rate of 1 ml min-1 on an 
RP-C18 column was identified, sufficiently establishing the retention time of the S-protein relative to the 
ligation product RNase A. A small additional peak in the S-protein trace corresponds to a nominal amount 
of intact RNase A.  
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Figure 4.3: Conformationally-assisted ligation of S-peptide N-(Me)sulfonamide with S-protein, with 
180 mM MPAA 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 13688.2 Da, calculated product 
mass = 13682.65 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), MPAA (180 mM), EDTA (2 mM), pH 7.5. HPLC conditions: Chromolith 
RP-8 column, 0 – 30 % B (TFA (0.1 %), AcN (90 %)) in 10 min, 3 ml min-1. A = S-peptide N-
(Me)sulfonamide, B = S-protein (peak truncated), C = S-peptide hydrolysis, D = S-peptide 
MPAA thioester, E = ligation product * = MPAA (peak truncated), *’ = oxidised MPAA (peak 
truncated). 
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4.2.4 S-peptide N-(Me)sulfonamide exchange with MPAA 
In all of the later ligation attempts we detected the peptide thioester 
intermediate, so it was decided to optimise the exchange conditions to raise the 
concentration of the more reactive species. Pre-exchanging the S-peptide N-
(Me)sulfonamide for the MPAA thioester eliminates the requirement for thiol additives 
in the ligation step. 
S-peptide N-(Me)sulfonamide (1 mM, 0.67 mg) was dissolved in degassed non-
denaturing buffer with MPAA (300 mM), pH 8.0. The reaction was performed at RT 
and monitored by analytical-HPLC: Chromolith RP-8 column with a linear gradient of 0 
– 30 % B in 10 min and a flow rate of 3 ml min-1 (Figure 4.4). The exchange product 
was collected and characterized by MALDI-TOF analysis: observed mass = 2317.3 Da 
in positive reflector mode, calculated mass = 2316.53 Da. After 5 h larger volumes were 
injected in order to collect the product, S-peptide MPAA thioester. Purified peptide 
freeze-dried (0.2 mg, 30 % yield). 
A later attempt reduced the amount of thiol present, though this lengthened the 
exchange time. S-peptide N-(Me)sulfonamide (1 mM, 0.15 mg) was resuspended in 
degassed non-denaturing buffer with TCEP-HCl (50 mM) and MPAA (60 mM), pH 7.0. 
The reaction was performed at 30 °C and monitored by analytical-HPLC: RP-C18 with 
a gradient of 0 – 50 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture 
diluted with 8 µl 0.1 % TFA for injection. Exchange is complete after 48 h. 
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Figure 4.4: S-peptide N-(Me)sulfonamide exchange with MPAA 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 2317.3 Da, calculated 
product mass = 2316.53 Da. 
b. Analytical-HPLC time course of exchange. Exchange conditions: peptide (1 mM), sodium 
phosphate (100 mM), MPAA (300 mM), pH 8.0. HPLC conditions: Chromolith RP-8 column, 0 
– 30 % B (TFA (0.1 %), AcN (90 %)) in 10 min, 3 ml min-1. A = S-peptide N-(Me)sulfonamide, 
B = S-peptide MPAA thioester, * = MPAA (peak truncated), *’ = oxidised MPAA (peak 
truncated), # = MPAA impurity. 
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4.2.5 S-peptide N-(Me)sulfonamide exchange with MESNA 
 It has been reported that thiols with pKa values ≥ 6.5 make for better thioester 
exchange steps, and so the S-peptide N-(Me)sulfonamide was exchanged to the 
MESNA thioester (MESNA pKa 9.2) (Johnson and Kent, 2006). 
 S-peptide N-(Me)sulfonamide (1 mM, 0.17 mg) was dissolved in degassed non-
denaturing buffer with TCEP-HCl (50 mM), MESNA (30 mM) and MPAA (60 mM), 
pH 7.0. The reaction was maintained at RT and monitored to completion by analytical-
HPLC: RP-C18 column with a linear gradient of 0 – 50 % B in 30 min and a flow rate 
of 1  ml min-1 (Figure 4.5). Exchange is complete in 24 h, the product collected for 
MALDI-TOF confirmation: observed mass = 2291.0 in positive reflector mode, 
calculated mass = 2290.51 Da. 
 
4.2.6 Ligation with pre-formed thioester 
The ligation was now repeated with the exchanged S-peptide MPAA thioester. 
S-peptide MPAA thioester (2 mM, 0.2 mg) was added to S-protein (1 mM, 0.5 
mg) in degassed non-denaturing buffer, pH 7.5. The reaction was performed at RT and 
monitored by analytical-HPLC: Chromolith RP-8 column with a linear gradient of 0 – 
35 % B in 10 min and a flow rate of 3 ml min-1 (Figure 4.6). Hydrolysis of the S-peptide 
MPAA thioester was detected at the t = 0 time point, but the ligation product was 
observed. The exact amount of ligation product is difficult to estimate due to the 
immediate hydrolysis of the S-peptide thioester, but there is relatively little. Again the 
product was confirmed by MALDI-TOF: observed mass = 13684.9 Da in positive linear 
mode, calculated mass = 13682.65 Da. An additional, unconfirmed peak was found to 
have an observed mass of 13599.3 Da in positive linear mode. 
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Figure 4.5: S-peptide N-(Me)sulfonamide exchange with MESNA 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 2291.0 Da, calculated 
product mass = 2290.51 Da. 
b. Analytical-HPLC time course of exchange. Exchange conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MESNA (30 mM), MPAA (60 mM), pH 7.0. HPLC 
conditions: RP-C18 column, 0 – 50 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = 
S-peptide N-(Me)sulfonamide, B = S-peptide MESNA thioester, * = MPAA (peak truncated). 
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Figure 4.6: Conformationally-assisted ligation of pre-formed S-peptide MPAA thioester with S-
protein 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 13684.9 Da, calculated 
product mass = 13682.65 Da. 
b. Analytical-HPLC of ligation at t = 0. Ligation conditions: S-peptide MPAA thioester (2 mM), S-
protein (1 mM), sodium phosphate (100 mM), pH 7.5. HPLC conditions: Chromolith RP-8 
column, 0 – 35 % B (TFA (0.1 %), AcN (90 %)) in 10 min, 3 ml min-1. A = S-protein, B = 
ligation product, C = S-peptide hydrolysis. 
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4.3 Biophysical characterization with BLI 
 With the results of the conformationally-assisted chemical ligation attempts 
between the RNase A partners, we examined different S-peptide variants from those 
reported to establish if any were more suitable for ligation than the full-length 20-mer 
investigated so far. Once the Kd of the full-length 20 residue S-peptide is established it 
can be compared to a number of variants: the 15-mer was chosen because of its smaller 
size; LB2 was reported in the literature for its high affinity for the S-protein, identified 
by phage display mutagenesis (Dwyer et al., 2001); we reasoned that a C-terminal Gly 
provided by an A20G mutation might assist ligation by minimizing steric hindrance. 
BLI was used to identify the affinity of these S-peptide variants for the S-protein, using 
the Octet system of FortéBio. Each S-peptide variant was biotinylated at its N-terminus 
for immobilization to streptavidin-coated sensors, and the interaction with the S-protein 
at its C-terminus was monitored. The peptide concentration was confirmed by UV/VIS 
spectrophotometry. 
 
4.3.1 Preparation of peptides 
Biotinylated S-peptide 20-mer 
Biotinylated S-peptide 20-mer was synthesized on pre-loaded Fmoc-Ala-Wang 
resin (0.42 mmol g-1 loading, 0.1 mmol). Upon completion of synthesis biotin (0.2 M) 
was coupled at the N-terminus, confirmed with a negative Kaiser test. Cleaved from the 
resin and purified by preparative-HPLC: RP-C18 column with a gradient of 10 – 50 % 
in 30 min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (38.2 mg, 13.4 % 
yield). 
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Biotinylated S-peptide 15-mer 
Biotinylated S-peptide 15-mer was synthesized on an AMS resin (0.1 mmol) 
with HMPAA linker. Upon completion of synthesis biotin (0.2 M) was coupled at the 
N-terminus, confirmed with a negative Kaiser test. Cleaved from the resin and purified 
by preparative-HPLC: RP-C18 column with a gradient of 10 – 50 % in 30 min and a 
flow rate of 15 ml min-1. Purified peptide freeze-dried (14.4 mg, 5.92 % yield). 
 
Biotinylated S-peptide LB2 
Biotinylated S-peptide LB2 was synthesized on pre-loaded Fmoc-Ala-Wang 
resin (0.1 mmol). Upon completion of synthesis biotin (0.2 M) was coupled at the N-
terminus, confirmed with a negative Kaiser test. Cleaved from the resin and purified by 
preparative-HPLC: RP-C18 column with a gradient of 20 – 50 % in 30 min and a flow 
rate of 15 ml min-1. Purified peptide freeze-dried (2 mg, 5.85 % yield). 
 
Biotinylated S-peptide A20G 
Biotinylated S-peptide A20G was synthesized on pre-loaded Fmoc-Gly-Wang 
resin (0.2 mmol). Upon completion of synthesis biotin (0.2 M) was coupled at the N-
terminus, confirmed with a negative Kaiser test. Cleaved from the resin and purified by 
preparative-HPLC: RP-C18 column with a gradient of 10 – 50 % in 30 min and a flow 
rate of 15 ml min-1. Purified peptide freeze-dried (7 mg, 4.94 % yield). 
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4.3.2 S-peptide 20-mer with S-protein 
Biotinylated S-peptide 20-mer (2 µg ml-1) binds streptavidin-coated sensors via 
its N-terminus and is introduced to varying concentrations of S-protein (0.9 – 15.7 µM), 
both peptides in a PBS buffer with TCEP-HCl (0.5 mM), pH 7.4. A Kd value of 730 nM 
± 130 nM was observed (Figure 4.7). 
 
4.3.3 S-peptide 15-mer with S-protein 
Biotinylated S-peptide 15-mer (2 µg ml-1) binds streptavidin-coated sensors via 
its N-terminus and is introduced to varying concentrations of S-protein (0.9 – 15.7 µM), 
both peptides in a PBS buffer with TCEP-HCl (0.5 mM), pH 7.4. A Kd value of 1.65 
µM ± 0.16 µM was observed (Figure 4.7). 
 
4.3.4 S-peptide LB2 with S-protein 
Biotinylated S-peptide LB2 (2 µg ml-1) binds streptavidin-coated sensors via its 
N-terminus and is introduced to varying concentrations of S-protein (0.65 – 11.9 µM), 
both peptides in a PBS buffer with TCEP-HCl (0.5 mM), pH 7.4. A Kd value of 450 nM 
± 170 nM was observed (Figure 4.8). 
 
4.3.5 S-peptide A20G with S-protein 
Biotinylated S-peptide A20G (2 µg ml-1) binds streptavidin-coated sensors via 
its N-terminus and is introduced to varying concentrations of S-protein (0.65 – 11.9 
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µM), both peptides in a PBS buffer with TCEP-HCl (0.5 mM), pH 7.4. A Kd value of 
900 nM ± 210 nM was observed (Figure 4.8). 
 
 
 
 
 
Figure 4.7: BLI comparison of 20-mer and 15-mer S-peptides 
The full-length 20-mer S-peptide is determined to have a Kd value of 730 nM ± 130 nM, white circles, in 
comparison to a Kd value of 1.65 µM ± 0.16 µM for the 15-mer S-peptide, black circles. In both cases the 
[S-protein] is plotted against the response detected. 
 
87	  
	  
 
 
Figure 4.8: BLI comparison of LB2 and A20G S-peptides 
The LB2 S-peptide is determined to have a Kd value of 450 nM ± 170 nM, white squares, in comparison 
to a Kd value of 900 nM ± 210 nM for the A20G S-peptide, black squares. In both cases the [S-protein] is 
plotted against the response detected. 
 
 
 
 
S-peptide variant Kd 
20-mer 730 nM 
15-mer 1.65 µM 
LB2 450 nM 
A20G 900 nM 
 
 
Table 4.2: Kd values for S-peptide variants obtained by BLI  
88	  
	  
4.4 Attempting conformationally-assisted reactions with RNase A 
4.4.1 Conformationally-assisted ligation 
 RNase A is the classic system for the study of protein folding and reconstitution, 
and we therefore chose it for our initial ligation studies. The first experiments with 
RNase A revolved around the conformationally-assisted ligation of the synthetic S-
peptide N-(Me)sulfonamide with commercial S-protein. Conformationally-assisted 
thioester ligation has previously been reported with RNase A by Beligere and Dawson 
and if we can replicate this, we can show the suitability of this reaction for the proposed 
labelling method. We began by attempting to replicate selected experiments using a 
peptide N-(Me)sulfonamide for ligation as established as a thioester substitute in 
Chapter 3. Though chosen for initial investigation the S-protein, at 104 residues in 
length, would not make this an ideal system for protein labelling as proposed as it is too 
large a tag with multiple disulfide bonds. Additionally ligation would result in a 
functional ribonuclease, which would not necessarily be compatible with cellular 
labelling. 
 The single overnight treatment with the methylation agent TMS-diazomethane 
that was sufficient with the previous model peptides in Chapter 3 now only yielded 
approximately 40 % methylated product. Following a synthesis with both the Nα,Nɛ-
bis-Boc-L-Lys-OH and Fmoc-Asp(OtBu)-Ser(ψMe,Mepro)-OH the amount of 
methylated product increased to around 67 %. With this improvement it was wondered 
whether increasing the temperature might help as temperature can often decrease 
aggregation. Conducted in a fume hood, as must always be done (Murphy et al., 2009), 
overnight treatment with TMS-diazomethane was carried out at first 30 °C and then 50 
°C. At 30 °C ~ 65 % was methylated, and ~ 66 % at 50 °C. As illustrated in Table 4.1 
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changing the temperature of the reaction had no significant effect on methylation, 
whereas the initial introduction of the pseudoproline increased the amount of 
methylated product by 25 % (Figure 4.1). The addition of the pseudoproline to the 
synthesis has improved on-resin solubility of the peptide and improved methylation, and 
subsequent temperature increases has not had any further effect. To improve solubility 
another method would be to add N-(2-hydroxy-4-methoxybenzyl) (Hmb)-protected 
amino acids into the synthesis, ideally every six or so residues (Johnson et al., 1993, 
Hyde et al., 1994, Simmonds, 1996), preceding the problematic area to disrupt the 
problematic hydrogen-bonding. Like pseudoprolines, these are easily cleaved at the end 
of the synthesis during the TFA treatment. 
 The first ligation attempt with S-peptide N-(Me)sulfonamide was conducted 
under folding conditions with thiophenol additive to replicate the conditions published 
for conformationally-assisted ligation with these peptides (Beligere and Dawson, 1999). 
An isocratic flow was established to distinguish between the ligation product and RNase 
A, predicting a small shift in the HPLC trace when ligating a small peptide onto a much 
larger one. 29 % B in 30 min on the RP-C18 column with a flow rate of 1 ml min-1 was 
found to sufficiently separate the two (Figure 4.2). When no ligation product was 
observed under these conditions it was decided to change the thiol from thiophenol to 
the more soluble MPAA to emulate the ligation conditions in Chapter 3, as this 
increased the concentration of active thioester in aqueous solution (Johnson and Kent, 
2006), however we were concerned it would denature S-protein by reducing disulfides. 
Though the isocratic flow distinguishes between the S-protein and the product the 
analytical-HPLC used did not have a column oven, and fluctuating temperature resulted 
in shifting of the peaks complicating identification leading to the identification of a 
suitable gradient using the Chromolith column. Here we see the first indication of 
90	  
	  
ligation product, with a small peak corresponding to RNase A adjacent to the S-protein 
peak (Figure 4.3). We also observe the thioester intermediate, where S-peptide N-
(Me)sulfonamide has exchanged to S-peptide MPAA thioester. Hydrolysis of S-peptide 
N-(Me)sulfonamide is visible from the t = 0 trace, along with oxidation of MPAA. 
Increasing the amount of thiol and lowering the pH had no effect. 
 In each ligation attempt the intermediate peptide thioester is visible by 
analytical-HPLC. Exchange was carried out separately to ligation, as the use of the pre-
formed S-peptide MPAA thioester should increase the rate by avoiding this rate-limiting 
step. Aryl thiols such as MPAA are good leaving groups for the final ligation step 
because of the stability of the thiophenolate anion, and pre-formed aryl thioesters give 
quicker ligations (Johnson and Kent, 2006). The first exchange used 300 mM MPAA 
and was complete in 5 h (Figure 4.4). In a later exchange MPAA was lowered to 60 mM 
and TCEP-HCl was added to the exchange buffer in an attempt to minimise hydrolysis 
of the S-peptide N-(Me)sulfonamide and oxidation of MPAA as no S-protein was 
present. Exchange was not complete until 48 h and this lengthened time allowed for 
competing hydrolysis of the starting material, with the hydrolysis product becoming 
more substantial from 24 h. A third exchange was conducted with MESNA as an 
alternative thiol with the reasoning that hydrolysis with a less activated thioester would 
be reduced, and with recent literature demonstrating its use in peptide ligation (Adams 
et al., 2013). This yielded the S-peptide MESNA thioester in 24 h with less hydrolysis 
(Figure 4.5). The product of the first exchange reaction was purified for ligation to the 
S-protein, hoping that the use of a pre-exchanged peptide thioester would not only 
increase the speed of ligation but that obviating the presence of thiols that could reduce 
disulfide bonds in the S-protein could also improve efficiency. Additionally we 
wondered if the sulfonamide component might be sterically hindering ligation. Under 
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such conditions the ligation product RNase A is observed but there is no real 
improvement on the amount of product generated without the pre-formed thioester 
(Figure 4.6).  
 Unlike the ligations in Chapter 3, the ligations with RNase A cannot use TCEP-
HCl. This is because the S-protein contains four disulfide bridges (Anfinsen et al., 1954, 
Sela et al., 1957) that need to be maintained for its secondary structure, and the addition 
of TCEP-HCl would reduce them and denature the protein. One of the main problems 
encountered was the shift of the large MPAA peak due to its oxidation, along with 
issues of hydrolysis with the S-peptide N-(Me)sulfonamide and thioester peptides. 
Another problem common to the attempts noted here is that the product forms such a 
small peak adjacent to the large S-protein peak by analytical-HPLC, and is difficult to 
separate by varying the gradient used. It is worth noting that in order to confirm the 
identity of the suspected product peak it should be isolated and assayed for activity, to 
confirm that S-peptide has not ligated to an S-protein side chain. None of the conditions 
examined yielded enough product to do this, and losses from hydrolysis made it 
impractical to continue. The reported conformationally-assisted ligation was limited to a 
single table entry with no further conditions give in the supplementary materials 
(Beligere and Dawson, 1999) and we concluded that their results was probably based on 
misinterpretation of mass spectrometry. Without experimental details for the published 
conformationally-assisted ligation with RNase A many different conditions have been 
attempted with limited success. Considering RNase A was not an ideal split protein 
system for labelling because of size and disulfide bridges, we decided to investigate 
other more promising, smaller split proteins with greater reported affinity.  
 Three different thiols were used in these ligation attempts, as the choice of thiol 
is important. A study to explore thiol exchange in peptide-α-thioesters using model 
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thioester peptides treated with an excess of a competing thiol showed that the use of a 
thiol additive that gives a more reactive leaving group can increase the rate of ligation 
through in situ transthioesterification (Dawson et al., 1997). Ligations with 4 % 
thiophenol were found to be complete in 7 h, whereas ligations with 4 % benzyl 
mercaptan were only 25 % complete in this time. Benzyl mercaptan (pKa 9.4) is a strong 
nucleophile but alkyl thioesters are less reactive, whereas thiophenol (pKa 6) is a poor 
nucleophile that provides highly activated thioesters. The more activated the ester the 
more susceptible it is to potential hydrolysis, as witnessed with the work in this chapter. 
Pre-formed thioesters ligate quicker by eliminating the thioester exchange step, and 
different thiols are better for the two NCL steps of exchange and transthioesterification. 
One of the most popular thiol additives in NCL is MPAA, having no offensive odour 
and higher solubility compared to many other thiol additives (Johnson and Kent, 2006). 
Aryl thiols, such as MPAA (pKa 6.6), provide thioesters that are very good leaving 
groups during the transthioesterification step of a ligation, though exchange can be rate-
limiting. Alkyl thiols, such as MESNA (pKa 9.2), provide alkyl thioesters that make for 
poor leaving groups due to their low reactivity, though the thioester exchange step with 
such a thiol is not rate-limiting in the ligation. The poor basicity of the alkyl thiolate 
makes it a poor leaving group in contrast to the conjucated thiophenolate anion. As such 
the addition of MESNA to a ligation with MPAA slows the reaction by competing 
during the exchange step. Model ligation with MPAA and turkey ovomucoid third 
domain (OMTKY3) established MPAA as one of the more popular thiol choices 
compared to other thiols, for the reasons described (Johnson and Kent, 2006). 
  
  
93	  
	  
4.4.2 Biophysical characterization with BLI 
 Under all conditions tested within this chapter the hydrolysis and oxidation were 
competing side reactions that caused problems. Having varied the pH, thiol, 
concentration of thiol and starting material, and the use of a pre-formed thioester 
peptide, we next thought to optimise the S-peptide. First binding of the full-length 20-
mer S-peptide to S-protein has been used, and the first step was to establish the affinity 
of it for the S-protein for comparison to that reported in the literature. BLI was the 
chosen technique for studying this interaction, after surface plasmon resonance (SPR) 
results in the literature established a Kd of 599.0 nM ± 68 nM (Dwyer et al., 2001). 
Though SPR had been used in this paper we have access to a FortéBio Octet red system 
within the division, allowing for a straightforward collaboration. BLI allows for 
calculation of Kd in a similar manner to SPR, the main difference being that BLI uses 
shaking rather than the fluidics of SPR. This same piece of literature also details the 
high-binding LB2 variant with an observed Kd of 5.4 nM ± 1.3 nM (Dwyer et al., 2001), 
and so this variant was synthesized for analysis by BLI. The truncated 15-mer S-peptide 
noted in the literature for its comparable affinity for the S-protein as the wt (Potts et al., 
1963) was also synthesized, along with a variant with the mutation A20G. The latter 
was synthesized in case the C-terminal Ala used in the ligation attempts provided too 
much steric hindrance. In each instance biotin was coupled to the N-terminus of the 
peptide in order for the S-peptide to be immobilised during experimentation, binding 
streptavidin-coated sensors to monitor the interaction at its C-terminus. By testing three 
alternative sequences we can establish if there are better S-peptides than that currently 
used for ligation. See Table 4.2 for an overview of our BLI results. 
 The Kd of the interaction between the full-length 20-mer S-peptide was 
determined as 730 nM (Figure 4.7), which is in agreement with the published value of 
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600 nM (Dwyer et al., 2001). The truncated complex with the 15-mer S-peptide was 
found to have a Kd of 1.65 µM (Figure 4.7), a reduced affinity compared to the original 
S-peptide. With this variant ruled out, the high-binding LB2 peptide provided a Kd of 
450 nM (Figure 4.8), suggesting an improved interaction to the 20-mer. The literature 
reports that the LB2 variant binds 110-fold more tightly than the wt with a Kd of 5.4 
nM, but we were unable to observe an affinity similar to that. We wondered if this 
difference could be due to the immobilised component in both experiments. In the 
published SPR work the S-protein is immobilised whereas we immobilise the S-peptide, 
and we wondered if as the S-protein is the larger component whether the interaction was 
obstructed by its proximity to the sensor. Perhaps the immobilized S-peptide is too close 
to the surface of the sensor and is less accessible to the S-protein, relayed to us as 
reduced affinity, which could be tested for by the addition of a linker region between 
the S-peptide and the biotin at its N-terminus. Finally the S-peptide with a C-terminal 
Gly was identified as having a similar affinity for the S-protein as the full-length 
peptide, with a Kd of 900 nM (Figure 4.8). Based on these experiments the only variant 
that could potentially improve ligation attempts with the S-protein is the LB2 peptide, 
and the possibility of synthesizing the S-peptide LB2 N-(Me)sulfonamide for further 
conformationally-assisted ligation work  has been left as a potential avenue of future 
work. It was decided to change the split protein system for a smaller one with a higher 
affinity. 
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4.5 Summary 
 Bovine RNase A was chosen as the first split protein system for investigation. 
Conformationally-assisted ligation was observed between the S-peptide N-
(Me)sulfonamide and the S-protein, but hydrolysis of various S-peptide thioesters was 
an issue and ligation itself was limited. A number of thiol additives were explored, 
along with the use of a pre-formed thioester peptide. With limited success alternative 
split proteins were studied. 
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5. Conformationally-assisted ligation with CI2 
5.1 Introduction 
With only limited conformationally-assisted ligation of RNase A components, 
CI2 was chosen as the next candidate. If this system proved successful for translation to 
the proposed labelling method it would be more suitable than RNase A: firstly it has a 
much smaller C-terminal peptide, the portion to be expressed on the target peptide, and 
secondly reconstitution would not generate a functional ribonuclease. As discussed in 
Chapter 1 there is an appreciable amount of literature available, and like RNase A is a 
classic protein for folding studies. 
The key work upon which the following experiments were based is that of 
Beligere and Dawson (Beligere and Dawson, 1999, Beligere and Dawson, 2000), where 
fragments of CI2 were employed to achieve regioselective coupling based upon their 
conformation. This relates to previous work on RNase A via the observation that both 
fragments of the protein maintain folding after subtilisin digestion (Richards and 
Vithayathil, 1959). They hypothesized that the conformation of CI2(1-39) and CI2(40-
64) would bring their interaction site C- and N-termini respectively into close proximity 
and induce ligation. In order to avoid ligation with a β–branched amino acid CI2(1-
39)T39D was synthesized, a substitution shown to have little impact on folding and 
stability (Itzhaki et al., 1995). After demonstrating ligation between CI2(1-39)T39D and 
CI2(40-64)M40C under denaturing conditions, they were influenced by such reactions 
as the ligation between coiled-coil peptides (Lee et al., 1996) to consider the effect of 
conformation on rate. Utilising the peptide conformation and the proximity of the two 
termini at the ligation site the rate was significantly improved under folding conditions 
not only with the native Thr but also with the native Met and no Cys, a ligation which 
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was not observed to occur under denaturing conditions. Later work also assembled a 4-
ester CI2 analogue by conformationally-assisted chemical ligation where four residues 
in the α–helix of CI2(1-39) were substituted with α–hydroxy acids, disrupting three 
neighbouring hydrogen bonds (Beligere and Dawson, 2000). This, along with the T39D 
substitution, would suggest some flexibility in choice of amino acids: in order to ligate 
these peptides must be folded, therefore these substitutions are permitted. 
 
5.2 Conformationally-assisted ligation of CI2(1-39)T39G  
N-(Me)sulfonamide with CI2(40-64) 
The work described by Dawson and colleagues demonstrated the influence of 
peptide conformation. Initial work with CI2 involved repeating the work described 
above, but using CI2(1-39)T39G N-(Me)sulfonamide. It was hypothesized that as 
substituting the β–branched Thr for Asp had no negative impact on ligation, substituting 
to Gly for minimal steric hindrance would cause no problems. CI2(40-64) was 
synthesized with the native Met at its N-terminus. 
 
5.2.1 Preparation of peptides 
CI2(1-39)T39G N-(Me)sulfonamide 
CI2(1-39)T39G N-(Me)sulfonamide was synthesized on PL rink resin (0.39 
mmol g-1 loading, 0.1 mmol) with Fmoc-Gly-4-sulfamylbutyric acid linker (3 eq) using 
microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine deprotection. 
Upon completion of synthesis the resin was methylated by solvation in DCM and 
overnight treatment with TMS-diazomethane in hexanes (2.0 M). Cleaved from the 
resin and purified by preparative-HPLC: RP-C18 column with a gradient of 15 – 30 % 
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B in 5 min, 30 – 60 % B in 30 min and a flow rate of 15 ml min-1. Purified peptide 
freeze-dried (16 mg, 3.12 % yield). 
 
CI2(40-64) 
CI2(40-64) was synthesized on pre-loaded Fmoc-Gly-Wang resin (0.76 mmol g-
1 loading, 0.1 mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling 
and piperidine deprotection. Cleaved from the resin and purified by preparative-HPLC: 
RP-C18 column with a gradient of 20 – 60 % B in 30 min and a flow rate of 15 ml min-
1. Purified peptide freeze-dried. 
 
5.2.2 Ligation with MPAA 
CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.47 mg) was mixed with CI2(40-
64) (1 mM, 0.32 mg) in non-denaturing buffer with TCEP-HCl (50 mM) and MPAA 
(60 mM), pH 6.3. The reaction monitored by analytical-HPLC: RP-C18 column with a 
gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture 
diluted with 8 µl 0.1 % TFA for injection. Over time observe the formation of CI2(1-
39)T39G MPAA thioester, but no ligation product (Figure 5.1). The thioester 
intermediate was collected for confirmation by MALDI-TOF: observed mass = 4427.3 
Da in positive reflector mode, calculated mass = 4424.43 Da. 
Another attempt replicated these conditions but the pH was raised from 6.3 to 
7.5. As with the initial attempt, we observe the formation of CI2(1-39)T39G MPAA 
thioester but no ligation product (data not shown). 
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Figure 5.1: Conformationally-assisted ligation of CI2(1-39)T39G N-(Me)sulfonamide with CI2(40-
64), with MPAA 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4427.3 Da, calculated 
product mass = 4424.43 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (60 mM), pH 6.3. HPLC conditions: RP-C18 
column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = CI2(1-39)T39G N-
(Me)sulfonamide, A’ = CI2(1-39)T39G impurity, B = CI2(40-64), C = CI2(1-39)T39G MPAA 
thioester, * = MPAA (peak truncated), *’ = MPAA impurity.	  
100	  
	  
5.2.3 Thioester exchange with MPAA and benzyl mercaptan 
 Ligation attempts so far have shown thioester exchange with CI2(1-39)T39G N-
(Me)sulfonamide, and it was decided to take advantage of this. By pre-exchanging we 
can introduce the CI2(1-39)T39G thioester directly to CI2(40-64) under the published 
folding conditions, without the requirement for thiol addition and bypassing the 
thioester exchange step to try to increase rate. Firstly the conditions of the above 
ligation attempts was used, with MPAA as the sole thiol. 
 CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.24 mg) was resuspended in non-
denaturing buffer with TCEP-HCl (50 mM) and MPAA (60 mM), pH 7.0. The reaction 
was monitored by analytical-HPLC: RP-C18 column with a gradient of 20 – 60 % B in 
30 min and a flow rate of 1 ml min-1. Exchange is taking place, though perhaps slower 
than ideal.  
 It is decided to add benzyl mercaptan (10 % v/v) before leaving overnight, being 
a strong nucleophile this should make the less reactive CI2(1-39)T39G benzyl 
mercaptan thioester which would be more stable if lengthy exchange times are to be 
expected. Following this we see in the 19 h trace that most of the starting material has 
been used and has converted to the benzyl mercaptan thioester, collected and 
characterized by MALDI-TOF analysis: observed mass = 4383.4 Da in positive 
reflector mode, calculated mass = 4380.22 Da (Figure 5.2). 
 Having converted CI2(1-39)T39G N-(Me)sulfonamide to the CI2(1-39)T39G 
benzyl mercaptan thioester, the exchange reaction was repeated with benzyl mercaptan 
alone. Though there is exchange product in the overnight time point it appears to be 
progressing slower than the previous reaction, suggesting that MPAA must be present 
as a catalyst (data not shown). 
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Figure 5.2: CI2(1-39)T39G N-(Me)sulfonamide thioester exchange with MPAA and benzyl 
mercaptan 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4383.4 Da, calculated 
product mass = 4380.22 Da. 
b. Analytical-HPLC time course of exchange. Exchange conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCL (50 mM), MPAA (60 mM), benzyl mercaptan (10 % v/v from 
4 h), pH 7.0. HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 
min, 1 ml min-1. A = CI2(1-39)T39G N-(Me)sulfonamide, A’ = CI2(1-39)T39G impurity, B = 
CI2(1-39)T39G benzyl mercaptan thioester, * = MPAA (peak truncated), *’ = MPAA impurity, 
# = benzyl mercaptan.	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5.2.4 Thioester exchange with MPAA and benzyl mercaptan at 40 °C 
 The conditions with both thiols were replicated but the temperature increased to 
40 °C to increase the rate, and to have both thiols present from t = 0. 
 CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.44 mg) was resuspended in non-
denaturing buffer with TCEP-HCL (50 mM), benzyl mercaptan (10 % v/v) and MPAA 
(60 mM), pH 7.0. The reaction was performed at 40 °C with 350 rpm shaking and 
monitored by analytical-HPLC: RP-C18 column with a gradient of 20 – 60 % B in 30 
min and a flow rate of 1 ml min-1. The exchange is now visibly quicker with a 
substantial amount of product by 7 h, collected and characterized by MALDI-TOF 
analysis: observed mass = 4381.9 Da in positive reflector mode, calculated mass = 
4380.22 Da (Figure 5.3).  
 This was then repeated on a larger scale to collect CI2(1-39)T39G benzyl 
mercaptan thioester to perform conformationally-assisted ligation with a pre-exchanged 
thioester peptide. CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 34 mg) dissolved in non-
denaturing buffer with TCEP-HCL (50 mM), MPAA (60 mM) and benzyl mercaptan 
(10 % v/final v), pH 7.0. Monitored at t = 0 and again after 8 h by analytical-HPLC: RP-
C18 column with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. At 
this time CI2(1-39)T39G benzyl mercaptan thioester purified by semi preparative-
HPLC: RP-C18 column with a gradient of 30 – 70 % B in 30 min and a flow rate of 5 
ml min-1. Purified peptide freeze-dried (8 mg, 23.5 % yield). 
 
5.2.5 Ligation with MPAA and benzyl mercaptan 
Returning to conformationally-assisted ligation, the successful thioester 
exchange conditions were used. CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.46 mg) 
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was mixed with CI2(40-64) (1 mM, 0.42 mg) in non-denaturing buffer with TCEP-HCl 
(50 mM), MPAA (60 mM) and benzyl mercaptan (10 %), pH 6.3. The reaction was 
monitored by analytical-HPLC: RP-C18 column with a gradient of 20 – 60 % B in 30 
min and a flow rate of 1 ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for 
injection. Over time the CI2(1-39)T39G benzyl mercaptan thioester forms, but no 
ligation product (data not shown). The intermediate was collected and characterized by 
MALDI-TOF analysis: observed mass = 4383.2 Da in positive reflector mode, 
calculated mass = 4380.22 Da. 
 
5.2.6 Ligation with pre-formed thioester peptide and thiophenol 
 With CI2(1-39)T39G as a thioester peptide, the published conditions of 
thiophenol (2 % v/v) (Beligere and Dawson, 1999) were used to attempt 
conformationally-assisted ligation with a pre-exchanged thioester peptide.  
CI2(1-39)T39G benzyl mercaptan thioester (1 mM, 0.22 mg) was mixed with 
CI2(40-64) (1 mM, 0.15 mg) in non-denaturing buffer with thiophenol (2 % v/v), pH 
7.5. The reaction was monitored by analytical-HPLC: RP-C18 column with a gradient 
of 30 – 60 % B in 30 min and a flow rate of 1 ml min-1. The thiophenol was added to the 
stock buffer and so 1 µl extra was added directly to the ligation reaction at 3 h in case 
not enough had been transferred. Over time observed the formation of CI2(1-39)T39G 
thiophenol thioester, but no ligation product (Figure 5.4). The thiophenol thioester was 
collected and confirmed by MALDI-TOF analysis: observed mass = 4369.2 Da in 
positive reflector mode, calculated mass = 4366.19 Da. 
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Figure 5.3: CI2(1-39)T39G N-(Me)sulfonamide thioester exchange with MPAA and benzyl 
mercaptan at 40 °C 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4381.9 Da, calculated 
product mass = 4380.22 Da. 
b. Analytical-HPLC time course of exchange. Exchange conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (60 mM), benzyl mercaptan (10 % v/v), pH 
7.0, 40 °C. HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 
min, 1 ml min-1. A = CI2(1-39)T39G N-(Me)sulfonamide, A’ = CI2(1-39)T39G impurity, B = 
CI2(1-39)T39G benzyl mercaptan thioester, * = MPAA (peak truncated), *’ = MPAA impurity, 
# = benzyl mercaptan.	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Figure 5.4: Conformationally-assisted ligation of CI2(1-39)T39G benzyl mercaptan thioester with 
CI2(40-64) 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4369.2 Da, calculated 
product mass = 4366.19 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptide (1 mM), sodium 
phosphate (100 mM), thiophenol (2 % v/v), pH 7.5. HPLC conditions: RP-C18 column, 30 – 60 
% B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = CI2(40-64), B = CI2(1-39)T39G 
benzyl mercaptan thioester, C = CI2(1-39)T39G thiophenol thioester.	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5.3 Biophysical characterization 
 Attempts to ligate with a Gly residue at the interaction site yielded no success, 
so the interaction was further investigated. After the success of BLI with the RNase S 
peptides this was the initial route of examination, followed by fluorescence 
spectroscopy. CI2(1-39)T39G was biotinylated at its N-terminus for immobilization to 
streptavidin-coated sensors, to monitor the interaction at its C-terminus with CI2(40-
64). The concentrations of the peptides were established by UV/VIS spectrophotometry. 
 
5.3.1 Preparation of peptides 
Biotinylated CI2(1-39)T39G 
Biotinylated CI2(1-39)T39G was synthesized on pre-loaded Fmoc-Gly-Wang 
resin (0.1 mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and 
piperidine deprotection. Upon completion of synthesis biotin was coupled at the N-
terminus, confirmed with a negative Kaiser test. Cleaved from the resin and purified by 
preparative-HPLC: RP-C18 column with a gradient of 20 – 70 % B in 30 min and a 
flow rate of 15 ml min-1. Purified peptide freeze-dried (14 mg, 2.76 % yield). 
 
5.3.2 BLI with CI2(1-39)T39G 
Biotin-CI2(1-39)T39G (2 µg ml-1) binds streptavidin-coated sensors via its N-
terminus and is introduced to varying concentrations of CI2(40-64) (20 – 100 nM) in a 
buffer of HEPES (10 mM), Tween (0.005 %) and EDTA (2 mM), pH 7.0. Unable to 
determine a value for the Kd after no interaction was observed. 
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5.3.3 Fluorescence spectroscopy 
After BLI proved inappropriate for surveying affinity, fluorescence spectroscopy 
was used. If the peptides are interacting, a decrease in fluorescence should be observed 
as Trp5 and Tyr42 become obscured when the two peptides interact and fold. 
Fluorescence data were obtained by titrating varying concentrations of CI2(40-
64) (1.88, 2.81 and 4.65 µM) into CI2(1-39)T39G (2.3 µM), and after 25 s the 
fluorescence at 345 nm monitored over 800 s. All peptides in a PBS buffer at pH 7.4. 
Decreased fluorescence and a concentration-dependent rate establishes a high affinity 
interaction is taking place (Figure 5.5). 
 
 
 
Figure 5.5: Fluorescence spectroscopy of CI2 peptide interaction 
CI2(40-64) (1.88, 2.81 and 4.65 µM) is titrated into CI2(1-39)T39G (2.3 µM), and after 25 s the 
fluorescence at 345 nm monitored over 800 s, in PBS buffer at pH 7.4.   
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5.4 Conformationally-assisted ligation of CI2(1-39)T39G N-(Me) 
 sulfonamide with CI2(40-64)M40C  
 Although the published work detailed in section 5.1 by Beligere and Dawson 
demonstrated conformationally-assisted chemical ligation with the native N-terminal 
Met  of CI2(40-64), the rate was significantly improved with its substitution for Cys, 
supporting the idea that peptide conformation can be exploited to encourage ligation at 
difficult sites. CI2(40-64)M40C was synthesized to encourage ligation with CI2(1-
39)T39G N-(Me)sulfonamide. 
 
5.4.1 Preparation of peptides 
CI2(40-64)M40C 
CI2(40-64)M40C was synthesized on pre-loaded Fmoc-Gly-Wang resin (0.1 
mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine 
deprotection. Cleaved from the resin and purified by preparative-HPLC: RP-C18 
column with a gradient of 15 – 30 % in 5 min, 30 – 50 % in 30 min and a flow rate of 
15 ml min-1. Purified peptide freeze-dried (21.4 mg, 5.85 % yield). 
 
5.4.2 Ligation with thiophenol 
This first ligation attempt used the thiol in the paper discussed in 5.1, 
thiophenol, and was carried out under folding conditions. 
CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.66 mg) added to CI2(40-
64)M40C (1 mM, 0.47 mg) in degassed non-denaturing buffer with TCEP-HCl (50 
mM) and thiophenol (20 % v/v), pH 6.3. The reaction was monitored by analytical-
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HPLC: RP-C18 column with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 
ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection.  20 % 
thiophenol was accidentally used rather than 2 %, but under these conditions the 
ligation was complete in 2 h (Figure 5.6). The ligation product was collected for 
MALDI-TOF confirmation: observed mass = 7238.0 Da in positive reflector mode, 
calculated mass = 7231.51 Da. 
 
5.4.3 Ligation with thiophenol, denaturing conditions 
To demonstrate that the ligation in section 5.4.2 is conformationally-assisted, a 
control reaction using denaturing conditions was carried out. 
CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.29 mg) added to CI2(40-
64)M40C (1 mM, 0.20 mg) in degassed denaturing buffer with TCEP-HCl (50 mM) and 
thiophenol (2 % v/v), pH 6.3. The reaction monitored by analytical-HPLC: RP-C18 
column with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl 
reaction mixture diluted with 8 µl 0.1 % TFA for injection.  Though 2 % thiophenol was 
used in this instance, no ligation is observed by 24 h (Figure 5.7). 
 
5.4.4 Ligation with MPAA 
 Its smell and solubility do not make thiophenol the ideal choice for a ligation 
thiol. As such the final ligation used MPAA. 
CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.29 mg) added to CI2(40-
64)M40C (1 mM, 0.20 mg) in degassed non-denaturing buffer with TCEP-HCl (50 
mM) and MPAA (60 mM), pH 6.5. The reaction monitored by analytical-HPLC: RP-C4 
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column with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. A C4 
column was chosen because of the poor separation of CI2(40-64)M40C and thiophenol 
in the previous section. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection 
(Figure 5.8).  Conformationally-assisted ligation proceeds to completion in 24 h, formed 
even in the t = 0 time point’s HPLC trace. The product was collected and characterized 
by MALDI-TOF analysis: observed mass = 7234.0 Da in positive linear mode, 
calculated mass = 7231.51 Da. 
Conformationally-assisted ligation with MPAA as the chosen thiol was repeated 
to deduce a yield for the reaction, taking time points at just t = 0 and the end of the 
reaction rather than monitoring throughout. 
CI2(1-39)T39G N-(Me)sulfonamide (1 mM, 0.30 mg) was mixed with CI2(40-
64)M40C (1 mM, 0.22 mg) in degassed non-denaturing buffer with TCEP-HCl (50 
mM) and MPAA (60 mM), pH 6.5. Time points were taken at t = 0 and 26 h and 
checked by analytical-HPLC: RP-C4 column with a gradient of 20 – 70 % B in 30 min 
and a flow rate of 1 ml min-1. Confirmed to be complete, the remaining volume was 
injected over four runs to collect the ligation product. Purified peptide freeze-dried (0.5 
mg, 96.2 % yield). 
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Figure 5.6: Conformationally-assisted ligation of CI2(1-39)T39G N-(Me)sulfonamide with CI2(40-
64)M40C, with thiophenol 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 7238.0 Da, calculated product 
mass = 7231.51 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), thiophenol (20 % v/v), pH 6.3. HPLC conditions: 
RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = CI2(1-
39)T39G N-(Me)sulfonamide, A’ = CI2(1-39)T39G impurity, B = CI2(40-64)M40C, C = 
ligation product * = thiophenol.	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Figure 5.7: Conformationally-assisted ligation of CI2(1-39)T39G N-(Me)sulfonamide with CI2(40-
64)M40C, denaturing conditions 
Analytical-HPLC time course of ligation. Ligation conditions: peptide (1 mM), sodium phosphate (100 
mM), TCEP-HCl (50 mM), thiophenol (2 % v/v), pH 6.3. HPLC conditions: RP-C18 column, 20 – 60 % 
B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = CI2(1-39)T39G N-(Me)sulfonamide, A’ = 
CI2(1-39)T39G impurity, B = CI2(40-64)M40C.  
113	  
	  
 
 
Figure 5.8: Conformationally-assisted ligation of CI2(1-39)T39G N-(Me)sulfonamide with CI2(40-
64)M40C, with MPAA 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 7234.0 Da, calculated product 
mass = 7231.51 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (60 mM), pH 6.5. HPLC conditions: RP-C4 
column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = CI2(1-39)T39G N-
(Me)sulfonamide, A’ = CI2(1-39)T39G impurity, B = CI2(40-64)M40C, C = ligation product * 
= MPAA (peak truncated).	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5.5 Attempting conformationally-assisted ligation with CI2 
5.5.1 Conformationally-assisted ligation 
 The idea of using CI2 to demonstrate conformationally-assisted ligation using a 
peptide N-(Me)sulfonamide was based upon the published work discussed at the 
beginning of this chapter, where CI2 peptide fragments were shown to ligate under 
folding conditions in both the presence and absence of a Cys at the ligation site 
(Beligere and Dawson, 1999). In this paper the native Thr at the C-terminus of CI2(1-
39) is replaced with Asp, so we hypothesized that replacing it with Gly would have no 
detrimental effect. A Gly at the ligation site should increase the opportunity for 
conformationally-assisted ligation by minimising steric hindrance at the reaction site. 
 This first set of ligations used CI2(1-39)T39G N-(Me)sulfonamide and CI2(40-
64), with its native N-terminal Met. The initial attempt used folding conditions and 60 
mM MPAA as the thiol additive, at pH 6.3 as with the work of Beligere and Dawson. 
The thioester exchange intermediate, CI2(1-39)T39G MPAA thioester, was observed 
but no ligation product (Figure 5.1). It was decided to raise the pH in line with the 
previous peptide N-(Me)sulfonamide ligations and so a replica experiment was 
conducted at pH 7.5. This too generated CI2(1-39)T39G MPAA thioester but no 
ligation product. 
 As the thioester exchange step readily occurs under these conditions it was 
decided to define the ideal conditions for this to take place, in order to collect enough to 
ligate with the pre-exchanged thioester peptide. Firstly the above ligation conditions 
were repeated but without the presence of CI2(40-64), and this exchange with MPAA 
was relatively slow. In order to leave the reaction overnight benzyl mercaptan was 
added with the thought that CI2(1-39)T39G benzyl mercaptan thioester might be more 
stable to this lengthy exchange, benzyl mercaptan being a strong nucleophile and thus 
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providing a less reactive thioester peptide. The time point of the following morning 
showed near complete conversion to the benzyl mercaptan thioester, and no remaining 
MPAA thioester (Figure 5.2). 
 Having observed this conversion the next reaction left out the MPAA and used 
benzyl mercaptan (10 % v/v) alone. Though the benzyl mercaptan thioester forms it 
does so slower than when MPAA is present, and so the MPAA is acting as a catalyst to 
this reaction. This combination of MPAA and benzyl mercaptan was re-employed but 
with increased temperature, the reaction now at 40 °C (Figure 5.3). There is substantial 
exchange product present by the 7 h time point, and so the reaction was repeated on a 
larger scale for collection of CI2(1-39)T39G benzyl mercaptan thioester to perform 
ligation with a pre-exchanged thioester peptide. 
 To conduct a thorough investigation of conformationally-assisted ligation 
between CI2(1-39)T39G N-(Me)sulfonamide and CI2(40-64), the successful exchange 
conditions combining MPAA and benzyl mercaptan were used. No ligation product is 
observed, despite the benzyl mercaptan thioester peptide readily forming under these 
conditions. Finally the pre-exchanged CI2(1-39)T39G benzyl mercaptan thioester was 
added to CI2(40-64) under conditions similar to those published, in non-denaturing 
buffer and with 2 % thiophenol (Figure 5.4). Due to the nature of thiophenol’s solubility 
an additional 1 µl was added directly to the reaction mix after 3 h, in case the lack of 
ligation was a result of not enough thiophenol transferred from the stock buffer. The 
CI2(1-39)T39G benzyl mercaptan thioester converts to the thiophenol thioester, which 
is more weakly activated and therefore less likely to ligate. Future work could involve 
using a pre-exchanged thioester peptide without any thiol additives, though no ligation 
was observed prior to the addition of extra thiophenol in this most recent attempt. 
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We wondered if the use of CI2(1-39)T39D was a true representation of 
conformationally-assisted ligation, or if an anhydride intermediate played a role. Since 
the publication of the ligation by Beligere and Dawson, Botti and co-workers identified 
the formation of a succinic anhydride intermediate of Asp-Cys ligation formed during 
attack by the Asp side chain (Villain et al., 2003) (Scheme 5.1). This reaction is later 
discussed by Kent and colleagues who confirmed the unsuitability of an Asp-Cys site 
for ligation (Dang et al., 2013). The succinic anhydride is more highly activated than the 
original thioester peptide, and may have been responsible for the increased observed 
rate of the published conformationally-assisted ligation. Future work could include the 
synthesis of CI2(1-39)T39D to try to replicate the Beligere and Dawson work, but even 
if we did the lack of selectivity provided by the anhydride would not be ideal for a 
protein labelling method, as we could not guarantee that coupling to other N-termini 
besides that targeted would not occur. 
 
 
Scheme 5.1: Succinic anhydride formation at a C-terminal Asp thioester peptide 
Attack of the C-terminal Asp side chain in the thioester peptide can form the succinic anhydride 
intermediate (Villain et al., 2003, Dang et al., 2013) that is more highly activated than the original 
thioester peptide, resulting in increased ligation rates but reduced selectivity.  
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5.5.2 Biophysical characterization 
 After no conformationally-assisted ligation was observed between CI2(1-
39)T39G N-(Me)sulfonamide and CI2(40-64) the interaction between these peptides 
was investigated further with biophysical techniques. The native Thr at the C-terminus 
of CI2(1-39) has been replaced by Gly, and though this was meant to minimise steric 
hindrance and promote ligation perhaps it has detrimentally affected the affinity 
between the peptides. 
 When the RNase A peptides were studied in this way, BLI was used to establish 
Kd values. CI2(1-39)T39G was synthesized with N-terminal biotin for immobilization to 
streptavidin-coated sensors, maintaining a free C-terminus for interaction with CI2(40-
64). Surprisingly no interaction was observed using this technique. One possibility 
could be if CI2(1-39)T39G is too close to the sensor for CI2(40-64) to access its C-
terminus, and to test this a linker could be introduced at its N-terminus. 
 Concerned that these peptides might not be interacting, fluorescence 
spectroscopy was used to probe further. Both peptides have aromatic residues capable 
of emitting fluorescence when excited, CI2(1-39)T39G with Trp5 and CI2(40-64) with 
Tyr42. If the peptides are interacting the emitted fluorescence should decrease, where 
these residues become buried upon peptide folding. CI2(40-64) was titrated into CI2(1-
39)T39G at varying concentrations, and after 25 s their interaction monitored at 345 nm 
for 800 s (Figure 5.5). A concentration-dependent interaction is observed, and the 
decrease in fluorescence over this time tells us that the peptides are definitely 
interacting and folding. Though this is promising in terms of their affinity for one 
another and theoretical capability for conformationally-assisted ligation, it does not help 
to explain why this has not yet taken place. As with RNase A no conditions besides that 
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of the ligation are provided in the literature for conformationally-assisted ligation with 
CI2, and so there were no obvious ideas for improvement.  
 
5.5.3 Conformationally-assisted ligation with Cys 
 Having established that a non-covalent interaction is taking place at this reaction 
site CI2(40-64)M40C was synthesized for renewed conformationally-assisted ligation 
attempts. Though ligation at a Gly-Met site was not demonstrated the fluorescence 
spectroscopy results show that interaction at this site is happening, and so introducing a 
Cys to this site should allow for ligation. Conformationally-assisted ligation with an 
Asp-Cys at the ligation site takes a quarter of the time as with the native Met (Beligere 
and Dawson, 1999), and so our Gly-Cys ligation should stand a better chance of 
working than the Gly-Met site investigated in section 5.2. 
 The first attempt between CI2(1-39)T39G N-(Me)sulfonamide and CI2(40-
64)M40C took place under the published conditions, phosphate buffer at pH 6.3 with 
thiophenol. 20 % thiophenol was used in place of the 2 % in literature, and under these 
conditions ligation was complete in 2 h (Figure 5.6). The addition of Cys has resulted in 
a fast ligation, and the thioester intermediate is not observed. 
 To show that the ligation is conformationally-assisted it was next conducted 
under denaturing conditions. Some ligation may be expected, as we are investigating a 
Gly-Cys ligation site, but without peptide conformation any ligation should be 
significantly slower. No ligation is observed and so it can be concluded that the 
previous ligation is in fact conformationally-assisted, with the structure of the peptides 
crucial to its success. Though 2 % thiophenol was used instead of 20 % in this instance 
there is still no evidence of ligation after 24 h (Figure 5.7). 
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 The offensive odour of thiophenol makes it not the favourite choice for ligation 
reactions. As discussed in Chapter 4 MPAA is commonly used as a thiol additive, and 
so the current ligation was repeated with MPAA. Ligation was complete in 24 h and the 
thioester intermediate is not observed, with ligation product visible from as early as the t 
= 0 trace (Figure 5.8). 
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5.6 Summary 
Following the ligation problems with RNase A, CI2 was chosen as the next split 
protein system. CI2(1-39)T39G N-(Me)sulfonamide was synthesized for 
conformationally-assisted ligation studies with CI2(40-64). No ligation is detected, even 
with the pre-formed thioester, but fluorescence spectroscopy confirmed that the peptides 
were interacting and folding. CI2(40-64)M40C was synthesized and successfully ligated 
to CI2(1-39)T39G N-(Me)sulfonamide under folding conditions. The search continues 
for a split protein capable of conformationally-assisted ligation at a Cys-free site. 
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6. Conformationally-assisted reactions with 
calbindin D9k 
6.1 Introduction 
 The work described so far on the limited success with both RNase A and CI2 
has led to the search for a third split protein. Following the work with RNase A, CI2 
was chosen for, among other reasons, its greater affinity. No conformationally-assisted 
ligation was observed in this split protein unless a Cys residue was introduced to the 
reaction site, and so we wanted to find a split protein with fragments possessing a 
higher affinity again. A split protein that stood out for us, noted from the Linse review 
upon which Table 1.2 is based (Carey et al., 2007), was a calbindin D9k variant. A very 
high affinity is reported between its two peptides, an interaction with a Kd of 3 pM 
(Berggård et al., 2001), in addition to the relatively small size of both peptides. The 
work published in this paper investigated the contributing factors of non-covalent 
interactions on protein structure, notably the role of residue substitutions in the 
hydrophobic core. It was demonstrated in reconstitution studies that the hydrophobic 
core of a protein plays a key role in the generation of fragment complexes with native 
structures and activities (Richards, 1958), and so SPR was employed to study the effect 
of introducing mutations in this area. Though dissociation curves were not observed as 
concentration-dependent, association curves were: the equilibrium association constant 
KA for wt-EF1 was determined as 3.5 x 1011 M-1. We thought that two peptides with 
such an affinity could surely undergo conformationally-assisted ligation, and so 
calbindin D9k was chosen as our final split protein to study. 
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6.2 Biophysical characterization 
 Fluorescence spectroscopy was also used by Linse and co-workers to confirm 
folding and complex formation, using an EF2 mutant with a F66W substitution. It was 
decided to use BLI to study the interaction between our synthetic EF1 and EF2 peptides, 
following successful Kd determination for RNase A in Chapter 4. The F66W variant 
was used rather than wt-EF2 to allow for concentration determination by UV/VIS 
spectrophotometry, and in each experiment the EF2 peptide was immobilized to a 
streptavidin-coated sensor via its biotinylated C-terminus. Three interaction sites were 
investigated by substituting the amino acids at the appropriate N- of C-termini. The first 
interaction was between wt-EF1 and EF2 F66W, with a Gly-Met interaction. The 
second used a Ser-Ser interaction, and the final investigated a Gly-Gly interaction. 
Following this CD spectroscopy was used to probe the extent of conformation 
held by the peptides possessing a Gly-Gly interaction site, and the effect of calcium on 
this conformation. 
 
6.2.1 Preparation of peptides 
EF1 
EF1 synthesized on pre-loaded Fmoc-Gly-Wang resin (0.76 mmol g-1 loading, 
0.1 mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and 
piperidine deprotection. Cleaved from the resin, resuspended in the denaturing buffer 
with TCEP-HCl (50 mM) and purified by preparative-HPLC: RP-C18 column with a 
gradient of 15 – 30 % B in 5 min, 30 – 70 % B in 30 min and a flow rate of 15 ml min-1. 
Purified peptide freeze-dried (68.3 mg, 12.1 % yield). 
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EF1+S 
EF1+S synthesized on pre-loaded Fmoc-Ser(tBu)-Wang resin (0.05 mmol) using 
microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine deprotection. 
Cleaved from the resin, resuspended in the denaturing buffer with TCEP-HCl (50 mM) 
and purified by preparative-HPLC: RP-C18 column with a gradient of 15 – 30 % B in 5 
min, 30 – 70 % B in 30 min and a flow rate of 15ml min-1. Purified peptide freeze-dried 
(64.8 mg, 22.6 % yield). 
 
EF2 F66W-PEG biotin 
EF2 F66W-PEG biotin was synthesized on Fmoc-PEG biotin NovaTag resin 
(0.36 mmol g-1 loading, 0.05 mmol) using microwave-assisted Fmoc-SPPS with 
DIC/HOBT coupling and piperidine deprotection. Cleaved from the resin, resuspended 
in the denaturing buffer with TCEP-HCl (50 mM) and purified by preparative-HPLC: 
RP-C18 column with a gradient of 15 – 35 % B in 5 min, 35 – 70 % in 30 min and a 
flow rate of 15 ml min-1. Purified peptide freeze-dried (6 mg, 2.54 % yield). 
 
EF2 ΔM43/F66W-PEG biotin 
EF2 ΔM43/F66W-PEG biotin was synthesized on Fmoc-PEG biotin NovaTag 
resin (0.36 mmol g-1 loading, 0.075 mmol) using microwave-assisted Fmoc-SPPS with 
DIC/HOBT coupling and piperidine deprotection. Cleaved from the resin, resuspended 
in the denaturing buffer with TCEP-HCl (50 mM) and purified by preparative-HPLC: 
RP-C18 column with a gradient of 15 – 35 % B in 5 min, 35 – 70 % in 30 min and a 
flow rate of 15ml min-1. Purified peptide freeze-dried (2.1 mg, 0.6 % yield). 
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EF2 ΔM43/S44G/F66W-PEG biotin 
EF2 ΔM43/S44G/F66W-PEG biotin was synthesized on Fmoc-PEG biotin 
NovaTag resin (0.36 mmol g-1 loading, 0.1 mmol) using microwave-assisted Fmoc-
SPPS with DIC/HOBT coupling and piperidine deprotection. Cleaved from the resin, 
resuspended in the denaturing buffer with TCEP-HCl (50 mM) and purified by 
preparative-HPLC: RP-C18 column with a gradient of 15 – 35 % B in 5 min, 35 – 70 % 
in 30 min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (32.8 mg, 7.18 % 
yield).  
 
EF2 ΔM43/S44GF66W-NH2 
EF2 ΔM43/S44G/F66W-NH2 was synthesized on PL rink resin (0.39 mmol g-1 
loading, 0.1 mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling 
and piperidine deprotection. Cleaved from the resin, resuspended in the denaturing 
buffer and purified by preparative-HPLC: RP-C18 column with a gradient of 15 – 35 % 
B in 5 min, 35 – 70 % B in 30 min and a flow rate of 15 ml min-1. Purified peptide 
freeze-dried (yield not determined). 
 
6.2.2 BLI of Gly-Met interaction 
EF2 F66W-PEG biotin (2 µg ml-1) binds streptavidin-coated sensors via its C-
terminus and is introduced to varying concentrations of EF1 (0.1 – 10 µM), both 
peptides in a buffer of HEPES (10 mM), Tween (0.005 %) and CaCl2 (2 mM) at pH 7.0. 
A Kd value of 47.7 nM ± 5.8 nM was observed for [EF1] 0.1 – 4 µM (Figure 6.1). 
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6.2.3 BLI of Ser-Ser interaction 
EF2 ΔM43/F66W-PEG biotin (2 µg ml-1) binds streptavidin-coated sensors via 
its C-terminus and is introduced to varying concentrations of EF1+S (0.1 – 10 µM), 
both peptides in a buffer of HEPES (10 mM), Tween (0.005 %) and CaCl2 (2 mM) at 
pH 7.0. A Kd value of 59.8 nM ± 12.8 nM was observed for [EF1+S] 0.1 – 4 µM 
(Figure 6.2). 
 
6.2.4 BLI of Gly-Gly interaction 
EF2 ΔM43/S44G/F66W-PEG biotin (2 µg ml-1) binds streptavidin-coated 
sensors via its C-terminus and is introduced to varying concentrations of EF1 (0.1 – 10 
µM), both peptides in a buffer of HEPES (10 mM), Tween (0.005 %) and CaCl2 (2 mM) 
at pH 7.0. A Kd value of 69.0 nM ± 9.8 nM was observed for [EF1] 0.1 – 10 µM (Figure 
6.3). 
 
6.2.5 BLI of Gly-Gly interaction in the presence of EDTA 
 The above BLI was repeated but in a buffer containing EDTA in place of 
calcium, to begin to establish the effect of calcium on the peptides’ interaction. 
 EF2 ΔM43/S44G/F66W-PEG biotin (2 µg ml-1) binds streptavidin-coated 
sensors via its C-terminus and is introduced to varying concentrations of EF1 (0.1 – 10 
µM), both peptides in a buffer of HEPES (10 mM), Tween (0.005 %) and EDTA (2 
mM) at pH 7.0. The raw data indicated non-specific binding to the sensor (Figure 6.4). 
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Figure 6.1: BLI analysis of Gly-Met interaction 
a. Raw data for [EF1] 0.1 – 1 µM interacting with immobilized EF2, along with controls with EF2 
blank replacements. E = equilibration, L = loading, W = wash, A = association, D = dissociation. 
b. Raw data for [EF1] 2 – 4 µM interacting with immobilized EF2, along with controls with EF2 
blank replacements. E = equilibration, L = loading, W = wash, A = association, D = dissociation. 
c. kobs plotted against [EF1], the gradient giving a Kd of 47.7 nM ± 5.8 nM. 
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Figure 6.2: BLI analysis of Ser-Ser interaction 
a. Raw data for [EF1+S] 0.1 – 1 µM interacting with immobilized EF2, along with controls with 
EF2 blank replacements. E = equilibration, L = loading, W = wash, A = association, D = 
dissociation. 
b. Raw data for [EF1+S] 2 – 4 µM interacting with immobilized EF2, along with controls with EF2 
blank replacements. E = equilibration, L = loading, W = wash, A = association, D = dissociation. 
c. kobs plotted against [EF1+S], the gradient giving a Kd of 59.8 nM ± 12.8 nM.  
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Figure 6.3: BLI analysis of Gly-Gly interaction 
a. Raw data for [EF1] 0.1 – 1 µM interacting with immobilized EF2, along with controls with EF2 
blank replacements. E = equilibration, L = loading, W = wash, A = association, D = dissociation. 
b. Raw data for [EF1] 2 – 10 µM interacting with immobilized EF2, along with controls with EF2 
blank replacements. E = equilibration, L = loading, W = wash, A = association, D = dissociation. 
c. kobs plotted against [EF1], the gradient giving a Kd of 69.0 nM ± 9.8 nM. 
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Figure 6.4: BLI analysis of Gly-Gly interaction with EDTA 
Raw data for [EF1] 0.1 – 1 µM interacting with immobilized EF2 in the presence of a chelator, along with 
controls with EF2 blank replacements. E = equilibration, L = loading, W = wash, A = association, D = 
dissociation. Non-specific binding is observed, illustrated by the response of the control experiments. 
 
 
6.2.6 CD spectroscopy of Gly-Gly interaction 
The next line of enquiry was to determine the level of folding under 2 mM 
calcium, and compare it to in the presence of a calcium chelator. CD experiments were 
conducted with both EF1 and EF2 ΔM43/S44G/F66W-NH2 in either the CD EDTA or 
calcium buffer, first individually and then when mixed at low micromolar 
concentrations. In the EDTA buffer EF1 (30.4 µM) and EF2 S44G/F66W-NH2 (25.2 
µM) were first analysed individually and then after mixing, in a 2 mm cuvette. In the 
calcium buffer EF1 (47.4 µM) and EF2 S44G/F66W-NH2 (41.5 µM) were again 
analysed separately before mixing, in a 1 mm cuvette (Figure 6.5). Wavelengths from 
200 – 250 nm were measured in both experiments. 
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In each buffer both EF1 and EF2 ΔM43/S44G/F66W-NH2 showed α–helical 
content (Table 6.1), and in the calcium buffer the interacting peptides had greater α-
helical content than that predicted. EF1 was found to contain 17.7 % α-helix in the 
EDTA-containing buffer in comparison with 43.8 % in the calcium-containing buffer, 
and EF2 was shown to consist of 19.8 % α-helix in the absence compared to 37.2 % 
with 2 mM calcium. 
 
 
 
 
 % 
 α-helix β-sheet Turn Random 
EF1 with EDTA 17.7 16.8 14.6 51.0 
EF2 with EDTA 19.8 14.6 14.7 50.9 
EF1 with calcium 43.8 11.8 16.0 28.4 
EF2 with calcium 37.2 16.6 18.2 28.0 
 
Table 6.1: The structural content of calbindin D9k peptides with 2 mM CaCl2 or 2 mM EDTA 
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Figure 6.5: CD analysis of Gly-Gly interaction, with either 2 mM CaCl2 or a calcium chelator 
a. In the presence of the chelator, the mixed (green spectrum) peptides EF1 (30.4 µM) and 
S44G/F66W EF2 (25.2 µM) have comparable level of ordered structure to that predicted (grey 
spectrum) from the spectra of the individual peptides (EF1 = red spectrum, EF2 
ΔM43/S44G/F66W = blue spectrum). Buffer: HEPES (10 mM), Tween (0.005 %), EDTA (0.5 
mM), pH 7.0. 2 mm cuvette. 
b. With 2 mM calcium, the mixed (green spectrum) peptides EF1 (47.4 µM) and S44G/F66W EF2 
(41.5 µM) have more ordered structure than that predicted from individual analysis (EF1 = red 
spectrum, EF2 ΔM43/S44G/F66W = blue spectrum). Buffer: HEPES (10 mM), Tween (0.005 
%), CaCl2 (0.5 mM), pH 7.0. 1 mm cuvette. 
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6.3 Conformationally-assisted chemical ligation and thioester 
 exchange 
Despite observing the thioester exchange intermediate during attempts with CI2 
in section 5.2 and only limited ligation in the attempt with RNase A peptides in section 
4.2, it was hypothesized that the combination of the demonstrated affinity and 
conformation upon interaction with calcium could encourage conformationally-assisted 
ligation. As such, under folding conditions and in the presence of thiols, a native amide 
bond would form at a cysteine-free site. These renewed attempts to demonstrate 
conformationally-assisted chemical ligation between split protein peptide fragments 
utilised EF1 as an N-(Me)sulfonamide peptide, and EF2 with a Gly at its N-terminus. 
 
6.3.1 Preparation of peptides 
EF1 N-(Me)sulfonamide 
EF1 N-(Me)sulfonamide was synthesized on pre-loaded Fmoc-Gly-4-
sulfamylbutyryl rink amide AM resin (0.26 mmol g-1 loading, 0.1 mmol) using 
microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine deprotection. 
Upon completion of synthesis the resin was methylated by solvation in DCM and 
overnight treatment with TMS-diazomethane in hexanes (2.0 M). Cleaved from the 
resin, resuspended in the denaturing buffer with TCEP-HCl (50 mM) and purified by 
preparative-HPLC: RP-C18 with a gradient of 15 – 35 % B in 5 min, 35 – 60 % B in 30 
min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (18.2 mg, 3.13 % 
yield). 
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6.3.2 Ligation with CaCl2 
The published buffer in which the very low Kd value was obtained contained 2 
mM CaCl2. Thus the calcium non-denaturing buffer was employed, where EDTA is 
replaced with CaCl2 (2 mM). 
EF1 N-(Me)sulfonamide (1 mM, 0.48 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.38 mg) in degassed calcium non-denaturing 
buffer with TCEP-HCl (50 mM) and MPAA (300 mM), pH 7.0. The reaction was 
performed at 30 °C and monitored by analytical-HPLC: RP-C18 with a gradient of 20 – 
60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture diluted with 8 µl 
0.1 % TFA for injection (Figure 6.6). The ligation was complete in 8 h, with the product 
collected and characterized by MALDI-TOF analysis: observed mass = 8844.3 Da in 
positive linear mode, calculated mass = 8840.96 Da.  
 
6.3.3 Ligation with EDTA 
As a control the ligation was repeated in an EDTA-containing buffer (2 mM), 
the biophysical data suggesting that the presence coordination of calcium will be 
critical. 
EF1 N-(Me)sulfonamide (1 mM, 0.35 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.27 mg) in degassed non-denaturing buffer 
with TCEP-HCl (50 mM) and MPAA (300 mM), pH 7.0. The reaction was performed at 
30 °C to ensure a constant temperature and monitored by analytical-HPLC: RP-C18 
column with a linear gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 
µl reaction mixture diluted with 8 µl 0.1 % TFA for injection (Figure 6.7). There is 
evidence of the ligation product from the 1 h time point, and there appears to be a slight 
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increase between the 8 h and 24 h time points though the MPAA seems to have oxidised 
during this time. The ligation product was collected and characterized by MALDI-TOF 
analysis: 8841.5 Da in positive linear mode, calculated mass = 8840.96 Da. 
 A comparison of the 4 h time points of ligations with and without calcium 
shows an increased rate with 2 mM calcium (Figure 6.8).  
 
6.3.4 Ligation in denaturing buffer 
 As a further control the use of a buffer containing GdnHCl to abolish any 
structure establishes whether conformation of the peptides is required, even if calcium is 
present. As such the above experiment was repeated to keep all conditions identical 
aside from the inclusion of GdnHCl. 
EF1N-(Me)sulfonamide (1 mM, 0.22 mg) was added to EF2 
ΔM43/S44G/F66W-NH2 (1 mM, 0.17 mg) in degassed denaturing buffer with TCEP-
HCl (50 mM), MPAA (300 mM) and CaCl2 (2 mM), pH 7.5. The reaction was 
performed at 30 °C and monitored by analytical-HPLC: RP-C18 with a gradient of 20 – 
60 % B in 30min and a flow rate of 1 ml min-1 (Figure 6.9). After 24 h there appears to 
be no obvious change in the abundance of both starting materials. 
 
. 
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Figure 6.6: Conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, with CaCl2 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8844.3 Da, calculated product 
mass = 8840.96 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (300 mM), CaCl2 (2 mM), pH 7.0, 30 °C. 
HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 N-(Me)sulfonamide, B = EF2 ΔM43/S44G/F66W-PEG biotin, C = EF1 
MPAA thioester, D = ligation product, * = MPAA (peak truncated), *’ = MPAA impurity. 
136	  
	  
 
Figure 6.7: Conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, with EDTA 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8841.5 Da, calculated product 
mass = 8840.96 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (300 mM), EDTA (2 mM), pH 7.0, 30 °C. 
HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 N-(Me)sulfonamide, B = EF2 ΔM43/S44G/F66W-PEG biotin, C = EF1 
MPAA thioester, D = ligation product, * = MPAA (peak truncated), *’ = MPAA impurity.	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Figure 6.8: Comparison of conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, with either CaCl2 or chelator 
A comparison of conformationally-assisted ligation under 2 mM calcium (top trace) and 2 mM EDTA 
(bottom trace). Both traces are the 4 h time point of each reaction. HPLC conditions: RP-C18 column, 20 
– 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 N-(Me)sulfonamide, B = EF2 
ΔM43/S44G/F66W-PEG biotin, C = EF1 MPAA thioester, D = ligation product, * = MPAA (peak 
truncated), *’ = MPAA impurity. 
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Figure 6.9: Conformationally-assisted peptide ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, in denaturing buffer 
Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), GdnHCl (6 M), sodium 
phosphate (200 mM), TCEP-HCl (50 mM), MPAA (300 mM) and CaCl2 (2 mM), pH 7.5, 30 °C. HPLC 
conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 N-
(Me)sulfonamide, B = EF2 ΔM43/S44G/F66W-PEG biotin, C = EF1 MPAA thioester, D = ligation 
product, * = MPAA (peak truncated), *’ = MPAA impurity. 
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6.3.5 Ligation without thiols, with either CaCl2 or a chelator 
 If conditions can be established whereby the addition of calcium is enough to 
switch the reaction on, this will provide greater synthetic control. To examine this 
experiments were set up in parallel whereby the extent of ligation was monitored in the 
absence of all thiols, with either 2 mM CaCl2 or 2 mM EDTA as a control. 
Firstly EF1 N-(Me)sulfonamide (1 mM, 0.34 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.27 mg) in degassed non-denaturing buffer, 
pH 7.0. The reaction was performed at 30 °C and monitored by analytical-HPLC: RP-
C18 column with a linear gradient of 20 – 60 % B in 30 min and a flow rate of 1 
ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection (Figure 6.10 
a.). Under these conditions no ligation is seen to take place. 
Following this EF1 N-(Me)sulfonamide (1 mM, 0.27 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.21 mg) in degassed calcium non-denaturing 
buffer, pH 7.0. The reaction was performed at 30 °C and monitored by analytical-
HPLC: RP-C18 column with a linear gradient of 20 – 60 % B in 30 min and a flow rate 
of 1 ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection (Figure 
6.10 b.). Unfortunately this reaction also did not provide ligation product. 
 
6.3.6 Ligation with CaCl2, MESNA 
 Previous chapters have explored the viability of different thiols in ligation, and 
so MPAA was replaced with MESNA (10 % w/v) (Adams et al., 2013) as the thiol 
catalyst. 
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 EF1 N-(Me)sulfonamide (1 mM, 0.26 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.20 mg) in degassed calcium non-denaturing 
buffer with TCEP-HCl (50 mM) and MESNA (10 % w/v), pH 7.0. The reaction was 
performed at 30 °C and monitored by analytical-HPLC: RP-C18 column with a linear 
gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture 
diluted with 8 µl 0.1 % TFA for injection (Figure 6.11). The thioester exchange step is 
complete after 8 h, but once again there is very little ligation product. The product was 
collected and confirmed by MALDI-TOF analysis: observed mass = 8844.6 Da in 
positive linear mode, calculated mass = 8840.96 Da. 
 
6.3.7 Ligation with CaCl2, less MPAA 
 The concentration of MPAA was lowered to test the effect of peptide structure 
with a reduced amount of thiol. 
 EF1 N-(Me)sulfonamide (1 mM, 0.35 mg) was added to EF2 
ΔM43/S44G/F66W-PEG biotin (1 mM, 0.28 mg) in degassed calcium non-denaturing 
buffer with TCEP-HCl (50 mM) and MPAA (60 mM), pH 7.0. The reaction was 
performed at 30 °C and monitored by analytical-HPLC: RP-C18 column with a linear 
gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture 
diluted with 8 µl 0.1 % TFA for injection (Figure 6.12). Ligation product appears after 2 
h and is not complete until around 24 h, and is collected for confirmation by MALDI-
TOF analysis: observed mass = 8842.3 Da in positive linear mode, calculated mass = 
8840.96 Da. 
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6.3.8 Ligation with CaCl2, 100 µM peptides 
 The ligation with calcium non-denaturing buffer and 300 mM MPAA was 
complete in 8 h with the peptides at 1 mM. The concentration of the peptides was 
lowered to establish the threshold for ligation under these conditions. 
 EF1 N-(Me)sulfonamide (100 µM, 0.35 mg) was added to EF2 
ΔM43/S44G/F66W-NH2 (100 µM, 0.25 mg) in degassed calcium non-denaturing buffer 
with TCEP-HCl (50 mM) and MPAA (300 mM), pH 7.0. The reaction was performed at 
30 °C and monitored by analytical-HPLC: RP-C18 column with a linear gradient of 20 
– 60 % B in 30 min and a flow rate of 1 ml min-1 (Figure 6.13). A problem encountered 
with this experiment is the amount of sample to load onto the analytical-HPLC: neat 
overloads the column with MPAA but the peptide peaks are visible, but when diluted 
the peptide peaks are too small to distinguish above the baseline. 
 
6.3.9 EF1 N-(Me)sulfonamide exchange with MESNA 
The thioester exchange intermediate was observed in first the CI2 experiments, 
and now with the calbindin D9k attempts. Investigating conformationally-assisted 
chemical ligation with MESNA revealed the thioester exchange step to be complete in 8 
h, so these conditions were used to examine this further. 
EF1 N-(Me)sulfonamide (1 mM, 4.32 mg) was resuspended in degassed calcium 
non-denaturing buffer with TCEP-HCl (50 mM) and MESNA (600 mM), pH 7.0. The 
reaction was performed at 30 °C and monitored by analytical-HPLC: RP-C18 with a 
gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture 
diluted with 8 µl 0.1 % TFA for injection (Figure 6.14). The exchange product was 
collected and characterized by MALDI-TOF analysis: observed mass = 4865.9 Da in 
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positive linear mode, calculated mass = 4871.58 Da. After 5 h the product was purified 
by preparative-HPLC: RP-C18 column with a gradient of 15-35 % B in 5 min, 35 - 60 
% B in 30 min and a flow rate of 15 ml min-1 to obtain EF1 MESNA thioester (1.75 mg, 
40.6 % yield).  
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Figure 6.10: Conformationally-assisted peptide ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, without thiols 
a. Analytical-HPLC time course of ligation with EDTA. Ligation conditions: peptides (1 mM), 
sodium phosphate (100 mM), EDTA (2 mM), pH 7.0, 30 °C. HPLC conditions: RP-C18 column, 
20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 N-(Me)sulfonamide, B 
= EF2 ΔM43/S44G/F66W-PEG biotin.	  
b. Analytical-HPLC time course of ligation with calcium. Ligation conditions: peptides (1 mM), 
sodium phosphate (100 mM), CaCl2 (2 mM), pH 7.0, 30 °C. HPLC conditions: RP-C18 column, 
20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 N-(Me)sulfonamide, B 
= EF2 ΔM43/S44G/F66W-PEG biotin.	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Figure 6.11: Conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, with MESNA 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8844.6 Da, calculated product 
mass = 8840.96 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MESNA (10 % w/v), CaCl2 (2 mM), pH 7.0, 30 °C. 
HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 N-(Me)sulfonamide, B = EF2 ΔM43/S44G/F66W-PEG biotin, C = EF1 
MESNA thioester, D = ligation product.	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Figure 6.12: Conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, with CaCl2, 60 mM MPAA 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8842.3 Da, calculated product 
mass = 8840.96 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MPAA (60 mM), CaCl2 (2 mM), pH 7.0, 30 °C. 
HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 N-(Me)sulfonamide, B = EF2 ΔM43/S44G/F66W-PEG biotin, C = EF1 
MPAA thioester, D = ligation product, * = MPAA (peak truncated). 
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Figure 6.13: Conformationally-assisted ligation of EF1 N-(Me)sulfonamide with EF2 
ΔM43/S44G/F66W-PEG biotin, 100 µM peptides 
Analytical-HPLC time course of ligation. Ligation conditions: peptides (100 µM), sodium phosphate (100 
mM), TCEP-HCl (50 mM), MPAA (300 mM), CaCl2 (2 mM), pH 7.0, 30 °C. HPLC conditions: RP-C18 
column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. * = MPAA (peak truncated), 
other peaks unconfirmed. 
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Figure 6.14: EF1 N-(Me)sulfonamide exchange with MESNA 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4865.9 Da, calculated 
product mass = 4871.58 Da. 
b. Analytical-HPLC time course of exchange. Exchange conditions: peptide (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), MESNA (600 mM), CaCl2 (2 mM), pH 7.0, 30 °C. 
HPLC conditions: RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 N-(Me)sulfonamide, B = EF1 MESNA thioester. 
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6.4 Proximity-assisted acyl transfer 
 The proposed labelling method would use a proximity-assisted chemical 
reaction to transfer a tag from a donor to an acceptor peptide bound to the protein of 
interest. Here we investigate proximity-assisted acyl transfer of a small peptide tag, 
LAPAG-MPAL thioester, from EF1 to EF2. A modified EF1 with cysteamine at its C-
terminus is loaded with the tag. Under folding conditions and with 2 mM calcium the 
conformation of the two calbindin D9k peptides should coordinate their reacting site 
termini for tag transfer. 
 
6.4.1 EF1 N-(Me)sulfonamide exchange with cysteamine hydrochloride 
Cysteamine hydrochloride (20 eq, 2.7 mg) was added to EF1 N-
(Me)sulfonamide (1 mM, 7.0 mg) in degassed calcium non-denaturing buffer with 
TCEP-HCl (50 mM), pH 7.0. The reaction was performed at 25 °C and monitored by 
analytical-HPLC: RP-C18 with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 
ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection (Figure 6.15). 
Exchange is complete by 7 h, with the product collected for characterization by 
MALDI-TOF analysis: observed mass = 4803.8 Da in positive linear mode, calculated 
mass = 4806.53 Da. 
 
6.4.2 Acyl transfer of tag between EF1 cysteamine and EF2 ΔM43/S44G/F66W  
EF1 cysteamine (1 mM, 0.53 mg) was mixed with LAPAG-MPAL thioester (1 
mM, 0.07 mg) and EF2 ΔM43/S44G/F66W-NH2 (1 mM, 0.39 mg) in degassed calcium 
non-denaturing buffer at pH 7.0-7.5. The tag was consumed while some EF1 
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cysteamine remained, so more LAPAG-MPAL thioester (made up to 10 eq total) was 
added at 5 h. The reaction was performed at 30 °C and monitored by analytical-HPLC: 
RP-C18 with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 ml min-1. 2 µl 
reaction mixture diluted with 8 µl 0.1 % TFA for injection (Figure 6.16). There is 
evidence of acyl transfer from 8 h, with potentially two peaks corresponding to the 
transfer product. Both were collected for MALDI-TOF analysis: observed mass of peak 
1 = 4085.8 Da and observed mass of peak 2 = 4088.1 Da in positive linear mode, 
calculated mass = 4092.47 Da. 
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Figure 6.15: EF1 N-(Me)sulfonamide exchange with cysteamine hydrochloride 
a. MALDI-TOF MS spectrum of exchange product. m/z identified as 4803.8 Da, calculated 
product mass = 4806.53 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), TCEP-HCl (50 mM), CaCl2 (2 mM), pH 7.0, 25 °C. HPLC conditions: 
RP-C18 column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 N-
(Me)sulfonamide, B = EF1 cysteamine. 
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Figure 6.16: Proximity-assisted acyl transfer of tag between EF1 cysteamine and EF2 
ΔM43/S44G/F66W-NH2, with CaCl2 
a. MALDI-TOF MS spectrum of acyl transfer product. m/z identified as 4085.8 Da for peak E and 
4088.1 Da for peak E’, calculated product mass = 4092.47 Da. 
b. Analytical-HPLC time course of acyl transfer. Transfer conditions: peptides (1 mM), tag (10 eq) 
sodium phosphate (100 mM), CaCl2 (2 mM), pH 7.0-7.5, 30 °C. HPLC conditions: RP-C18 
column, 20 – 60 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 cysteamine, B 
= LAPAG thioester, C = EF2 ΔM43/S44G/F66W-NH2, D = EF1-LAPAG, E/E’ = LAPAG-EF2 
ΔM43/S44G/F66W-NH2.	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6.5 Conformationally-assisted and Cu-free click chemistry 
Two reports of proximity-assisted AAC in the literature are noted in Chapter 1, 
used in the search for enzyme inhibitors. During the study of inhibitors for HDAC an 
increased rate was observed and only the 1,4-regioisomer product formed, suggestive of 
the presence of trace amounts of Cu(I) (Suzuki et al., 2010). Human recombinant 
HDAC8 was used to further investigate, monitoring by analytical-HPLC. With 1 mM 
starting materials product was only observed in the presence of HDAC8 unless the 
active site inhibitor vorinostat was also present, confirming that the components were 
reacting at the active site. Use of the Cu(I) chelator bathocuprine disulfonic acid 
inhibited product formation, confirming that Cu(I) is present in the active site and is 
responsible for the increase in rate observed. The proximity-assisted nature of the 
reaction was also confirmed by repeating in the presence of Cu but no HDAC8, where 
no triazole product formed. This was the first example reported whereby a Cu-protein 
complex induced a proximity-assisted AAC reaction. Earlier work on the search for 
inhibitors of AChE report a similar proximity-assisted click reaction, though in the 
absence of Cu (Lewis et al., 2002). The confined binding site of the enzyme acted as a 
template for 1,3-dipolar cycloaddition, confirmed by the inhibition of product formation 
when the active site was blocked. The binding site orientates the azide and alkyne 
components such that a click reaction can take place. 
It was hypothesized that the combination of structure and affinity held by the 
calbindin D9k peptides could encourage conformationally-assisted and Cu-free click 
ligation. EF1 was synthesized with a C-terminal azide and EF2 with an N-terminal 
alkyne. 
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6.5.1 Preparation of peptides 
EF1 azide 
EF1 azide was synthesized on Fmoc-azido-NovaTag resin (0.1 mmol) using 
microwave-assisted Fmoc-SPPS with DIC/HOBT coupling and piperidine deprotection. 
Cleaved from the resin, resuspended in denaturing buffer and purified by preparative-
HPLC: RP-C18 column with a gradient of 15 – 30 % B in 5 min, 30 – 60 % B in 30 min 
and a flow rate of 15 ml min-1. Purified peptide freeze-dried. 
 
EF2 ΔM43/S44alkyne/F66W 
EF2 ΔM43/S44alkyne/F66W was synthesized on PL rink resin (0.39 mmol g-1 
loading, 0.1 mmol) using microwave-assisted Fmoc-SPPS with DIC/HOBT coupling 
and piperidine deprotection. In place of the N-terminal Gly, propiolic acid was coupled. 
Addition of propiolic acid (1 mmol, 70 mg) in minimal DMF, DIC in DMSO (0.5 ml of 
0.8 M) and HOBT in DMF (1 ml of 0.5 M) resulted in a peptide with N-terminal alkyne 
after 45 min. Cleaved from the resin, resuspended in the denaturing buffer and purified 
by preparative-HPLC: RP-C18 with a gradient of 15 – 35 % B in 5 min, 35 – 65 % B in 
30 min and a flow rate of 15 ml min-1. Purified peptide freeze-dried (6.3 mg, 1.71 % 
yield). 
 
6.5.2 Ligation with 10 mM peptides, 50 °C 
 The first attempt at a click reaction was carried out under folding conditions. 
The peptides were at 1 mM and the temperature at 30 °C, a temperature significantly 
lower than those observed in traditional click reactions. The reaction was monitored by 
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analytical-HPLC (RP-C18 with a gradient of 20 – 60 % B in 30 min and a flow rate of 1 
ml min-1) but no change was observed, and the ligation appeared unsuccessful (data not 
shown). To improve the likelihood of successful ligation the peptide concentrations 
were increased, along with temperature. 
 EF1 azide (10 mM, 1.7 mg) was added to EF2 ΔM43/S44alkyne/F66W (10 mM, 
1.2 mg) in degassed calcium non-denaturing buffer, pH 7.5 and without any additives. 
The reaction was performed at 50 °C and monitored by analytical-HPLC: RP-C18 with 
an initial gradient of 20 – 60 % B in 30 min and then a gradient of 20 – 60 % B in 
30min, both with a flow rate of 1 ml min-1 (Figure 6.17). The gradient change was 
implemented following the observation of a reduced EF2 peak after 2 h, and so it was 
lengthened in case the ligation product eluted at a higher percentage of AcN. With this 
new gradient we can now see product for the 4 h time point onwards, collected for 
confirmation by MALDI-TOF analysis: observed mass = 8495.5 Da in positive linear 
mode, calculated mass = 8492.47 Da. 
 
6.5.3 Ligation with 1 mM peptides, 37 °C 
 Both the concentration of the starting materials and the temperature were now 
lowered, after observing ligation product with 10 mM peptides and at 50 °C. 
EF1 azide (1 mM, 0.4 mg) was added to EF2 ΔM43/S44alkyne/F66W (1 mM, 
0.29 mg) in the calcium non-denaturing buffer at pH 7.5, without any additives. In this 
instance the buffer was not degassed prior to its addition to the peptides. The reaction 
was performed at 37 °C and monitored by analytical-HPLC: RP-C18 with a gradient of 
20 – 90 % B in 30min and a flow rate of 1 ml min-1 (Figure 6.18). There is evidence of 
ligation product in the 1 h trace, and significant amounts of product in a 25 h time point. 
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The ligation product was collected and characterized by MALDI-TOF analysis: 
observed mass = 8491.8 Da in positive linear mode, calculated mass = 8492.47 Da. 
 
6.5.4 Ligation with 1 mM peptides, denaturing buffer 
 As a control experiment similar to that conducted in section 6.3.4 the denaturing 
buffer was used to remove peptide secondary structure. Even with 2 mM calcium this 
should confirm the role of peptide structure in this ligation.  
EF1 azide (1 mM, 0.35 mg) was added to EF2 ΔM43/S44alkyne/F66W (1 mM, 
0.25 mg) in the denaturing buffer, with CaCl2 (2 mM) at pH 7.5. In this instance the 
buffer was not degassed prior to its addition to the peptides. The reaction was performed 
at 37 °C and monitored by analytical-HPLC: RP-C18 with a gradient of 20 – 90 % B in 
30min and a flow rate of 1 ml min-1 (Figure 6.19). After 24 h there appears to be no 
change in the abundance of either starting material and no ligation product is observed. 
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Figure 6.17: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 10 mM peptides, 50 °C 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8495.5 Da, calculated product 
mass = 8492.47 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (0.25 mM EF1 azide, 0.5 
mM EF2 ΔM43/S44alkyne/F66W), sodium phosphate (100 mM), CaCl2 (2 mM), pH 7.5, 50 °C 
HPLC conditions: RP-C18 column, 20 – 90 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1     
ml min-1. A = EF1 azide, B = EF2 ΔM43/S44alkyne/F66W, C = ligation product.	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Figure 6.18: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 1 mM peptides, 37 °C 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8491.8 Da, calculated product 
mass = 8492.47 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium 
phosphate (100 mM), CaCl2 (2 mM), pH 7.5, 37 °C HPLC conditions: RP-C18 column, 20 – 90 
% B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 azide, B = EF2 
ΔM43/S44alkyne/F66W, C = ligation product. 
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Figure 6.19: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, in denaturing buffer 
Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), GdnHCl (6 M), sodium 
phosphate (200 mM), CaCl2 (2 mM), pH 7.5, 37 °C. HPLC conditions: RP-C18 column, 20 – 90 % B 
(TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 azide, B = EF2 ΔM43/S44alkyne/F66W. 
 
 
6.5.5 Ligation with 1 mM peptides, 50 °C 
 Attempting to increase the rate of the ligation, the temperature was increased to 
the original 50 °C. As these conditions had previously shown promising progress it was 
decided to maintain the peptide concentration at 1 mM.  
 EF1 azide (1 mM, 0.48 mg) was added to EF2 ΔM43/S44alkyne/F66W (1 mM, 
0.35 mg) in the calcium non-denaturing buffer at pH 7.5, without any additives or 
degassing since no negative effects were observed in section 6.5.3. The reaction was 
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performed at 50 °C and monitored by analytical-HPLC: RP-C18 with a gradient of 20 – 
90 % B in 30min and a flow rate of 1 ml min-1 (Figure 6.20). Under these conditions the 
ligation appears complete by 24 h. 
 
6.5.6 Ligation with 0.5 mM peptides, 50 °C 
 The previous ligation at 50 °C was the best so far, and to investigate the effect of 
peptide concentration on the rate the concentration of both starting materials was 
lowered. 
 EF1 azide (0.5 mM, 0.18 mg) was added to EF2 ΔM43/S44alkyne/F66W (0.5 
mM, 0.13 mg) in the calcium non-denaturing buffer at pH 7.5, without any additives or 
degassing. The reaction was performed at 50 °C and monitored by analytical-HPLC: 
RP-C18 with a gradient of 20 – 90 % B in 30min and a flow rate of 1 ml min-1 (Figure 
6.21). Under these conditions the ligation also appears complete by 24 h, and the 
product collected for confirmation by MALDI-TOF analysis: observed mass = 8494.0 
Da in positive linear mode, calculated mass = 8492.47 Da. 
 
6.5.7 Ligation with 0.25 mM EF1 azide, 50 °C 
 Each ligation attempt appears to have an amount of EF1 azide remaining once 
EF2 ΔM43/S44alkyne/F66W is depleted, thus its concentration was halved relative to 
its partner alkyne peptide. 
 EF1 azide (0.25 mM, 0.17 mg) was added to EF2 ΔM43/S44alkyne/F66W (0.5 
mM, 0.24 mg) in the calcium non-denaturing buffer at pH 7.5, without any additives or 
degassing. The reaction was performed at 50 °C and monitored by analytical-HPLC: 
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RP-C18 with a gradient of 20 – 90 % B in 30min and a flow rate of 1 ml min-1 (Figure 
6.22). Despite reducing the concentration of one of the starting materials these 
conditions still encourage the completion of ligation by 24 h, and the ligation product 
was collected for confirmation by MALDI-TOF: observed mass = 8494.2 Da in positive 
linear mode, calculated mass = 8492.47 Da.  
 
6.5.8 Ligation with 0.25 mM EF1 azide, 45 °C 
 Having established that the ligation does not appear concentration-dependent at 
this level the temperature is now lowered to 45 °C. 
 EF1 azide (0.25 mM, 0.13 mg) was added to EF2 ΔM43/S44alkyne/F66W (0.5 
mM, 0.19 mg) in the calcium non-denaturing buffer at pH 7.5, without any additives or 
degassing. The reaction was performed at 45 °C and monitored by analytical-HPLC: 
RP-C18 with a gradient of 20 – 90 % B in 30min and a flow rate of 1 ml min-1 (Figure 
6.23). Unlike the equivalent experiment at 50 °C there is still a substantial amount of 
both starting materials at 24 h, and the reaction is completed by 48 h. The ligation 
product was collected and characterized by MALDI-TOF analysis: observed mass = 
8494.2 Da in positive linear mode, calculated mass = 8492.47 Da. 
 Reproducibility was tested by repeating this experiment, and nanodrop was used 
to confirm the peptide concentrations. 
EF1 azide (0.34 mM) and EF2 ΔM43/S44alkyne/F66W (0.65 mM) were each 
dissolved in half the total volume of the calcium non-denaturing buffer at pH 7.5. Their 
concentrations were confirmed by nanodrop analysis, and the peptides were then mixed. 
The reaction was monitored by analytical-HPLC: RP-C18 with a gradient of 20 – 90 % 
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B in 30 min and a flow rate of 1 ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % 
TFA for injection. The ligation was again complete by 48 h. 
This ligation was repeated on a larger scale and the product purified by 
preparative-HPLC. EF1-azide (0.25 mM, 1.02 mg) and EF2 ΔM43/S44alkyne/F66W 
(0.5 mM, 1.47 mg) were mixed under the same conditions as section 6.4.2, the reaction 
monitored at t = 0 and 48 h by analytical-HPLC: RP-C18 20 – 90 % B in 30 min, 1 
ml min-1. 2 µl reaction mixture diluted with 8 µl 0.1 % TFA for injection. Product 
purification by preparative-HPLC: RP-C18 with a gradient of 20 – 90 % B in 30 min, 
15 ml min-1. Purified peptide freeze-dried (0.6 mg, 24.1 % yield). 
 
6.5.9 Nuclear magnetic resonance (NMR) spectroscopy 
 The work in this section was carried out by Dr Geoff Kelly. Following the 
conformationally-assisted Cu-free click reaction with the azide and alkyne peptides we 
sought to investigate the distribution of the product triazole, using the purified product 
described in section 6.5.8. The triazole isomers can be identified by 1H/13C-HSQC using 
gated decoupling, with the C5 signal of the 1,4-regioisomer at δ~120 ppm and the C4 
signal of the 1,5-regioisomer at δ~133 ppm (Creary et al., 2012) (Figure 6.24). The 
product peptide was prepared as unbuffered sample in H2O (95 %) and D2O (5 %), at 
pH 6.0. 
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Figure 6.20: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 1 mM peptides, 50 °C 
Analytical-HPLC time course of ligation. Ligation conditions: peptides (1 mM), sodium phosphate (100 
mM), CaCl2 (2 mM), pH 7.5, 50 °C HPLC conditions: RP-C18 column, 20 – 90 % B (TFA (0.1 %), AcN 
(90 %)) in 30 min, 1 ml min-1. A = EF1 azide, B = EF2 ΔM43/S44alkyne/F66W, C = ligation product. 
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Figure 6.21: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 0.5 mM peptides, 50 °C 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8494.0 Da, calculated product 
mass = 8492.47 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (0.5 mM), sodium 
phosphate (100 mM), CaCl2 (2 mM), pH 7.5, 50 °C HPLC conditions: RP-C18 column, 20 – 90 
% B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 ml min-1. A = EF1 azide, B = EF2 
ΔM43/S44alkyne/F66W, C = ligation product. 
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Figure 6.22: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 0.25 mM EF1 azide, 50 °C 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8494.2 Da, calculated product 
mass = 8492.47 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (0.25 mM EF1 azide, 0.5 
mM EF2 ΔM43/S44alkyne/F66W), sodium phosphate (100 mM), CaCl2 (2 mM), pH 7.5, 50 °C. 
HPLC conditions: RP-C18 column, 20 – 90 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 azide, B = EF2 ΔM43/S44alkyne/F66W, C = ligation product. 
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Figure 6.23: Conformationally-assisted and Cu-free click chemistry with EF1 azide and EF2 
ΔM43/S44alkyne/F66W, with 0.25 mM EF1 azide, 45 °C 
a. MALDI-TOF MS spectrum of ligation product. m/z identified as 8494.2 Da, calculated product 
mass = 8492.47 Da. 
b. Analytical-HPLC time course of ligation. Ligation conditions: peptides (0.25 mM EF1 azide, 0.5 
mM EF2 ΔM43/S44alkyne/F66W), sodium phosphate (100 mM), CaCl2 (2 mM), pH 7.5, 45 °C. 
HPLC conditions: RP-C18 column, 20 – 90 % B (TFA (0.1 %), AcN (90 %)) in 30 min, 1 
ml min-1. A = EF1 azide, B = EF2 ΔM43/S44alkyne/F66W, C = ligation product. 
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Figure 6.24: 1H/13C-HSQC NMR spectrum of calbindin D9k Cu-free click product 
The aromatic region of a 1H/13C-HSQC NMR spectrum for the product of the calbindin D9k Cu-free click 
reaction, displaying signals of protonated carbons. With at least 7 signals in the ~120 ppm region this 
indicates a 1,4-disubstituted triazole, accounting for signals from Tyr and Trp. To accurately assign 
signals signal-to-noise must be improved, particularly for those in the ~130 ppm region. Peptide prepared 
as unbuffered sample in H2O (95 %) and D2O (5 %) at pH 6.0. 
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6.6 Calbindin D9k peptides can perform conformationally-assisted 
and Cu-free click ligations 
6.6.1 Biophysical characterization 
 Work with the calbindin D9k EF1 and EF2 peptides began by establishing 
the affinity of modified EF-hand peptides for one another using BLI. As discussed in 
Chapter 4 BLI is able to provide Kd values in a similar manner to SPR, the technique 
used in the work discussed in this chapter’s introduction. In the paper by Linse and co-
workers discussed in the introduction to this chapter, SPR was conducted using a 
BIAcore biosensor system with a flow buffer of HEPES/KOH (10 mM, pH 7.4), NaCl 
(0.15 M), Tween 20 (0.005 %), NaN3 (0.02 %) and either CaCl2 (2 mM) or EDTA (3.4 
mM). Previous BLI experiments with the split proteins in earlier chapters immobilized 
the N-terminal fragment, however here it was decided to immobilize EF2 rather than 
EF1. Linse and colleagues measured the interaction between EF1 and immobilized EF2 
for different EF1 variants. They also monitored the interaction between EF2 and 
immobilized EF1. The dissociation rate varied between mutants and was not 
concentration-dependent, but the association rate was also not found to be concentration 
dependent. Therefore association is governed by a separate rate-limiting step, thought to 
be the dissociation of EF1 dimers.   
The first experiment, Gly-Met, was chosen based upon the P43M mutation used 
to separate the calbindin D9k peptides (Finn et al., 1992). For this interaction site a Kd 
value of 47.7 nM ± 5.8 nM was determined (Figure 6.1), which is significantly higher 
than that published. We wondered if the cleavage by CNBr at this mutated P43M site 
resulted in a homoserine lactone ligation, actually forming an amide bond. We discuss 
in Chapter 1 studies of cytochrome c where CNBr cleavage generates two fragments 
that can reconstitute, catalysed by the proximity of the two reacting site termini 
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(Corradin and Harbury, 1974, Proudfoot et al., 1989). We wondered if the affinity 
reported in the literature for calbindin D9k could be a result of the known side effect of 
CNBr cleavage at a Met-Ser site, the homoserine lactone formed being reactive under 
such conditions of proximity and generating an amide bond following attack by the Ser 
side chain. Therefore this value could represent a covalent rather than non-covalent 
interaction. 
 To investigate further the peptides were modified to contain a Ser-Ser 
interaction site. This was to serve as preliminary work before the more expensive 
homoserine was to be included, using pre-loaded Ser resin in its place. With these 
peptides we were able to identify a Kd value of 59.8 nM ± 12.8 nM (Figure 6.2). It 
seems that changing two residues at the interaction site has had little impact on the 
interaction of the peptides.  
 Following this a Gly-Gly interaction was studied, and with a Kd of 69.0 nM ± 
9.8 nM (Figure 6.3) this confirms synthetic flexibility at the interaction site. It appears 
that as this site is situated in the loop region between EF1 and EF2 in the intact protein, 
mutating the residues at these reacting termini – at least to the extent that we have 
probed – has had little effect on the affinity of the peptides for one another. 
Subsequently a Gly-Gly interaction site was decided upon for further experiments, 
hypothesized to be the most likely site with which to successfully observe 
conformationally-assisted ligation. 
 The final BLI experiment repeated the Gly-Gly work but in an EDTA-
containing buffer to establish the effect of the absence of calcium on the affinity. In this 
case the results showed non-specific binding of EF1 to the sensor, where the response 
traces of the control experiments mirrored those of the actual interaction (Figure 6.4). 
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CD spectroscopy was next used to study the conformation of these peptides 
prior to attempting their conformationally-assisted ligation. In the work described in the 
introduction to this chapter, fluorescence spectroscopy was also carried out using the 
Tyr of EF1 to monitor complex formation when wt-EF1 and wt-EF2 were mixed. An 
EF2 variant with and additional reporter by the substitution F66W was also used. They 
observed a linear change in fluorescence upon titration of the added peptide until the 1:1 
stoichiometry was achieved, confirming that these peptides fold and form the complex 
upon interaction. They also used competition experiments to compare the competition 
between binding of EF2 variants and F66W-EF2 with wt-EF1. Three variants, including 
wt-EF2, displayed a similar affinity to F66W-EF2, which enabled us to use EF2 with 
Trp66. Though these results were less precise, they were in agreement with those of the 
SPR experiments. 
 The BLI results in section 6.2 demonstrate the importance of the role of calcium, 
with affinities in the low nM range in its presence and non-specific binding when a 
chelator was present. CD provided greater insight into the conformation of the peptides 
under both conditions (Figure 6.5). Each experiment gives four spectra, where first both 
peptides were analysed separately before mixing and re-investigating. In both sets of 
CD spectra, with and without calcium, minima at 208 nm and 222 nm are indicative of 
the α–helical content expected given the published structure. In the EDTA experiment 
the analysis of the peptides when mixed exactly matches that predicted based on their 
individual analyses. However in the calcium buffer the peptides when mixed appear to 
develop greater α–helical content than they possess when separate. Each peptide binds 
one calcium ion which coordinates structure, and it appears that the combination of this 
along with their interaction when mixed is conducive to further secondary structure 
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formation. This experiment demonstrates the effect of the presence of calcium in the 
reaction buffer, and is in agreement with the results of the BLI work.  
 
Some difficulties were encountered during the synthesis of these peptides, 
particularly with EF2. It was found necessary to resuspend both peptides in denaturing 
buffer for purification by preparative-HPLC, as they formed a gel when HPLC buffers 
were used as standard. As determined by these CD results the peptides have sufficient 
secondary structure in the absence of calcium that their folding in HPLC buffers has 
reduced their solubility. As solubility is a problem future syntheses of this peptide could 
include aggregation-minimizing modifications as discussed in previous chapters, for 
example pseudoprolines, to improve the efficiency of the synthesis. 
 
6.6.2 Conformationally-assisted peptide N-(Me)sulfonamide ligation 
 Though the conformationally-assisted ligation attempts with the other split 
proteins studied, RNase A and CI2, have not been particularly successful we were 
optimistic of greater success with the calbindin D9k peptides. For conformationally-
assisted ligation EF1 was synthesized as a peptide N-(Me)sulfonamide, in concurrence 
with the previous attempts using S-peptide N-(Me)sulfonamide and CI2(1-39) N-
(Me)sulfonamide. The BLI and CD results demonstrate the effect of calcium on these 
peptides, so the non-denaturing buffer contained 2 mM CaCl2 in the first ligation 
attempt. Here we see both the EF1 MPAA thioester and the ligation product after 1 h, 
and the reaction is complete by 8 h, with clean HPLC traces (Figure 6.6). To 
demonstrate the effect of the coordination of calcium ions the experiment was repeated 
with EDTA instead (Figure 6.7), and though the ligation could be seen to be completed 
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at similar times under both conditions it is clear that the 2 mM calcium present has 
increased the rate from the start and the reaction has reached its plateau sooner than in 
its absence. This is probably most easily visualised by comparing the 4 h traces for both 
experiments, where in the presence of 2 mM calcium both starting material peaks are 
reduced and the product peak is much more substantial (Figure 6.8).  
 In order to establish the true effect of secondary structure on this ligation, and to 
prove that it is in fact conformationally-assisted, the above experiment was repeated in 
the denaturing buffer. The presence of GdnHCl, even with calcium, should abolish any 
conformation of the peptides. After 24 h we see no change in the HPLC traces aside 
from the shift of the MPAA peak, both starting materials are still present and there is no 
evidence of product formation (Figure 6.9). There is a hint of a peak at an elution time 
corresponding to that of the ligation product but there is also a small peak in this area in 
the t = 0 time point, and perhaps is an impurity in the buffer. This confirms that the 
calbindin D9k peptides used here are reliant on their secondary structure to drive 
ligation, and thus it is conformationally-assisted. 
 The identification of conditions where ligation could be “switched on and off” 
simply by the addition of calcium was of interest. As ligation was shown to occur to 
variable extents in the absence of calcium but in the presence of excess thiols, it was 
considered whether the addition of calcium to a thiol-free mixture could be enough to 
induce ligation. Though increasing the amount of MPAA increased the rate of ligation, 
the difference made by the addition of calcium could allow for ligation in the complete 
absence of any thiols. Two ligation attempts were set up in parallel, both using non-
denaturing buffer but one with EDTA and one with CaCl2. The EDTA-containing 
ligation experiment did not generate any product as anticipated, and neither did the 
calcium-containing experiment (Figure 6.10). This confirms that thiols are necessary, at 
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least when using EF1 N-(Me)sulfonamide. Future work could investigate the effect of 
synthesizing EF1 as alternative peptide thioesters, work that was not permitted in the 
time allowed for this project. 
 A ligation with MESNA (10 % w/v) as an alternative thiol was based upon 
published work generating MESNA thioesters with this amount (Adams et al., 2013). 
Thioester exchange was complete by 8 h, potentially at around 4 h in the experiment 
with calcium, though there is little ligation (Figure 6.11). Therefore MESNA can be 
ruled out as an appropriate thiol for this reaction. Future work could investigate the 
effect of other thiols on the rate of conformationally-assisted ligation, perhaps including 
benzyl mercaptan or thiophenol as previously used with the other split proteins studied 
herein. 
 Thus far the only ligation with both calcium and MPAA present has used 300 
mM thiol. It was decided to reduce the MPAA to 60 mM. Ligation product is visible 
after 2 h, though only goes to completion overnight, by 24 h (Figure 6.12). This is 
significantly slower than the 8 h completion with 300 mM MPAA. 
 Having demonstrated conformationally-assisted ligation with these peptides at 1 
mM the concentration of both starting materials was lowered to test the effect, reducing 
the concentration to just 100 µM. The problem of finding analytical-HPLC conditions to 
monitor such a reaction soon became apparent: injecting neat reaction mix overloaded 
the column with MPAA, but diluting it left the reactant peaks too small to identify 
against the baseline (Figure 6.13). One method by which this ligation could possibly be 
monitored is by running sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS PAGE), though this in itself contains potential problems. A higher percentage of 
acrylamide would be needed in order to increase cross-linking as the ligation product, 
being little over 8 kDa, is quite small by electrophoresis standards. However in doing 
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this the resolution of the bands will be much lower, adding to the difficulty in 
identifying the product. Another alternative could be to dialyse the sample to remove 
the MPAA, with mini dialysis tubes available for volumes as small as 10 µl with 
molecular weight cut-off (MWCO) as low as 2 kDa, and microdialysis plates for 
volumes as low as 10 µl and MWCO from 3.5 kDa. This would permit HPLC analysis 
of the time points, even when the ligation is conducted on a small scale as many in this 
chapter are. 
  
 The final experiment in this section explored the thiolysis step in the ligation, 
EF1 N-(Me)sulfonamide converting to EF1 MESNA thioester. Thioester exchange has 
been demonstrated in previous chapters with both S-peptide N-(Me)sulfonamide and 
CI2(1-39) N-(Me)sulfonamide, and having observed this exchange in the calbindin D9k 
conformationally-assisted ligations a separate experiment was carried out to monitor it. 
Under the same conditions as in the ligation with MESNA EF1 N-(Me)sulfonamide was 
cleanly and successfully converted to EF1 MESNA thioester in just over 4 h (Figure 
6.14). This is quicker than the same step in the prior MESNA ligation because there is 
no EF2 present for EF1 to interact with, making EF1 more readily accessible. 
 
6.6.3 Proximity-assisted acyl transfer 
 Following the success of the conformationally-assisted ligations the focus then 
shifted to proximity-assisted acyl transfer. Chapter 1 contains examples of proximity-
induced chemical reactions, notably the FLAG-tag and CA6D4 work (Nonaka et al., 
2009, Nonaka et al., 2010). Additionally proximity-assisted acyl transfer has been 
performed with coiled-coils that mimic the aminoacyl transfer reactions of ribosomes 
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and non-ribosomal peptide synthetases, designed to increase rate by positioning the 
reacting components in close proximity (Leman et al., 2007). A proximity-assisted 
chemical reaction such as acyl transfer has not been attempted in previous chapters of 
with any of the other split proteins because their ligation has not been as successful as 
anticipated. We propose that the observed ligation in these systems was potentially 
sufficient for proximity-assisted acyl transfer. Here we examine the prospect for transfer 
of a tag from the C-terminus of EF1 to the N-terminus of EF2. 
 The first step was to modify EF1 N-(Me) sulfonamide for a C-terminal 
cysteamine using cysteamine hydrochloride (Figure 6.15). This allows loading of the 
tag onto EF1 before transfer to EF2. EF1 cysteamine and EF2 were mixed with a small 
peptide tag, LAPAG-MPAL thioester, at a 1:1:1 ratio. This tag was chosen for its small 
size, considered ideal for a first attempt. EF1 loaded with the tag is seen at 2 h, and the 
tag is the first component to be depleted. With EF1 cysteamine remaining more tag was 
added, and so at 5 h the total amount of tag relative to EF1 cysteamine was 10 eq. The 
first evidence of acyl transfer occurs in the 8 h time point where a new peak appears 
with an observed mass of 4085.8 Da by MALDI-TOF, corresponding to the calculated 
mass of 4092.47 for EF2 with the tag bound. A time point the next day at 26 h shows 
this peak has increased, though an additional peak with an observed mass of 4088.1 Da 
has also appeared (Figure 6.16). One explanation for this could be that the tag has 
bound to a site other than at the α–amino group. Future work to test this would be to cap 
the N-terminus of EF2 to prevent transfer of the tag to the expected site. If one peak still 
appears then this would indicate transfer of the tag to an unknown site.  
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6.6.4 Conformationally-assisted and Cu-free click chemistry 
 With successful conformationally-assisted at a Gly-Gly interaction site, section 
6.5 sees the investigation into conformationally-assisted and Cu-free click chemistry, 
using the combination of affinity and structure to encourage a reaction that typically 
requires high temperature or the presence of a catalyst such as Cu to proceed. EF1 was 
synthesized with a C-terminal azide using the Fmoc-azido-NovaTag resin, and EF2 with 
an N-terminal alkyne by coupling propiolic acid at the end of the synthesis. Both are 
fully automated processes, achieved using microwave-assisted Fmoc-SPPS. 
 The first attempt did not appear successful and so to encourage ligation both the 
peptide concentration and the temperature were increased. With the peptides now at 10 
mM and the temperature at 50 °C it appeared that the EF2 ΔM43/S44alkyne/F66W peak 
was smaller in the 2 h time point. In case the ligation product was eluting at a higher 
percentage of AcN the gradient was extended to 20 – 90 % B in 30 min. During the next 
HPLC injection, of the 4 h time point, we now see a clear third peak not visible before, 
corresponding to the ligation product (Figure 6.17). With this knowledge a shoulder on 
the EF2 ΔM43/S44alkyne/F66W peak is now apparent in the 2 h trace, corresponding to 
poor separation of the ligation product. Looking back to the first ligation attempt, solely 
analysed with this incorrect analytical-HPLC gradient, here too is evidence of a 
shoulder to the EF2 ΔM43/S44alkyne/F66W peak. 
 Though only monitored to 8 h the ligation is clearly progressing under these 
conditions. To explore whether the conditions for the first attempt had indeed been 
conducive to the reaction’s progress the peptides were once again lowered to 1 mM. 
The temperature was however lowered to 37 °C rather than 30 °C, as the ligation was 
still not complete by 8 h at 50 °C. Ligation product is visible from 1 h, and a substantial 
amount in the 25 h time point (Figure 6.18). Note the 25 h HPLC trace is shifted with 
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respect to the previous time points as the HPLC injection loop was changed from 100 µl 
to 20 µl. Significantly for the possible application of this technique the buffer was not 
degassed prior to its addition to the peptides and no negative side effects were observed, 
with classic click chemistry performed under rigorously air-free conditions. From this 
point on the ligation buffer was never degassed for any click ligation. This makes the 
ligation conditions much easier, facilitating the ease of handling. 
 In a similar control experiment to that in section 6.3 a denaturing buffer was 
employed to determine if this ligation was not just Cu-free but conformationally-
assisted. Under denaturing conditions no ligation product was observed by 24 h (Figure 
6.19), and so we can conclude that the reaction does depend on the peptides having 
sufficient secondary structure. 
 These findings are encouraging and once established to occur, conditions were 
sought to improve the rate of the ligation. Returning to the calcium non-denaturing 
buffer the temperature was increased once more to 50 °C. A ligation under these 
conditions was only followed to 8 h in the earlier attempt, and ligation appeared 
complete by 24 h (Figure 6.20). These early attempts without Cu(I) as a catalyst are 
encouraging. 
 Having established the effect of temperature on the speed of the ligation, peptide 
concentration was lowered to observe its effect. With a peptide concentration of 0.5 mM 
ligation again appears complete in 24 h (Figure 6.21). As with previous ligation 
attempts EF2 ΔM43/S44alkyne/F66W is depleted before EF1 azide, and so the next 
ligation reduced the amount of EF1 azide to 0.25 mM. Once again the ligation is 
complete in 24 h (Figure 6.22). At this point the 8h analytical-HPLC traces from the last 
three experiments are compared: 1 mM peptides at 50 °C, 0.5 mM peptides at 50 °C and 
0.25 mM EF1 azide with 0.5 mM EF2 ΔM43/S44alkyne/F66W-NH2 at 50 °C. In each 
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experiment the ratio of all three peaks is comparable, confirming that the ligation is not 
concentration-dependent in this range (data not shown). 
 The work by Mock and colleagues discussed in Chapter 1 with a cucurbituril 
additive was conducted at 40 °C and provided an 11-fold enhancement to the rate of 
triazole formation (Mock et al., 1983, Mock et al., 1989). With half the amount of EF1 
azide relative to EF2 ΔM43/S44alkyne/F66W-NH2 the temperature was lowered to 45 
°C. Under these conditions the ligation is now not complete until 48 h (Figure 6.23). To 
test reproducibility, and to confirm the concentrations of both starting materials, this 
ligation was repeated with concentrations determined by NanoDrop.  
 The final click experiment used NMR spectroscopy (carried out by Dr Geoff 
Kelly) to probe for which triazole isoform is present. As discussed in Chapter 1 Cu(I)-
catalysed AAC solely results in the 1, 4-regioisomer (Tornoe et al., 2002, Rostovtsev et 
al., 2002), but as our reaction is Cu(I)-free we wanted to confirm which isomer had 
formed. The literature states that the protonated carbon of the two isomers occurs at 
different chemical shifts, with that of a 1,4-distributed 1,2,3-triazole at around 120 ppm 
and that of a 1,5-distributed 1,2,3-triazole at around 130 ppm (Creary et al., 2012). 
These signals occur in the aromatic region of a 1H/13C-HSQC spectrum, and with the 
~120 ppm region for our calbindin D9k product containing just the one signal from the 
single Tyr and the five signals from the introduced Trp we should be able to identify a 
signal for the 1,4-regioisomer if present. Due to insufficient peptide concentration the 
signal-to-noise of the recorded 1H/13C-HSQC spectrum is poor, though at least seven 
signals are observed in the ~120 ppm region (Figure 6.24). This extra signal is 
indicative of the 1,4-regioisomer having formed, though the experiment will have to be 
repeated with more sample to improve signal-to-noise. Additionally denaturing 
conditions could be used to unfold the click product, generating a sharper spectrum with 
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peaks from aromatic resides in random coil formation to improve signal assignment. 
This applies not only to the ~120 ppm region for identification of the 1,4-regioisomer 
but also to the ~130 ppm region to probe for a signal from the 1,5-regioisomer. Without 
accurate signal assignment in these regions we can at this point only conclude that the 
presence of the 1,4-regioisomer is indicated, future work establishing if the 1,5-
regioisomer is also present. 
 
This work has successfully demonstrated conformationally-assisted and Cu-free 
click chemistry using the calbindin D9k peptides. We have established the effect of 
temperature on rate, and thus far not observed a decrease in rate when lowering the 
starting material concentrations. Future work could study this further, lowering the 
concentration to 100 µM as in the conformationally-assisted ligation using EF1 N-
(Me)sulfonamide. Unlike that ligation, here we would not have to be concerned with 
thiols overloading the column, in theory allowing for HPLC analysis of lower and lower 
peptide concentrations.  
Propiolic acid was chosen as the N-terminal alkyne component of EF2 based on 
work by Meldal and colleagues who used it for CuAAC on solid phase (Tornoe et al., 
2002). In this instance the alkyne is a Michael acceptor that could be encouraging 
triazole formation. To investigate this future work could include alkyne variants such as 
the strained alkynes used in Cu-free click reactions mentioned in Chapter 1. A first 
attempt has been conducted using dibenzocyclooctyne-acid, though appropriate 
conditions for this reaction have yet to be determined as a result of time constraints. 
Future work could investigate alternative reaction azide and strained alkyne 
components. Although encouraging, the rate of the reaction is still too low to be an 
effective method for protein labelling in vivo. However, as demonstrated here it can 
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significantly assist a reaction that doesn’t occur in its absence, suggesting that it could 
accelerate reactions that are currently too slow to be effective for protein labelling 
(Lang and Chin, 2014). 
 
Future work applicable to all ligations discussed within this chapter could 
investigate interactions aside from just Gly-Gly. Gly-Met and Ser-Ser were observed to 
possess comparable affinities and demonstrate a level of flexibility to the amino acids at 
the reaction site, and so other ligation junctions could be studied. Additionally a 
homoserine lactone could be added to the C-terminus of EF1 to see what effect this will 
have, in case it can form an amide bond upon proximity to the N-terminal Ser of EF2. 
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6.7 Summary 
Calbindin D9k was chosen as the final split protein, with the synthesis of EF1 
and EF2 variants to create a sterically-unhindered Gly-Gly interaction site. We 
measured a Kd of 69.0 nM between the peptides, significantly different to the 3 pM 
affinity which had attracted us to this system initially. The discrepancy was probably 
caused by relegation of the homoserine lactone. The presence of 2 mM calcium 
improved conformationally assisted peptide N-(Me)sulfonamide ligation by enhancing 
α–helical structure, as confirmed by CD. Finally these peptides were demonstrated to 
perform conformationally-assisted and Cu-free click chemistry between a peptide azide 
and alkyne, establishing this system as the most promising for our proposed labelling 
method. 
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7. Concluding remarks 
 The aim of the project was to explore the use of split proteins in a novel protein 
labelling method. We would express a small portion of a split protein at the N-terminus 
of the protein of interest, which would be selectively targeted by its complementing 
split protein fragment carrying the label. The inherent structure of the split protein 
fragments will be used to induce a conformationally-assisted ligation, where the two 
peptides become covalently bound and the target protein is labelled via this complex. 
Chapter 1 discusses the wide range of labelling methods available from the classic GFP 
to site-directed mutagenesis for covalent labelling to Cys residues. The more recent 
enzyme-, affinity- and proximity- based methods that have been developed show that 
bioorthogonal labelling is an expanding area of work of great interest interest (Lang and 
Chin, 2014). 
 In each split protein system the conformationally-assisted ligation of 
synthetically prepared peptide fragments was the first point of study, to confirm the 
suitability of their particular interaction site for use in the proposed labelling method. In 
place of synthesizing peptides with a C-terminal thioester we demonstrated the direct 
use of a peptide N-(Me)sulfonamide in NCL, discussed in Chapter 3. Following model 
ligation BPTI peptides demonstrated ligation comparable to that of NCL, without the 
need for a separate thioester exchange step. This performance led us to their use in the 
investigation of conformationally-assisted ligation in the split protein systems studied. 
 RNase A was chosen as the first split protein system for investigation, being a 
classic split protein system and the first demonstrated example of reconstitution. We 
began by attempting to demonstrate conformationally-assisted ligation between a 
synthesized S-peptide N-(Me)sulfonamide and commercially-available S-protein. 
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Though ligation occurred we encountered a problem in the extent of hydrolysis of S-
peptide N-(Me)sulfonamide, which we attempted to rectify by experimenting with 
thioesters of different reactivity. Oxidation of the thiol also proved problematic due to 
the absence of reducing agent in the buffer, as TCEP-HCl could not be included in the 
ligation buffer because of the disulfide bonds in the S-protein required for 
conformationally-assisted ligation. In addition to this we conducted the thioester 
exchange step separately to obtain the pre-formed S-peptide thioester, though ligation 
was still limited. Without obtaining ideal conditions the direction of study turned to 
alternative S-peptide variants to partner S-protein. BLI was used to establish the affinity 
of the full-length S-peptide, the truncated 15-mer peptide, the high-binding LB2 variant, 
and a variant with a C-terminal Gly for S-protein. The lowest Kd observed was 450 nM, 
belonging to the LB2 interaction with LB2, compared to the bench mark of 730 nM for 
the full-length S-peptide.  
 Though the result for the full-length S-peptide is in agreement with the 
Kossiakoff and co-workers, the Kd for RNase S varies in the literature depending on 
technique and conditions used to establish it. For example Richards and Vithayathil 
observed a 5 nM affinity (Richards and Vithayathil, 1959), whereas Woodfin and 
Massey identified an affinity of 20 µM (Woodfin and Massey, 1968). Discussions with 
co-workers suggest that the 599 nM Kd with the full-length S-peptide established by 
Kossiakoff and colleagues appears reasonable based on data obtained, however their 
LB2 data are not consistent with a 5 nM (personal communication with Dr Steve 
Martin). We also wondered if the discrepancy between our BLI results and published 
affinities may be due to immobilization of the S-peptide to the sensor. Kossiakoff and 
colleagues used SPR which should give comparable data to BLI, but they immobilized 
S-protein. S-protein is much larger so perhaps its N-terminus was more readily 
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accessible to S-peptide than the C-terminus of S-peptide was to S-protein in our 
experiments.  
 The work described on the study of RNase A has not replicated that published. 
A number of variations were made but instead of spending more time on this system we 
decided to move on to CI2, another well-studied split protein system. The literature 
reports a Kd value of 40 nM (de Prat Gay et al., 1994), and the peptides have undergone 
conformationally-assisted ligation (Beligere and Dawson, 1999). Conformationally-
assisted ligation is first attempted at a Gly-Met interaction site, with CI2(1-39)T39G N-
(Me)sulfonamide and CI2(40-64). A Gly is substituted at the C-terminus of CI2(1-39) to 
minimise steric hindrance after published data demonstrated conformationally-assisted 
ligation with the native Thr replaced with Asp. No ligation between the peptides is 
observed at this Gly-Met site, but conditions for thioester exchange with benzyl 
mercaptan are determined. As with RNase A we pre-exchanged for a thioester peptide 
and repeated ligation, but were still unable to replicate the published results. 
Fluorescence spectroscopy confirmed the peptides were interacting, with a 
concentration-dependent decrease in fluorescence. The next ligations substitute the 
native Met at the N-terminus of CI2(40-64) for Cys, and ligations with CI2(1-39)T39G 
N-(Me)sulfonamide are complete in 24 h with MPAA and just 2 h with thiophenol. The 
same ligations under denaturing conditions did not proceed, confirming the 
conformationally-assisted nature of the reaction.  
 The introduction of a Cys at this site and the following ligation demonstrates the 
ability of these peptides for conformationally-assisted ligation, but not at a Cys-free site. 
We wondered if the C-terminal Asp in the published conformationally-assisted ligation 
may increase ligation rates by way of an anhydride, resulting from the C-terminal Asp. 
The succinic anhydride formed is more reactive than the initial thioester and can ligate 
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quicker when in proximity to the N-terminus of the partner peptide as a result of their 
conformation. We considered synthesizing CI2(1-39)T39D N-(Me)sulfonamide to try to 
replicate the published conformationally-assisted ligation but decided that even if we 
observed a comparable affinity to that published, this peptide would not be appropriate 
for the labelling method. The activity of the anhydride could potentially result in 
labelling of other N-termini besides that targeted, and we would lose the 
chemoselectivity provided by a conformationally-assisted reaction. A control to test for 
this would be to perform ligation in the presence of other peptides or proteins, but as 
later publications disputed the suitability of an Asp-Cys ligation site it was decided 
move on to a third split protein system. 
  
Calbindin D9k was chosen as its peptide fragments are reported to interact with a 
high affinity, and neither fragment is of too large a size for consideration in our 
proposed labelling method. A number of variants on these peptides were synthesized by 
Fmoc-SPPS, to investigate three sets of reacting site termini. Changing these amino 
acids was not found to significantly affect the affinity of the peptides for one another, 
and so with a Kd of 69.0 nM as established by BLI a Gly-Gly interaction site was used 
for further experimentation. These peptides performed conformationally-assisted 
ligation in 8 h at low millimolar concentrations. An initial attempt at proximity-assisted 
acyl transfer of a small peptide tag between these peptides gave promising results, and 
the conditions will need to be further studied to identify those best suited.  
In addition to conformationally-assisted ligation with a peptide N-
(Me)sulfonamide these peptides demonstrated conformationally-assisted and Cu-free 
click chemistry. EF1 was synthesized with a C-terminal azide, and EF2 with an N-
terminal alkyne, and at relatively low temperatures and low millimolar concentrations 
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ligated to form the triazole-linked product. An initial attempt at establishing the triazole 
isoform was conducted using 1H/13C-HSQC based on work by Funk and co-workers 
(Creary et al., 2012). The results of this first experiment were not reliable enough to 
draw conclusions though a signal in the ~120 ppm region indicates the 1,4-
disubstituted-1,2,3-triazole, and so this will have to be repeated with product collected 
from a ligation of larger scale.  
Ultimately we intend to continue working with calbindin D9k to develop the best 
system for protein labelling by optimising the peptide components. The work described 
in Chapter 6 is highly promising for the development of a proximity-assisted labelling 
method, with impressive conformationally-assisted ligations. Future work will involve 
the investigation of alternative azide and alkyne components, reducing peptide size 
without compromising affinity to allow for incorporation of the smallest peptides 
possible into the proposed labelling method, and exploring non-canonical amino acids. 
There are a number of routes by which we can optimise this interaction, and improve 
upon these exciting initial results.  
 
The experiments performed thus far have concentrated on establishing the ideal 
split protein system for these conformationally-assisted chemical reactions. If the work 
with RNase A and CI2 had not required such iterative condition changes we would have 
concluded with the first demonstration of in vivo protein labelling, or at least in vitro 
labelling. Calbindin D9k proved to be the most exciting candidate, combining relatively 
small peptides with high affinity, and so we will begin labelling investigation with this 
split protein. In addition to its peptide lengths reconstitution of calbindin D9k results in a 
calcium-transporter complex and not a functional ribonuclease as with RNase A, for 
example, and so is better suited for cellular labelling. In the proposed method EF1 
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would be the donor peptide carrying the label or tag and EF2 would be the acceptor 
peptide expressed on the target protein. If the method of ligation using a peptide N-
(Me)sulfonamide were to be employed we would first need to pre-exchange to the 
thioester peptide, so as to not add thiols to the cellular environment. However the click 
azide and alkyne components have been shown to be physiologically compatible 
(Prescher and Bertozzi, 2005), and so this form of ligation could be incorporated into 
the labelling method. The first step would be to perform in vitro labelling of a target 
protein, by expressing EF2 as the acceptor peptide at the protein’s N-terminus. The first 
target for consideration would be a small ubiquitin-like modifier (SUMO) protein, as 
these are small in size and labelling could be monitored by HPLC (Marblestone et al., 
2006). A larger protein target will also be investigated, for though SUMO labelling 
should be easy to monitor we would need to ensure that the tag was not perturbing its 
activity due to its size. Maltose-binding protein (MBP) is a commonly used solubility 
enhancer (Fox and Waugh, 2003), and could be an ideal candidate for demonstration of 
labelling. With either target we could begin with biotin as the tag, using streptavidin 
pull-down for isolation and identification of potential labelled target protein. 
Once we have demonstrated in vitro labelling the goal would be to label a 
cellular protein. We have considered beginning with a muscarinic G-protein coupled 
receptor (GPCR), as its extracellular N-terminus will provide easier labelling for initial 
investigation. Expression of the acceptor peptide at this exosite allows for both the 
agonist and antagonist binding sites to remain free, retaining full signalling activity of 
the receptor. This also allows for tests to confirm the successful expression of the 
modified receptor at the cell membrane by using the fluorescent antagonist Cy3B-
telenzepine (Hern et al., 2010). Live cell single-molecule imaging could be used to 
estimate the level of expression of the modified muscarinic receptor, and it should be 
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possible to use plasmids encoding the muscarinic receptor fused to GFP by replacing 
the GFP sequence with the desired peptide sequence. CHO cells are one cell type for 
consideration because these do not express any muscarinic receptors on the plasma 
membrane, so any fluorescent molecules we can visualise during the imaging 
experiments will be the modified receptors. The initial fluorophore for testing will be 
Cy3B, a bright fluorophore that will make it easier to visualise the labelled receptors. 
Cy3B is brighter than GFP (Nenasheva et al., 2011) and alongside the specific affinity 
of the donor peptide for the small expressed acceptor peptide this method could prove to 
be a new and very powerful labelling technique. 
 
 
 
 
 
 
  
188	  
	  
References 
ADAMS,	   A.	   L.,	   COWPER,	   B.,	   MORGAN,	   R.	   E.,	   PREMDJEE,	   B.,	   CADDICK,	   S.	   &	  MACMILLAN,	   D.	  
2013.	   Cysteine	   Promoted	  C-­‐Terminal	  Hydrazinolysis	   of	  Native	   Peptides	   and	   Proteins.	  
Angewandte	  Chemie	  International	  Edition,	  52,	  13062-­‐13066.	  
AGARD,	  N.	  J.,	  PRESCHER,	  J.	  A.	  &	  BERTOZZI,	  C.	  R.	  2004.	  A	  Strain-­‐Promoted	  [3	  +	  2]	  Azide-­‐Alkyne	  
Cycloaddition	   for	  Covalent	  Modification	  of	  Biomolecules	   in	  Living	  Systems.	  Journal	  of	  
the	  American	  Chemical	  Society,	  126,	  15246-­‐15047.	  
AGNEW,	  H.	  D.,	  ROHDE,	  R.	  D.,	  MILLWARD,	  S.	  W.,	  NAG,	  A.,	  YEO,	  W.-­‐S.,	  HEIN,	  J.	  E.,	  PITRAM,	  S.	  M.,	  
TARIQ,	  A.	  A.,	  BURNS,	  V.	  M.,	  KROM,	  R.	  J.,	  FOKIN,	  V.	  V.,	  SHARPLESS,	  K.	  B.	  &	  HEATH,	  J.	  R.	  
2009.	   Iterative	   In	   Situ	   Click	   Chemistry	   Creates	   Antibody-­‐like	   Protein-­‐Capture	   Agents.	  
Angewandte	  Chemie	  International	  Edition,	  48,	  4944-­‐4948.	  
ANFINSEN,	  C.	  B.,	  REDFIELD,	  R.	  R.,	  CHOATE,	  W.	  L.,	  PAGE,	  J.	  &	  CARROLL,	  W.	  R.	  1954.	  Studies	  on	  
the	  Gross	  Structure,	  Cross-­‐Linkages	  and	  Terminal	  Sequences	   in	  Ribonuclease.	   Journal	  
of	  Biological	  Chemistry,	  207,	  201-­‐210.	  
ANTOS,	  J.	  M.,	  CHEW,	  G.	  L.,	  GUIMARAES,	  C.	  P.,	  YODER,	  N.	  C.,	  GROTENBREG,	  G.	  M.,	  POPP,	  M.	  W.	  
L.	   &	   PLOEGH,	   H.	   L.	   2009.	   Site-­‐Specific	   N-­‐	   and	   C-­‐Terminal	   Labeling	   of	   a	   Single	  
Polypeptide	  Using	  Sortases	  of	  Different	  Specificity.	   Journal	  of	   the	  American	  Chemical	  
Society,	  131,	  10800-­‐+.	  
BACSA,	  B.,	  DESAI,	  B.,	  DIBÓ,	  G.	  &	  KAPPE,	  C.	  O.	  2006.	  Rapid	  solid-­‐phase	  peptide	  synthesis	  using	  
thermal	  and	  controlled	  microwave	  irradiation.	  Journal	  of	  Peptide	  Science,	  12,	  633-­‐638.	  
BASKIN,	  J.	  M.,	  PRESCHER,	  J.	  A.,	  LAUGHLIN,	  S.	  T.,	  AGARD,	  N.	  J.,	  CHANG,	  P.	  V.,	  MILLER,	  I.	  A.,	  LO,	  
A.,	  CODELLI,	   J.	  A.	  &	  BERTOZZI,	  C.	  R.	  2007.	  Copper-­‐free	  click	  chemistry	   for	  dynamic	   in	  
vivo	  imaging.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences,	  104,	  16793-­‐16797.	  
BELIGERE,	   G.	   S.	   &	   DAWSON,	   P.	   E.	   1999.	   Conformationally	   assisted	   protein	   ligation	   using	   C-­‐
terminal	  thioester	  peptides.	  Journal	  of	  the	  American	  Chemical	  Society,	  121,	  6332-­‐6333.	  
BELIGERE,	  G.	  S.	  &	  DAWSON,	  P.	  E.	  2000.	  Design,	  Synthesis,	  and	  Characterization	  of	  4-­‐Ester	  CI2,	  a	  
Model	   for	  Backbone	  Hydrogen	  Bonding	   in	  Protein	  α-­‐Helices.	   Journal	  of	   the	  American	  
Chemical	  Society,	  122,	  12079-­‐12082.	  
BERGGÅRD,	   T.,	   JULENIUS,	   K.,	   OGARD,	   A.,	   DRAKENBERG,	   T.	   &	   LINSE,	   S.	   2001.	   Fragment	  
complementation	   studies	   of	   protein	   stabilization	   by	   hydrophobic	   core	   residues.	  
Biochemistry,	  40,	  1257-­‐1264.	  
BLAKELEY,	   B.	   D.,	   CHAPMAN,	   A.	   M.	   &	   MCNAUGHTON,	   B.	   R.	   2012.	   Split-­‐superpositive	   GFP	  
reassembly	   is	   a	   fast,	   efficient,	   and	   robust	   method	   for	   detecting	   protein–protein	  
interactions	  in	  vivo.	  Molecular	  BioSystems,	  8,	  2036.	  
BODANSZKY,	   M.	   &	   KWEI,	   J.	   Z.	   1978.	   Side	   Reactions	   in	   Peptide-­‐Synthesis	   .7.	   Sequence	  
Dependence	   in	   Formation	   of	   Aminosuccinyl	   Derivatives	   from	   Beta-­‐Benzyl-­‐Aspartyl	  
Peptides.	  International	  Journal	  of	  Peptide	  and	  Protein	  Research,	  12,	  69-­‐74.	  
BURLINA,	   F.,	   MORRIS,	   C.,	   BEHRENDT,	   R.,	   WHITE,	   P.	   &	   OFFER,	   J.	   2012.	   Simplifying	   native	  
chemical	   ligation	   with	   an	   N-­‐acylsulfonamide	   linker.	   Chemical	   Communications,	   48,	  
2579.	  
BURLINA,	  F.,	  PAPAGEORGIOU,	  G.,	  MORRIS,	  C.,	  WHITE,	  P.	  D.	  &	  OFFER,	  J.	  2014.	  In	  situ	  thioester	  
formation	  for	  protein	  ligation	  using	  α-­‐methylcysteine.	  Chemical	  Science,	  5,	  766-­‐770.	  
CABANTOUS,	  S.,	  NGUYEN,	  H.	  B.,	  PEDELACQ,	  J.-­‐D.,	  KORAÏCHI,	  F.,	  CHAUDHARY,	  A.,	  GANGULY,	  K.,	  
LOCKARD,	  M.	  A.,	  FAVRE,	  G.,	  TERWILLIGER,	  T.	  C.	  &	  WALDO,	  G.	  S.	  2013.	  A	  New	  Protein-­‐
Protein	  Interaction	  Sensor	  Based	  on	  Tripartite	  Split-­‐GFP	  Association.	  Scientific	  Reports,	  
3.	  
CABANTOUS,	  S.,	  TERWILLIGER,	  T.	  C.	  &	  WALDO,	  G.	  S.	  2005.	  Protein	  tagging	  and	  detection	  with	  
engineered	   self-­‐assembling	   fragments	   of	   green	   fluorescent	   protein.	   Nature	  
Biotechnology,	  23,	  102-­‐107.	  
189	  
	  
CAREY,	   J.,	   LINDMAN,	   S.,	   BAUER,	   M.	   &	   LINSE,	   S.	   2007.	   Protein	   reconstitution	   and	   three-­‐
dimensional	  domain	  swapping:	  Benefits	  and	  constraints	  of	  covalency.	  Protein	  Science,	  
16,	  2317-­‐2333.	  
CHAO,	   H.	   M.,	   BAUTISTA,	   D.	   L.,	   LITOWSKI,	   J.,	   IRVIN,	   R.	   T.	   &	   HODGES,	   R.	   S.	   1998.	   Use	   of	   a	  
heterodimeric	   coiled-­‐coil	   system	   for	   biosensor	   application	   and	   affinity	   purification.	  
Journal	  of	  Chromatography	  B,	  715,	  307-­‐329.	  
CHATTOPADHYAYA,	   R.,	   MEADOR,	  W.	   E.,	   MEANS,	   A.	   R.	   &	   QUIOCHO,	   F.	   A.	   1992.	   Calmodulin	  
Structure	  Refined	  at	  1.7	  Angstrom	  Resolution.	  Journal	  of	  Molecular	  Biology,	  228,	  1177-­‐
1192.	  
CORRADIN,	   G.	   &	   HARBURY,	   H.	   A.	   1970.	   Cleavage	   of	   Cytochrome-­‐C	  with	   Cyanogen	   Bromide.	  
Biochimica	  Et	  Biophysica	  Acta,	  221,	  489-­‐&.	  
CORRADIN,	   G.	   &	   HARBURY,	   H.	   A.	   1971.	   Reconstitution	   of	   Horse	   Heart	   Cytochrome	   C	   -­‐	  
Interaction	   of	   Components	   Obtained	   Upon	   Cleavage	   of	   Peptide	   Bond	   Following	  
Methionine	  Residue	  65.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  
States	  of	  America,	  68,	  3036-­‐&.	  
CORRADIN,	   G.	   &	   HARBURY,	   H.	   A.	   1974.	   Reconstitution	   of	   Horse	   Heart	   Cytochrome-­‐C	   -­‐	  
Reformation	  of	  Peptide-­‐Bond	  Linking	  Residues	  65	  and	  66.	  Biochemical	  and	  Biophysical	  
Research	  Communications,	  61,	  1400-­‐1406.	  
COTTON,	  G.	   J.	  &	  MUIR,	   T.	  W.	  2000.	  Generation	  of	   a	  dual-­‐labeled	   fluorescence	  biosensor	   for	  
Crk-­‐II	   phosphorylation	   using	   solid-­‐phase	   expressed	   protein	   ligation.	   Chemistry	   &	  
Biology,	  7,	  253-­‐261.	  
CREARY,	  X.,	  ANDERSON,	  A.,	  BROPHY,	  C.,	  CROWELL,	  F.	  &	  FUNK,	  Z.	  2012.	  Method	  for	  Assigning	  
Structure	  of	  1,2,3-­‐Triazoles.	  The	  Journal	  of	  Organic	  Chemistry,	  77,	  8756-­‐8761.	  
CRICK,	  F.	  H.	  C.	  1953.	  The	  Packing	  of	  α-­‐Helices:	  Simple	  Coiled-­‐Coils.	  Acta.	  Cryst.,	  6.	  
DANG,	   B.,	   KUBOTA,	   T.,	   MANDAL,	   K.,	   BEZANILLA,	   F.	   &	   KENT,	   S.	   B.	   H.	   2013.	   Native	   Chemical	  
Ligation	  at	  Asx-­‐Cys,	  Glx-­‐Cys:	  Chemical	  Synthesis	  and	  High-­‐Resolution	  X-­‐ray	  Structure	  of	  
ShK	   Toxin	   by	   Racemic	   Protein	   Crystallography.	   Journal	   of	   the	   American	   Chemical	  
Society,	  135,	  11911-­‐11919.	  
DAWSON,	   P.	   E.,	   CHURCHILL,	   M.	   J.,	   GHADIRI,	   M.	   R.	   &	   KENT,	   S.	   B.	   H.	   1997.	   Modulation	   of	  
reactivity	   in	  native	  chemical	   ligation	  through	  the	  use	  of	  thiol	  additives.	  Journal	  of	  the	  
American	  Chemical	  Society,	  119,	  4325-­‐4329.	  
DAWSON,	  P.	  E.,	  MUIR,	  T.	  W.,	  CLARKLEWIS,	   I.	  &	  KENT,	  S.	  B.	  H.	  1994.	  Synthesis	  of	  Proteins	  by	  
Native	  Chemical	  Ligation.	  Science,	  266,	  776-­‐779.	  
DE	   PRAT	   GAY,	   G.	   &	   FERSHT,	   A.	   R.	   1994.	   Generation	   of	   a	   family	   of	   protein	   fragments	   for	  
structure-­‐folding	   studies.	   1.	   Folding	   complementation	   of	   two	   fragments	   of	  
chymotrypsin	   inhibitor-­‐2	   formed	   by	   cleavage	   at	   its	   unique	   methionine	   residue.	  
Biochemistry,	  33,	  7957-­‐63.	  
DE	  PRAT	  GAY,	  G.,	  RUIZ-­‐SANZ,	  J.,	  DAVIS,	  B.	  &	  FERSHT,	  A.	  R.	  1994.	  The	  structure	  of	  the	  transition	  
state	   for	   the	   association	   of	   two	   fragments	   of	   the	   barley	   chymotrypsin	   inhibitor	   2	   to	  
generate	   native-­‐like	   protein:	   Implications	   for	   mechinsms	   of	   protein	   folding.	  
Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America,	  91,	  
10943-­‐10946.	  
DWYER,	  J.	  J.,	  DWYER,	  M.	  A.	  &	  KOSSIAKOFF,	  A.	  A.	  2001.	  High	  affinity	  RNase	  S-­‐peptide	  variants	  
obtained	  by	  phage	  display	  have	  a	  novel	  "hot-­‐spot"	  of	  binding	  energy.	  Biochemistry,	  40,	  
13491-­‐13500.	  
ELMASRY,	  N.	  F.	  &	  FERSHT,	  A.	  R.	  1994.	  Mutational	  Analysis	  of	  the	  N-­‐Capping	  Box	  of	  the	  Alpha-­‐
Helix	  of	  Chymotrypsin	  Inhibitor-­‐2.	  Protein	  Engineering,	  7,	  777-­‐782.	  
FIELDS,	   S.	   &	   SONG,	   O.	   1989.	   A	   novel	   genetic	   system	   to	   detect	   protein-­‐protein	   interactions.	  
Nature,	  340,	  245-­‐6.	  
FINN,	  B.	  E.,	  KӦRDEL,	  J.,	  THULIN,	  E.,	  SELLERS,	  P.	  &	  FORSÉN,	  S.	  1992.	  Dissection	  of	  Calbindin	  Dgk	  
into	   two	   Ca2”-­‐binding	   subdomains	   by	   a	   combination	   of	   mutagenesis	   and	   chemical	  
cleavage.	  FEBS	  Lett.,	  298,	  211-­‐214.	  
190	  
	  
FOX,	   J.	  D.	  &	  WAUGH,	  D.	   S.	   2003.	  Maltose-­‐Binding	  Protein	  as	   a	   Solubility	   Enhancer.	  Methods	  
Mol	  Biol,	  205,	  99-­‐117.	  
FREEMAN,	   W.	   A.,	   MOCK,	   W.	   L.	   &	   SHIH,	   N.	   Y.	   1981.	   Cucurbituril.	   Journal	   of	   the	   American	  
Chemical	  Society,	  103,	  7367-­‐7368.	  
FUKUCHI,	   S.	   &	   NISHIKAWA,	   K.	   2001.	   Protein	   surface	   amino	   acid	   compositions	   distinctively	  
differ	   between	   thermophilic	   and	   mesophilic	   bacteria.	   Journal	   of	   Molecular	   Biology,	  
309,	  835-­‐843.	  
GHOSH,	   I.,	   HAMILTON,	  A.	  D.	  &	  REGAN,	   L.	   2000.	   Antiparallel	   Leucine	   Zipper-­‐Directed	   Protein	  
Reassembly:	   Application	   to	   the	   Green	   Fluorescent	   Protein.	   J.	   Am.	   Chem.	   Soc.,	   122,	  
5658-­‐5659.	  
GIRIAT,	   I.	  &	  MUIR,	  T.	  W.	  2003.	  Protein	   semi-­‐synthesis	   in	   living	  cells.	   Journal	  of	   the	  American	  
Chemical	  Society,	  125,	  7180-­‐7181.	  
GREENFIELD,	   N.	   &	   FASMAN,	   G.	   D.	   1969.	   Computed	   Circular	   Dichroism	   Spectra	   for	   the	  
Evaluation	  of	  Protein	  Conformation.	  Biochemistry,	  8,	  4108-­‐4116.	  
GREENFIELD,	   N.	   J.	   2006.	   Using	   circular	   dichroism	   spectra	   to	   estimate	   protein	   secondary	  
structure.	  Nature	  Protocols,	  1,	  2876-­‐2890.	  
GROSS,	   E.	   &	   WITKOP,	   B.	   1962.	   Nonenzymatic	   cleavage	   of	   peptide	   bonds:	   the	   methionine	  
residues	  in	  bovine	  pancreatic	  ribonuclease.	  J	  Biol	  Chem,	  237,	  1856-­‐60.	  
HAACK,	  T.	  &	  MUTTER,	  M.	  1992.	  Serine	  Derived	  Oxazolidines	  as	  Secondary	  Structure	  Disrupting,	  
Solubilizing	  Building-­‐Blocks	  in	  Peptide-­‐Synthesis.	  Tetrahedron	  Letters,	  33,	  1589-­‐1592.	  
HACKENG,	  T.	  M.,	  GRIFFIN,	   J.	  H.	  &	  DAWSON,	  P.	  E.	  1999.	  Protein	   synthesis	  by	  native	  chemical	  
ligation:	   Expanded	   scope	   by	   using	   straightforward	   methodology.	   Proceedings	   of	   the	  
National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America,	  96,	  10068-­‐10073.	  
HANCOCK,	   W.	   S.	   &	   BATTERSBY,	   J.	   E.	   1976.	   New	   Micro-­‐Test	   for	   Detection	   of	   Incomplete	  
Coupling	   Reactions	   in	   Solid-­‐Phase	   Peptide-­‐Synthesis	   Using	   2,4,6-­‐Trinitrobenzene-­‐
Sulphonic	  Acid.	  Analytical	  Biochemistry,	  71,	  260-­‐264.	  
HANTGAN,	   R.	   R.	   &	   TANIUCHI,	   H.	   1977.	   Formation	   of	   a	   Biologically-­‐Active,	   Ordered	   Complex	  
from	  2	  Overlapping	  Fragments	  of	  Cytochrome-­‐C.	  Journal	  of	  Biological	  Chemistry,	  252,	  
1367-­‐1374.	  
HERN,	   J.	   A.,	   BAIG,	   A.	   H.,	   MASHANOV,	   G.	   I.,	   BIRDSALL,	   B.,	   CORRIE,	   J.	   E.	   T.,	   LAZARENO,	   S.,	  
MOLLOY,	  J.	  E.	  &	  BIRDSALL,	  N.	  J.	  M.	  2010.	  Imaging	  individual	  myosin	  molecules	  within	  
living	  cells,	  methods	  in	  molecular	  biology.	  PNAS,	  107,	  2693-­‐2698.	  
HIRATA,	   R.,	   OHSUMI,	   Y.,	   NAKANO,	   A.,	   KAWASAKI,	   H.,	   SUZUKI,	   K.	   &	   ANRAKU,	   Y.	   1990.	  
Molecular-­‐Structure	   of	   a	   Gene,	   Vma1,	   Encoding	   the	   Catalytic	   Subunit	   of	   H+-­‐
Translocating	   Adenosine-­‐Triphosphatase	   from	   Vacuolar	   Membranes	   of	  
Saccharomyces-­‐Cerevisiae.	  Journal	  of	  Biological	  Chemistry,	  265,	  6726-­‐6733.	  
HIRS,	   C.	   H.,	   MOORE,	   S.	   &	   STEIN,	   W.	   H.	   1960.	   The	   sequence	   of	   the	   amino	   acid	   residues	   in	  
performic	  acid-­‐oxidized	  ribonuclease.	  Journal	  of	  Biological	  Chemistry,	  235,	  633-­‐47.	  
HOLM,	  L.,	  MOODY,	  P.	  &	  HOWARTH,	  M.	  2009.	  Electrophilic	  Affibodies	  Forming	  Covalent	  Bonds	  
to	  Protein	  Targets.	  Journal	  of	  Biological	  Chemistry,	  284,	  32906-­‐32913.	  
HOLMGREN,	   A.	   1972.	   Thioredoxin-­‐C'	   -­‐	   Reconstitution	   of	   an	   Active	   Form	   of	   Escherichia-­‐Coli	  
Thioredoxin	  from	  2	  Noncovalently	  Linked	  Cyanogen	  Bromide	  Peptide	  Fragments.	  Febs	  
Letters,	  24,	  351-­‐&.	  
HOLZWARTH,	  G.	  &	  DOTY,	  P.	  1965.	  The	  Ultraviolet	  Circular	  Dichroism	  of	  Polypeptides.	  Journal	  
of	  the	  American	  Chemical	  Society,	  87,	  218-­‐228.	  
HOSSAN,	   A.,	   ABU-­‐MELHA,	   H.,	   AL-­‐OMAR,	   M.	   &	   AMR,	   A.	   2012.	   Synthesis	   and	   Antimicrobial	  
Activity	  of	  Some	  New	  Pyrimidinone	  and	  Oxazinone	  Derivatives	  Fused	  with	  Thiophene	  
Rings	   Using	   2-­‐Chloro-­‐6-­‐ethoxy-­‐4-­‐acetylpyridine	   as	   Starting	   Material.	   Molecules,	   17,	  
13642-­‐13655.	  
HUISGEN,	  R.	  1963.	  1,3-­‐Dipolar	  Cycloadditions	  Past	  and	  Future.	  Angew.	  Chem.	  Int.	  Ed.,	  2,	  565-­‐
632.	  
191	  
	  
HYDE,	   C.,	   JOHNSON,	   T.,	   OWEN,	   D.,	   QUIBELL,	   M.	   &	   SHEPPARD,	   R.	   C.	   1994.	   Some	   Difficult	  
Sequences	   Made	   Easy	   -­‐	   a	   Study	   of	   Interchain	   Association	   in	   Solid-­‐Phase	   Peptide-­‐
Synthesis.	  International	  Journal	  of	  Peptide	  and	  Protein	  Research,	  43,	  431-­‐440.	  
INGENITO,	  R.,	  BIANCHI,	  E.,	  FATTORI,	  D.	  &	  PESSI,	  A.	  1999.	  Solid	  phase	  synthesis	  of	  peptide	  C-­‐
terminal	  thioesters	  by	  Fmoc/t-­‐Bu	  chemistry.	  Journal	  of	  the	  American	  Chemical	  Society,	  
121,	  11369-­‐11374.	  
ITZHAKI,	   L.	   S.,	   OTZEN,	   D.	   E.	   &	   FERSHT,	   A.	   R.	   1995.	   The	   Structure	   of	   the	   Transition	   State	   for	  
Folding	   of	   Chymotrypsin	   Inhibitor	   2	   Analysed	   by	   Protein	   Engineering	   Methods:	  
Evidence	   for	  a	  Nucleation-­‐condensation	  Mechanism	   for	  Protein	  Folding.	   J.	  Mol.	  Biol.,	  
254,	  260-­‐288.	  
JACOB,	   E.	   &	   UNGER,	   R.	   2007.	   A	   tale	   of	   two	   tails:	   why	   are	   terminal	   residues	   of	   proteins	  
exposed?	  Bioinformatics,	  23,	  e225-­‐e230.	  
JEWETT,	  J.	  C.	  &	  BERTOZZI,	  C.	  R.	  2010.	  Cu-­‐free	  click	  cycloaddition	  reactions	  in	  chemical	  biology.	  
Chemical	  Society	  Reviews,	  39,	  1272.	  
JOHNSON,	   E.	   C.	   B.	   &	   KENT,	   S.	   B.	   H.	   2006.	   Insights	   into	   the	  mechanism	   and	   catalysis	   of	   the	  
native	  chemical	  ligation	  reaction.	  Journal	  of	  the	  American	  Chemical	  Society,	  128,	  6640-­‐
6646.	  
JOHNSON,	  T.,	  QUIBELL,	  M.,	  OWEN,	  D.	  &	  SHEPPARD,	  R.	  C.	  1993.	  A	  Reversible	  Protecting	  Group	  
for	  the	  Amide	  Bond	  in	  Peptides	  -­‐	  Use	  in	  the	  Synthesis	  of	  Difficult	  Sequences.	  Journal	  of	  
the	  Chemical	  Society-­‐Chemical	  Communications,	  369-­‐372.	  
JOHNSSON,	  N.	  &	  VARSHAVSKY,	  A.	  1994.	  Split	  Ubiquitin	  as	  a	  Sensor	  of	  Protein	  Interactions	  in-­‐
Vivo.	  Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America,	  
91,	  10340-­‐10344.	  
KAISER,	   E.,	   COLESCOT.RL,	  BOSSINGE.CD	  &	  COOK,	  P.	   I.	   1970.	  Color	   Test	   for	  Detection	  of	   Free	  
Terminal	  Amino	  Groups	   in	  Solid-­‐Phase	  Synthesis	  of	  Peptides.	  Analytical	  Biochemistry,	  
34,	  595-­‐&.	  
KAISER,	   R.	   &	   METZKA,	   L.	   1999.	   Enhancement	   of	   cyanogen	   bromide	   cleavage	   yields	   for	  
methionyl-­‐serine	   and	   methionyl-­‐threonine	   peptide	   bonds.	   Analytical	   Biochemistry,	  
266,	  1-­‐8.	  
KANG,	   J.	   &	   MACMILLAN,	   D.	   2010.	   Peptide	   and	   protein	   thioester	   synthesis	   via	   N→S	   acyl	  
transfer.	  Organic	  &	  Biomolecular	  Chemistry,	  8,	  1993.	  
KARAS,	   M.,	   BACHMANN,	   D.	   &	   HILLENKAMP,	   F.	   1985.	   Influence	   of	   the	  Wavelength	   in	   High-­‐
Irradiance	   Ultraviolet-­‐Laser	   Desorption	   Mass-­‐Spectrometry	   of	   Organic-­‐Molecules.	  
Analytical	  Chemistry,	  57,	  2935-­‐2939.	  
KELEMEN,	   B.	   R.,	   KLINK,	   T.	   A.,	   BEHLKE,	  M.	   A.,	   EUBANKS,	   S.	   R.,	   LELAND,	   P.	   A.	  &	   RAINES,	   R.	   T.	  
1999.	   Hypersensitive	   substrate	   for	   ribonucleases.	  Nucleic	   Acids	   Research,	   27,	   3696-­‐
3701.	  
KENNER,	  G.	  W.,	  MCDERMOTT,	  J.	  R.	  &	  SHEPPARD,	  R.	  C.	  1971.	  The	  safety	  catch	  principle	  in	  solid	  
phase	  peptide	  synthesis.	  Journal	  of	  the	  Chemical	  Society	  D:	  Chemical	  Communications,	  
636.	  
KENT,	  S.	  B.	  H.	  2009.	  Total	  chemical	  synthesis	  of	  proteins.	  Chemical	  Society	  Reviews,	  38,	  338.	  
KIICK,	   K.	   L.,	   SAXON,	   E.,	   TIRRELL,	   D.	   A.	   &	   BERTOZZI,	   C.	   R.	   2001.	   Incorporation	   of	   azides	   into	  
recombinant	   proteins	   for	   chemoselective	   modification	   by	   the	   Staudinger	   ligation.	  
Proceedings	  of	  the	  National	  Academy	  of	  Sciences,	  99,	  19-­‐24.	  
KOBAYASHI,	   N.,	   HONDA,	   S.,	   YOSHII,	   H.,	   UEDAIRA,	   H.	   &	   MUNEKATA,	   E.	   1995.	   Complement	  
assembly	   of	   2	   fragments	   of	   the	   streptococcal	   protein-­‐G	   B1	   domain	   in	   aqueous-­‐
solution.	  FEBS	  Lett.,	  366,	  99-­‐103.	  
KOJETIN,	  D.	  J.,	  VENTERS,	  R.	  A.,	  KORDYS,	  D.	  R.,	  THOMPSON,	  R.	  J.,	  KUMAR,	  R.	  &	  CAVANAGH,	  J.	  
2006.	   Structure,	   binding	   interface	   and	   hydrophobic	   transitions	   of	   Ca2+-­‐loaded	  
calbindin-­‐D28K.	  Nature	  Structural	  &#38;	  Molecular	  Biology,	  13,	  641-­‐647.	  
KOLB,	  H.	  C.,	  FINN,	  M.	  G.	  &	  SHARPLESS,	  K.	  B.	  2001.	  Click	  chemistry:	  Diverse	  chemical	  function	  
from	  a	  few	  good	  reactions.	  Angewandte	  Chemie-­‐International	  Edition,	  40,	  2004-­‐+.	  
192	  
	  
KOSAKA,	   N.,	   OGAWA,	   M.,	   CHOYKE,	   P.	   L.,	   KARASSINA,	   N.,	   CORONA,	   C.,	   MCDOUGALL,	   M.,	  
LYNCH,	  D.	  T.,	  HOYT,	  C.	  C.,	  LEVENSON,	  R.	  M.,	  LOS,	  G.	  V.	  &	  KOBAYASHI,	  H.	  2009.	  In	  Vivo	  
Stable	   Tumor-­‐Specific	   Painting	   in	   Various	   Colors	   Using	   Dehalogenase-­‐Based	   Protein-­‐
Tag	  Fluorescent	  Ligands.	  Bioconjugate	  Chemistry,	  20,	  1367-­‐1374.	  
KRETSINGER,	  R.	  H.	  &	  NOCKOLDS,	  C.	  E.	  1973.	  Carp	  muscle	  calcium-­‐binding	  protein.	  II.	  Structure	  
determination	  and	  general	  description.	  Journal	  of	  Biological	  Chemistry,	  248,	  3313-­‐26.	  
KUNITZ,	  M.	  1946.	  A	  spectrophotometric	  method	  for	  the	  measurement	  of	  ribonuclease	  activity.	  
Journal	  of	  Biological	  Chemistry,	  164,	  563-­‐8.	  
LANG,	   K.	   &	   CHIN,	   J.	   W.	   2014.	   Bioorthogonal	   Reactions	   for	   Labeling	   Proteins.	   Acs	   Chemical	  
Biology,	  9,	  16-­‐20.	  
LEE,	  D.	  L.,	  GRANJA,	  J.	  R.,	  MARTINEZ,	  J.	  A.,	  SEVERIN,	  K.	  &	  GHADIRI,	  M.	  R.	  1996.	  A	  self-­‐replicating	  
peptide.	  Nature,	  382,	  525-­‐528.	  
LEMAN,	   L.	   J.,	  WEINBERGER,	   D.	   A.,	   HUANG,	   Z.	   Z.,	  WILCOXEN,	   K.	  M.	   &	   GHADIRI,	  M.	   R.	   2007.	  
Functional	  and	  mechanistic	  analyses	  of	  biomimetic	  aminoacyl	  transfer	  reactions	  in	  de	  
novo	  designed	  coiled	  coil	  peptides	  via	   rational	  active	   site	  engineering.	   Journal	  of	   the	  
American	  Chemical	  Society,	  129,	  2959-­‐2966.	  
LEWIS,	  W.	  G.,	  GREEN,	  L.	  G.,	  GRYNSZPAN,	  F.,	  RADIC,	  Z.,	  CARLIER,	  P.	  R.,	  TAYLOR,	  P.,	  FINN,	  M.	  G.	  
&	   SHARPLESS,	   K.	   B.	   2002.	   Click	   chemistry	   in	   situ:	   Acetylcholinesterase	   as	   a	   reaction	  
vessel	   for	   the	  selective	  assembly	  of	  a	   femtomolar	   inhibitor	   from	  an	  array	  of	  building	  
blocks.	  Angewandte	  Chemie-­‐International	  Edition,	  41,	  1053-­‐+.	  
LI,	   Z.,	   SEOK,	   T.	   S.	   &	   JU,	   J.	   2004.	   1,3-­‐Dipolar	   cycloaddition	   of	   azides	   with	   electron-­‐deﬁcient	  
alkynes	  under	  mild	  condition	  in	  water.	  Tetrahedron	  letters,	  45,	  3143-­‐3146.	  
LINSE,	  S.,	  BRODIN,	  P.,	  JOHANSSON,	  C.,	  THULIN,	  E.,	  GRUNDSTROM,	  T.	  &	  FORSEN,	  S.	  1988.	  The	  
Role	  of	  Protein	  Surface-­‐Charges	  in	  Ion	  Binding.	  Nature,	  335,	  651-­‐652.	  
LINSE,	  S.,	  JOHANSSON,	  C.,	  BRODIN,	  P.,	  GRUNDSTROM,	  T.,	  DRAKENBERG,	  T.	  &	  FORSEN,	  S.	  1991.	  
Electrostatic	  Contributions	   to	   the	  Binding	  of	  Ca2+	   in	  Calbindin	  D9k.	  Biochemistry,	  30,	  
154-­‐162.	  
LOS,	  G.	  V.,	  ENCELL,	  L.	  P.,	  MCDOUGALL,	  M.	  G.,	  HARTZELL,	  D.	  D.,	  KARASSINA,	  N.,	  ZIMPRICH,	  C.,	  
WOOD,	   M.	   G.,	   LEARISH,	   R.,	   OHANA,	   R.	   F.,	   URH,	   M.,	   SIMPSON,	   D.,	   MENDEZ,	   J.,	  
ZIMMERMAN,	   K.,	   OTTO,	   P.,	   VIDUGIRIS,	   G.,	   ZHU,	   J.,	   DARZINS,	   A.,	   KLAUBERT,	   D.	   H.,	  
BULLEIT,	  R.	  F.	  &	  WOOD,	  K.	  V.	  2008.	  HaloTag:	  a	  novel	  protein	   labeling	   technology	   for	  
cell	  imaging	  and	  protein	  analysis.	  ACS	  Chem	  Biol,	  3,	  373-­‐82.	  
LU,	  W.,	  STAROVASNIK,	  M.	  A.	  &	  KENT,	  S.	  B.	  1998.	  Total	  Chemical	  Synthesis	  of	  Bovine	  Pancreatic	  
Trypsin	  Inhibitor	  by	  Native	  Chemical	  Ligation.	  FEBS	  Lett.,	  429,	  31-­‐35.	  
LUDVIGSEN,	  S.,	  SHEN,	  H.,	  KJAER,	  M.,	  MADSEN,	  J.	  C.	  &	  POULSEN,	  F.	  M.	  1991.	  Refinement	  of	  the	  
3-­‐Dimensional	   Solution	   Structure	   of	   Barley	   Serine	   Proteinase	   Inhibitor-­‐2	   and	  
Comparison	  with	  the	  Structures	  in	  Crystals.	  Journal	  of	  Molecular	  Biology,	  222,	  621-­‐635.	  
LUPAS,	   A.	   1996.	   Coiled	   coils:	   new	   structures	   and	   new	   functions.	   Trends	   in	   Biochemical	  
Sciences,	  21,	  375-­‐82.	  
MAMIDYALA,	  S.	  K.	  &	  FINN,	  M.	  G.	  2010.	  In	  situ	  click	  chemistry:	  probing	  the	  binding	  landscapes	  
of	  biological	  molecules.	  Chemical	  Society	  Reviews,	  39,	  1252.	  
MARBLESTONE,	   J.	   G.,	   EDAVETTAL,	   S.	   C.,	   LIM,	   Y.,	   LIM,	   P.,	   ZUO,	   X.	   &	   BUTT,	   T.	   R.	   2006.	  
Comparison	   of	   SUMO	   fusion	   technology	   with	   traditional	   gene	   fusion	   systems:	  
Enhanced	  expression	  and	  solubility	  with	  SUMO.	  Protein	  Science,	  15,	  182-­‐189.	  
MENDE,	   F.	   &	   SEITZ,	   O.	   2011.	   9-­‐Fluorenylmethoxycarbonyl-­‐Based	   Solid-­‐Phase	   Synthesis	   of	  
Peptide	  α-­‐Thioesters.	  Angewandte	  Chemie	  International	  Edition,	  50,	  1232-­‐1240.	  
MEZZATO,	   S.,	   SCHAFFRATH,	  M.	  &	  UNVERZAGT,	   C.	   2005.	   An	  Orthogonal	   Double-­‐Linker	   Resin	  
Facilitates	   the	   Efficient	   Solid-­‐Phase	   Synthesis	   of	   Complex-­‐Type	   N-­‐Glycopeptide	  
Thioesters	   Suitable	   for	   Native	   Chemical	   Ligation.	   Angewandte	   Chemie	   International	  
Edition,	  44,	  1650-­‐1654.	  
193	  
	  
MILLWARD,	  S.	  W.,	  AGNEW,	  H.	  D.,	  LAI,	  B.,	  LEE,	  S.	  S.,	  LIM,	  J.,	  NAG,	  A.,	  PITRAM,	  S.,	  ROHDE,	  R.	  &	  
HEATH,	   J.	  R.	  2013.	   In	  situ	  click	  chemistry:	   from	  small	  molecule	  discovery	  to	  synthetic	  
antibodies.	  Integrative	  Biology,	  5,	  87.	  
MOCK,	  W.	   L.,	   IRRA,	   T.	   A.,	   WEPSIEC,	   J.	   P.	   &	   ADHYA,	   M.	   1989.	   Catalysis	   by	   Cucurbituril.	   The	  
Significance	  of	  Bound-­‐Substrate	  Destabilization	  for	  Induced	  Triazole	  Formation.	  J.	  Org.	  
Chem.,	  54,	  5302-­‐5308.	  
MOCK,	  W.	  L.,	  IRRA,	  T.	  A.,	  WEPSIEC,	  J.	  P.	  &	  MANIMARAN,	  T.	  L.	  1983.	  Cycloaddition	  Induced	  by	  
Cucurbituril	   -­‐	   a	   Case	   of	   Pauling	   Principle	   Catalysis.	   Journal	   of	  Organic	   Chemistry,	   48,	  
3619-­‐3620.	  
MOOTZ,	  H.	  D.	  2009.	  Split	   Inteins	  as	  Versatile	  Tools	   for	  Protein	  Semisynthesis.	  ChemBioChem,	  
10,	  2579-­‐2589.	  
MUIR,	   T.	   W.	   2003.	   Semisynthesis	   Ofproteins	   Byexpressedproteinligation.	   Annual	   Review	   of	  
Biochemistry,	  72,	  249-­‐289.	  
MUIR,	  T.	  W.,	  SONDHI,	  D.	  &	  COLE,	  P.	  A.	  1998.	  Expressed	  protein	  ligation:	  A	  general	  method	  for	  
protein	   engineering.	  Proceedings	   of	   the	  National	   Academy	   of	   Sciences	   of	   the	  United	  
States	  of	  America,	  95,	  6705-­‐6710.	  
MÜLLER,	  J.	  &	  JOHNSSON,	  N.	  2008.	  Split-­‐Ubiquitin	  and	  the	  Split-­‐Protein	  Sensors:	  Chessman	  for	  
the	  Endgame.	  ChemBioChem,	  9,	  2029-­‐2038.	  
MURALIDHARAN,	   V.	   &	   MUIR,	   T.	   W.	   2006.	   Protein	   ligation:	   an	   enabling	   technology	   for	   the	  
biophysical	  analysis	  of	  proteins.	  Nature	  Methods,	  3,	  429-­‐438.	  
MURPHY,	  N.	  G.,	  VARNEY,	  S.	  M.,	  TALLON,	   J.	  M.,	  THOMPSON,	   J.	  R.	  &	  BLANC,	  P.	  D.	  2009.	  Fatal	  
occupational	  exposure	  to	  trimethylsilyl-­‐diazomethane.	  Clinical	  Toxicology,	  47,	  712.	  
NENASHEVA,	  T.	  A.,	  MASHANOV,	  G.	  I.,	  PECKHAM,	  M.	  &	  MOLLOY,	  J.	  E.	  2011.	  Imaging	  Individual	  
Myosin	  Molecules	  Within	  Living	  Cells.	  778,	  123-­‐142.	  
NICOLAS,	   E.,	   PEDROSO,	   E.	  &	  GIRALT,	   E.	   1989.	   Formation	   of	   Aspartimide	   Peptides	   in	   Asp-­‐Gly	  
Sequences.	  Tetrahedron	  Letters,	  30,	  497-­‐500.	  
NONAKA,	  H.,	   FUJISHIMA,	  S.-­‐H.,	  UCHINOMIYA,	  S.-­‐H.,	  OJIDA,	  A.	  &	  HAMACHI,	   I.	  2009.	  FLAG-­‐tag	  
selective	   covalent	   protein	   labeling	   via	   a	   binding-­‐induced	   acyl-­‐transfer	   reaction.	  
Bioorganic	  &	  Medicinal	  Chemistry	  Letters,	  19,	  6696-­‐6699.	  
NONAKA,	   H.,	   FUJISHIMA,	   S.,	   UCHINOMIYA,	   S.,	   OJIDA,	   A.	   &	   HAMACHI,	   I.	   2010.	   Selective	  
Covalent	   Labeling	   of	   Tag-­‐Fused	   GPCR	   Proteins	   on	   Live	   Cell	   Surface	   with	   a	   Synthetic	  
Probe	   for	   Their	   Functional	   Analysis.	   Journal	   of	   the	   American	   Chemical	   Society,	   132,	  
9301-­‐9309.	  
OFFER,	   J.,	  QUIBELL,	  M.	  &	  JOHNSON,	  T.	  1996.	  On-­‐resin	  solid-­‐phase	  synthesis	  of	  asparagine	  N-­‐
linked	  glycopeptides:	  Use	  of	  N-­‐(2-­‐acetoxy-­‐4-­‐methoxybenzyl)	   (AcHmb)	  aspartyl	  amide-­‐
bond	  protection	  to	  prevent	  unwanted	  aspartimide	  formation.	  Journal	  of	  the	  Chemical	  
Society-­‐Perkin	  Transactions	  1,	  175-­‐182.	  
PAULING,	   L.	   &	   COREY,	   R.	   B.	   1953.	   Compound	   helical	   configurations	   of	   polypeptide	   chains:	  
structure	  of	  proteins	  of	  the	  alpha-­‐keratin	  type.	  Nature,	  171,	  59-­‐61.	  
PAULUS,	  H.	  2000.	  Protein	  splicing	  and	  related	  forms	  of	  protein	  autoprocessing.	  FEBS	  Lett.,	  69,	  
447-­‐496.	  
POTTS,	  J.	  T.,	  BERGER,	  A.,	  COOKE,	  J.	  &	  ANFINSEN,	  C.	  B.	  1962.	  A	  reinvestigation	  of	  the	  sequence	  
of	  residues	  11	  to	  18	  in	  bovine	  pancreatic	  ribonuclease.	  Journal	  of	  Biological	  Chemistry,	  
237,	  1851-­‐5.	  
POTTS,	  J.	  T.,	  JR.,	  YOUNG,	  D.	  M.	  &	  ANFINSEN,	  C.	  B.	  1963.	  Reconstitution	  of	  fully	  active	  RNase	  S	  
by	  carboxypeptidase-­‐degraded	  RNase	  S-­‐peptide.	   Journal	  of	  Biological	  Chemistry,	  238,	  
2593-­‐4.	  
PRESCHER,	  J.	  A.	  &	  BERTOZZI,	  C.	  R.	  2005.	  Chemistry	  in	  Living	  Systems.	  Nature	  Chemical	  Biology,	  
1,	  13-­‐21.	  
PROUDFOOT,	   A.	   E.	   I.,	   ROSE,	   K.	   &	   WALLACE,	   C.	   J.	   A.	   1989.	   Conformation-­‐Directed	  
Recombination	  of	  Enzyme-­‐Activated	  Peptide-­‐Fragments	  -­‐	  a	  Simple	  and	  Efficient	  Means	  
194	  
	  
to	  Protein	  Engineering	  -­‐	  Its	  Use	  in	  the	  Creation	  of	  Cytochrome-­‐C	  Analogs	  for	  Structure-­‐
Function	  Studies.	  Journal	  of	  Biological	  Chemistry,	  264,	  8764-­‐8770.	  
QUIBELL,	   M.,	   OWEN,	   D.,	   PACKMAN,	   L.	   C.	   &	   JOHNSON,	   T.	   1994.	   Suppression	   of	   Piperidine-­‐
Mediated	  Side	  Product	  Formation	   for	  Asp(Obu(T))-­‐Containing	  Peptides	  by	   the	  Use	  of	  
N-­‐(2-­‐Hydroxy-­‐4-­‐Methoxybenzyl)	   (Hmb)	   Backbone	   Amide	   Protection.	   Journal	   of	   the	  
Chemical	  Society-­‐Chemical	  Communications,	  2343-­‐2344.	  
RAINES,	   R.	   T.,	  MCCORMICK,	  M.,	   VAN	  OOSBREE,	   T.	   R.	  &	  MIERENDORF,	   R.	   C.	   2000.	   The	   S.Tag	  
fusion	  system	  for	  protein	  purification.	  Methods	  Enzymol,	  326,	  362-­‐76.	  
RICHARDS,	  F.	  M.	  1958.	  On	  the	  Enzymic	  Activity	  of	  Subtilisin-­‐Modified	  Ribonuclease.	  Proc	  Natl	  
Acad	  Sci	  U	  S	  A,	  44,	  162-­‐6.	  
RICHARDS,	  F.	  M.	  &	  VITHAYATHIL,	  P.	  J.	  1959.	  The	  preparation	  of	  subtilisn-­‐modified	  ribonuclease	  
and	   the	   separation	   of	   the	   peptide	   and	   protein	   components.	   Journal	   of	   Biological	  
Chemistry,	  234,	  1459-­‐65.	  
ROSTOVTSEV,	  V.	  V.,	  GREEN,	  L.	  G.,	  FOKIN,	  V.	  V.	  &	  SHARPLESS,	  K.	  B.	  2002.	  A	  stepwise	  Huisgen	  
cycloaddition	   process:	   Copper(I)-­‐catalyzed	   regioselective	   "ligation"	   of	   azides	   and	  
terminal	  alkynes.	  Angewandte	  Chemie-­‐International	  Edition,	  41,	  2596-­‐+.	  
RUDINGER,	  J.	  1963.	  Organic	  chemistry	  in	  peptide	  synthesis.	  Pure	  Appl.	  Chem.,	  7.	  
RYADNOV,	   M.	   G.	   &	   WOOLFSON,	   D.	   N.	   2007.	   Self-­‐assembled	   templates	   for	   polypeptide	  
synthesis.	  Journal	  of	  the	  American	  Chemical	  Society,	  129,	  14074-­‐14081.	  
SAGLE,	   L.	  B.,	  ZIMMERMANN,	   J.,	  DAWSON,	  P.	  E.	  &	  ROMESBERG,	  F.	  E.	  2004.	  A	  high-­‐resolution	  
probe	  of	  protein	  folding.	  Journal	  of	  the	  American	  Chemical	  Society,	  126,	  3384-­‐3385.	  
SAGLE,	   L.	   B.,	   ZIMMERMANN,	   J.,	   MATSUDA,	   S.,	   DAWSON,	   P.	   E.	   &	   ROMESBERG,	   F.	   E.	   2006.	  
Redox-­‐coupled	   dynamics	   and	   folding	   in	   cytochrome	   c.	   Journal	   of	   the	   American	  
Chemical	  Society,	  128,	  7909-­‐7915.	  
SANCHEZ-­‐RUIZ,	   J.	  M.,	   RAO,	   T.,	   RUIZ-­‐GÓMEZ,	   G.,	   HILL,	   T.	   A.,	   HOANG,	   H.	   N.,	   FAIRLIE,	   D.	   P.	   &	  
MASON,	  J.	  M.	  2013.	  Truncated	  and	  Helix-­‐Constrained	  Peptides	  with	  High	  Affinity	  and	  
Specificity	  for	  the	  cFos	  Coiled-­‐Coil	  of	  AP-­‐1.	  PLoS	  ONE,	  8,	  e59415.	  
SANTORO,	  J.,	  GONZALEZ,	  C.,	  BRUIX,	  M.,	  NEIRA,	  J.	  L.,	  NIETO,	  J.	  L.,	  HERRANZ,	  J.	  &	  RICO,	  M.	  1993.	  
High-­‐resolution	   three-­‐dimensional	   structure	   of	   ribonuclease	   A	   in	   solution	   by	   nuclear	  
magnetic	  resonance	  spectroscopy.	  Journal	  of	  Molecular	  Biology,	  229,	  722-­‐34.	  
SAXON,	   E.	   2000.	   Cell	   Surface	   Engineering	   by	   a	   Modified	   Staudinger	   Reaction.	   Science,	   287,	  
2007-­‐2010.	  
SCHROEDER,	  W.	  A.,	  SHELTON,	  J.	  B.	  &	  SHELTON,	  J.	  R.	  1969.	  An	  examination	  of	  conditions	  for	  the	  
cleavage	   of	   polypeptide	   chains	   with	   cyanogen	   bromide:	   application	   to	   catalase.	  
Archives	  of	  Biochemistry	  and	  Biophysics,	  130,	  551-­‐6.	  
SCOTT,	  C.	  P.,	  ABEL-­‐SANTOS,	  E.,	  WALL,	  M.,	  WAHNON,	  D.	  C.	  &	  BENKOVIC,	  S.	  J.	  1999.	  Production	  
of	   cyclic	   peptides	   and	   proteins	   in	   vivo.	   Proceedings	   of	   the	   National	   Academy	   of	  
Sciences	  of	  the	  United	  States	  of	  America,	  96,	  13638-­‐13643.	  
SELA,	  M.,	  WHITE,	  F.	  H.,	  JR.	  &	  ANFINSEN,	  C.	  B.	  1957.	  Reductive	  cleavage	  of	  disulfide	  bridges	  in	  
ribonuclease.	  Science,	  125,	  691-­‐2.	  
SEVERIN,	   K.,	   LEE,	   D.	   H.,	   KENNAN,	   A.	   J.	   &	   GHADIRI,	   M.	   R.	   1997.	   A	   synthetic	   peptide	   ligase.	  
Nature,	  389,	  706-­‐9.	  
SEVERINOV,	  K.	  &	  MUIR,	  T.	  W.	  1998.	  Expressed	  protein	   ligation,	  a	  novel	  method	   for	   studying	  
protein-­‐protein	   interactions	   in	   transcription.	   Journal	   of	   Biological	   Chemistry,	   273,	  
16205-­‐16209.	  
SHAH,	  N.	  H.	  &	  MUIR,	  T.	  W.	  2014.	  Inteins:	  nature's	  gift	  to	  protein	  chemists.	  Chemical	  Science,	  5,	  
446.	  
SHI,	  J.	  X.	  &	  MUIR,	  T.	  W.	  2005.	  Development	  of	  a	  tandem	  protein	  trans-­‐splicing	  system	  based	  on	  
native	   and	   engineered	   split	   inteins.	   Journal	   of	   the	   American	   Chemical	   Society,	   127,	  
6198-­‐6206.	  
195	  
	  
SHOEMAKER,	   K.	   R.,	   FAIRMAN,	   R.,	   KIM,	   P.	   S.,	   YORK,	   E.	   J.,	   STEWART,	  M.	   J.	   &	   BALDWIN,	   R.	   L.	  
1987.	  The	  C-­‐peptide	  helix	   from	  ribonuclease	  A	  considered	  as	  an	  autonomous	   folding	  
unit.	  Cold	  Spring	  Harb	  Symp	  Quant	  Biol.	  ,	  52,	  391-­‐398.	  
SIMMONDS,	  R.	  G.	  1996.	  Use	  of	  the	  Hmb	  backbone-­‐protecting	  group	  in	  the	  synthesis	  of	  difficult	  
sequences.	  International	  Journal	  of	  Peptide	  and	  Protein	  Research,	  47,	  36-­‐41.	  
SMITH,	  V.	  F.	  &	  MATTHEWS,	  C.	  R.	  2001.	  Testing	  the	  role	  of	  chain	  connectivity	  on	  the	  stability	  
and	  structure	  of	  dihydrofolate	  reductase	  from	  E-­‐coli:	  Fragment	  complementation	  and	  
circular	  permutation	  reveal	  stable,	  alternatively	  folded	  forms.	  Protein	  Science,	  10,	  116-­‐
128.	  
SONG,	  H.	  &	  ISMAGILOV,	  R.	  F.	  2003.	  Millisecond	  kinetics	  on	  a	  microfluidic	  chip	  using	  nanoliters	  
of	  reagents.	  Journal	  of	  the	  American	  Chemical	  Society,	  125,	  14613-­‐14619.	  
STAGLJAR,	  I.,	  KOROSTENSKY,	  C.,	  JOHNSSON,	  N.	  &	  TE	  HEESEN,	  S.	  1998.	  A	  genetic	  system	  based	  
on	  split-­‐ubiquitin	  for	  the	  analysis	  of	  interactions	  between	  membrane	  proteins	  in	  vivo.	  
Proceedings	  of	  the	  National	  Academy	  of	  Sciences	  of	  the	  United	  States	  of	  America,	  95,	  
5187-­‐5192.	  
SUZUKI,	  T.,	  OTA,	  Y.,	  KASUYA,	  Y.,	  MUTSUGA,	  M.,	  KAWAMURA,	  Y.,	  TSUMOTO,	  H.,	  NAKAGAWA,	  
H.,	   FINN,	  M.	   G.	   &	  MIYATA,	   N.	   2010.	   An	   Unexpected	   Example	   of	   Protein-­‐Templated	  
Click	  Chemistry.	  Angewandte	  Chemie	  International	  Edition,	  49,	  6817-­‐6820.	  
SVENDSEN,	  I.,	  JONASSEN,	  I.,	  HEJGAARD,	  J.	  &	  BOISEN,	  S.	  1980.	  Amino-­‐Acid-­‐Sequence	  Homology	  
between	   a	   Serine	   Protease	   Inhibitor	   from	   Barley	   and	   Potato	   Inhibitor-­‐1.	   Carlsberg	  
Research	  Communications,	  45,	  389-­‐395.	  
SVENSSON,	   L.	   A.,	   THULIN,	   E.	   &	   FORSEN,	   S.	   1992.	   Proline	   Cis-­‐Trans	   Isomers	   in	   Calbindin	   D9k	  
Observed	  by	  X-­‐Ray	  Crystallography.	  Journal	  of	  Molecular	  Biology,	  223,	  601-­‐606.	  
TANAKA,	  K.,	  SHIROTSUKI,	  S.,	  IWATA,	  T.,	  KAGEYAMA,	  C.,	  TAHARA,	  T.,	  NOZAKI,	  S.,	  SIWU,	  E.	  R.	  O.,	  
TAMURA,	  S.,	  DOUKE,	  S.,	  MURAKAMI,	  N.,	  ONOE,	  H.,	  WATANABE,	  Y.	  &	  FUKASE,	  K.	  2012.	  
Template-­‐Assisted	  and	  Self-­‐Activating	  Clicked	  Peptide	  as	  a	  Synthetic	  Mimic	  of	  the	  SH2	  
Domain.	  Acs	  Chemical	  Biology,	  7,	  637-­‐645.	  
TANAKA,	  K.,	  WAKI,	  H.,	  IDO,	  Y.,	  AKITA,	  S.,	  YOSHIDA,	  Y.	  &	  YOSHIDA,	  T.	  1988.	  Protein	  and	  Polymer	  
Analyses	   up	   to	   mlz	   100	   000	   by	   Laser	   Ionization	   Time-­‐of-­‐flight	   Mass	   Spectrometry.	  
Rapid	  communications	  in	  mass	  spectrometry,	  2,	  151-­‐153.	  
THOMAS,	  C.	  L.	  &	  MAULE,	  A.	  J.	  2000.	  Limitations	  on	  the	  use	  of	  fused	  green	  fluorescent	  protein	  
to	   investigate	   structure-­‐function	   relationships	   for	   the	   cauliflower	   mosaic	   virus	  
movement	  protein.	  Journal	  of	  General	  Virology,	  81,	  1851-­‐1855.	  
THOMAS,	  F.,	  BOYLE,	  A.	  L.,	  BURTON,	  A.	  J.	  &	  WOOLFSON,	  D.	  N.	  2013.	  A	  Set	  ofde	  NovoDesigned	  
Parallel	   Heterodimeric	   Coiled	   Coils	   with	   Quantified	   Dissociation	   Constants	   in	   the	  
Micromolar	  to	  Sub-­‐nanomolar	  Regime.	  Journal	  of	  the	  American	  Chemical	  Society,	  135,	  
5161-­‐5166.	  
TORNOE,	  C.	  W.,	  CHRISTENSEN,	  C.	  &	  MELDAL,	  M.	  2002.	  Peptidotriazoles	  on	  solid	  phase:	  [1,2,3]-­‐
triazoles	   by	   regiospecific	   copper(I)-­‐catalyzed	   1,3-­‐dipolar	   cycloadditions	   of	   terminal	  
alkynes	  to	  azides.	  Journal	  of	  Organic	  Chemistry,	  67,	  3057-­‐3064.	  
TSIEN,	  R.	  Y.	  1998.	  The	  green	  fluorescent	  protein.	  Annual	  Review	  of	  Biochemistry,	  67,	  509-­‐544.	  
TSUKIJI,	   S.	   &	   NAGAMUNE,	   T.	   2009.	   Sortase-­‐Mediated	   Ligation:	   A	   Gift	   from	   Gram-­‐Positive	  
Bacteria	  to	  Protein	  Engineering.	  ChemBioChem,	  10,	  787-­‐798.	  
VENYAMINOV,	   S.	  U.,	   BAIKALOV,	   I.	   A.,	   SHEN,	   Z.	  M.,	  WU,	  C.-­‐S.	  H.	  &	  YANG,	   J.	   T.	   1993.	   Circular	  
dichroic	   analysis	   of	   denatured	   proteins:	   inclusion	   of	   denatures	   proteins	   in	   the	  
reference	  set.	  Analytical	  Biochemistry,	  214,	  17-­‐24.	  
VILLAIN,	   M.,	   GAERTNER,	   H.	   &	   BOTTI,	   P.	   2003.	   Native	   Chemical	   Ligation	   with	   Aspartic	   and	  
Glutamic	   Acids	   asC-­‐Terminal	   Residues:	   Scope	   and	   Limitations.	   European	   Journal	   of	  
Organic	  Chemistry,	  2003,	  3267-­‐3272.	  
WALLACE,	  C.	   J.	  A.,	  CORRADIN,	  G.,	  MARCHIORI,	  F.	  &	  BORIN,	  G.	  1986.	  Cytochrome-­‐C	  Chimerae	  
from	   Natural	   and	   Synthetic	   Fragments	   -­‐	   Significance	   of	   the	   Biological	   Properties.	  
Biopolymers,	  25,	  2121-­‐2132.	  
196	  
	  
WALLACE,	   C.	   J.	   A.	   &	   PROUDFOOT,	   A.	   E.	   I.	   1987.	   On	   the	   Relationship	   between	   Oxidation	  
Reduction	  Potential	   and	  Biological-­‐Activity	   in	  Cytochrome-­‐C	  Analogs	   -­‐	  Results	   from	  4	  
Novel	  2-­‐Fragment	  Complexes.	  Biochemical	  Journal,	  245,	  773-­‐779.	  
WANG,	   J.,	   YU,	   Y.	   &	   XIA,	   J.	   2014.	   Short	   Peptide	   Tag	   for	   Covalent	   Protein	   Labeling	   Based	   on	  
Coiled	  Coils.	  Bioconjugate	  Chemistry,	  25,	  178-­‐187.	  
WASSERMAN,	  R.	  H.,	  CHANDLER,	  J.	  S.,	  MEYER,	  S.	  A.,	  SMITH,	  C.	  A.,	  BRINDAK,	  M.	  E.,	  FULLMER,	  C.	  
S.,	   PENNISTON,	   J.	   T.	   &	   KUMAR,	   R.	   1992.	   Intestinal	   Calcium-­‐Transport	   and	   Calcium	  
Extrusion	  Processes	  at	  the	  Basolateral	  Membrane.	  Journal	  of	  Nutrition,	  122,	  662-­‐671.	  
WAY,	  J.	  C.	  2000.	  Covalent	  modification	  as	  a	  strategy	  to	  block	  protein-­‐protein	  interactions	  with	  
small-­‐molecule	  drugs.	  Current	  Opinion	  in	  Chemical	  Biology,	  4,	  40-­‐46.	  
WEHR,	   M.	   C.,	   LAAGE,	   R.,	   BOLZ,	   U.,	   FISCHER,	   T.	   M.,	   GRÜNEWALD,	   S.,	   SCHEEK,	   S.,	   BACH,	   A.,	  
NAVE,	  K.-­‐A.	  &	  ROSSNER,	  M.	  J.	  2006.	  Monitoring	  regulated	  protein-­‐protein	  interactions	  
using	  split	  TEV.	  Nature	  Methods,	  3,	  985-­‐993.	  
WOHR,	   T.	   &	   MUTTER,	   M.	   1995.	   Pseudo-­‐Prolines	   in	   Peptide-­‐Synthesis	   -­‐	   Direct	   Insertion	   of	  
Serine	   and	   Threonine	   Derived	   Oxazolidines	   in	   Dipeptides.	   Tetrahedron	   Letters,	   36,	  
3847-­‐3848.	  
WOMBACHER,	  R.	  &	  CORNISH,	  V.	  W.	  2011.	  Chemical	  tags:	  Applications	  in	  live	  cell	  fluorescence	  
imaging.	  Journal	  of	  Biophotonics,	  4,	  391-­‐402.	  
WOODFIN,	   B.	  M.	  &	  MASSEY,	   V.	   1968.	   Spectrophotometric	   determination	   of	   the	   dissociation	  
constant	  of	  ribonuclease	  S'.	  Journal	  of	  Biological	  Chemistry,	  243,	  889-­‐92.	  
WU,	  H.,	  HU,	  Z.	  M.	  &	  LIU,	  X.	  Q.	  1998.	  Protein	  trans-­‐splicing	  by	  a	  split	   intein	  encoded	  in	  a	  split	  
DnaE	   gene	   of	   Synechocystis	   sp.	   PCC6803.	   Proceedings	   of	   the	   National	   Academy	   of	  
Sciences	  of	  the	  United	  States	  of	  America,	  95,	  9226-­‐9231.	  
XUE,	  W.-­‐F.,	  CAREY,	   J.	  &	  LINSE,	  S.	  2004.	  Multi-­‐method	  global	  analysis	  of	   thermodynamics	  and	  
kinetics	  in	  reconstitution	  of	  monellin.	  Proteins:	  Structure,	  Function,	  and	  Bioinformatics,	  
57,	  586-­‐595.	  
YAMAMURA,	   Y.,	   HIRAKAWA,	   H.,	   YAMAGUCHI,	   S.	   &	   NAGAMUNE,	   T.	   2011.	   Enhancement	   of	  
sortase	   A-­‐mediated	   protein	   ligation	   by	   inducing	   a	   β-­‐hairpin	   structure	   around	   the	  
ligation	  site.	  Chemical	  Communications,	  47,	  4742.	  
YAO,	   S.,	   GHOSH,	   I.,	   ZUTSHI,	   R.	   &	   CHMIELEWSKI,	   J.	   1997.	   A	   pH-­‐modulated,	   self-­‐replicating	  
peptide.	  Journal	  of	  the	  American	  Chemical	  Society,	  119,	  10559-­‐10560.	  
YI,	  L.,	  SUN,	  H.,	  ITZEN,	  A.,	  TRIOLA,	  G.,	  WALDMANN,	  H.,	  GOODY,	  R.	  S.	  &	  WU,	  Y.-­‐W.	  2011.	  One-­‐Pot	  
Dual-­‐Labeling	   of	   a	   Protein	   by	   Two	   Chemoselective	   Reactions.	   Angewandte	   Chemie	  
International	  Edition,	  50,	  8287-­‐8290.	  
ZAKERI,	   B.,	   FIERER,	   J.	   O.,	   CELIK,	   E.,	   CHITTOCK,	   E.	   C.,	   SCHWARZ-­‐LINEK,	   U.,	   MOY,	   V.	   T.	   &	  
HOWARTH,	  M.	  2012.	  Peptide	  tag	  forming	  a	  rapid	  covalent	  bond	  to	  a	  protein,	  through	  
engineering	   a	   bacterial	   adhesin.	  Proceedings	   of	   the	  National	  Academy	  of	   Sciences	   of	  
the	  United	  States	  of	  America,	  109,	  E690-­‐E697.	  
 
